UPS und DOWNS bei den AMI-Werten!

[actr]

Identix Incorporated
12.01.06 20:19 Uhr

7,13 USD

+23,36 % [+1,35]

http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=IDNX.NAS&lColors=0x000000&sSym=IDNX.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=IDNX.NAS&lColors=0x000000&sSym=IDNX.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=IDNX.NAS&lColors=0x000000&sSym=IDNX.NAS&hcmask=

Börse
NASDAQ

Aktuell
7,13 USD

Zeit
12.01.06 20:19

Diff. Vortag
+23,36 %

Tages-Vol.
131,39 Mio.

Gehandelte Stück
20 Mio.

Viisage and Identix to Merge to Create Biometric Identity Solution Leader

BILLERICA, Mass. & MINNETONKA, Minn., Jan 12, 2006 (BUSINESS WIRE) -- Viisage Technology, Inc. (Nasdaq: VISGD) and Identix Incorporated (Nasdaq: IDNX):
-- Establishes the Industry's Most Comprehensive Multi-Modal Biometric Platform for Securing and Protecting Personal Identities

-- Management Team to be Led by Robert V. LaPenta as Chairman and Chief Executive Officer

-- Combined Pro Forma Calendar 2006 Estimated Revenue of $220 Million and EBITDA of at Least $40 Million

Identity solutions provider Viisage Technology, Inc. (Nasdaq: VISGD) and biometric technology innovator Identix Incorporated (Nasdaq: IDNX) today announced they have entered into a definitive agreement to merge in an all stock transaction. The combined company will blend two complementary approaches to solving the challenge of protecting and securing personal identities by establishing the industry's most comprehensive single platform for multi-modal finger, face, skin and imaging identity solutions. The combination has been approved by the respective boards of directors of each company.

The combined company, on a pro forma calendar 2006 basis, is expected to have revenue of approximately $220 million and EBITDA of at least $40 million, including synergies and operating efficiencies.

Under the terms of the transaction, Identix shareholders will receive a fixed exchange ratio of 0.473 newly issued shares of Viisage stock for each share of Identix stock. The transaction is expected to be tax-free to shareholders of both companies for U.S. federal income tax purposes. Based on Viisage's closing stock price of $17.69 on January 11, 2006, the transaction is valued at approximately $770 million on a fully diluted basis.

Upon completion of the transaction, current Identix shareholders will own approximately 59 percent of the combined company and current Viisage shareholders will own approximately 41 percent of the combined company. The combined company's board of directors will consist of 12 directors, with seven of the members designated by Viisage and affiliates and five designated by Identix. The headquarters of the combined company will be in Stamford, Connecticut. In addition, certain affiliates of both Viisage and Identix have agreed to vote their shares in favor of the merger.

Following the close of the transaction, the company expects to evaluate alternatives for repurchasing outstanding shares, including the potential issuance of convertible debt.

"The combination of Identix' advanced multi-biometric search technology with Viisage's expertise in secure credentials, document authentication and verification will create a global leader in biometric security, providing end-to-end identity solutions for state, local, national and foreign government use, as well as a wide application across the commercial sector," said Robert V. LaPenta, Chairman of the Board of Viisage. "With its proven technology, strength of management and services, and marquee customer base, the combined entity has the ability to achieve significant revenue growth and profitability."

Upon completion of the merger, Mr. LaPenta, Viisage's Chairman, will become Chairman and Chief Executive Officer of the combined company. Mr. LaPenta is the Chairman, CEO and founder of L-1 Investment Partners, Chairman of the Board of Viisage, and former President, Chief Financial Officer and co-founder of L-3 Communications. Dr. Joseph J. Atick, currently Chief Executive Officer of Identix, will become Vice Chairman of the combined company's Board of Directors and Chief Strategic Officer.

"This is a fantastic opportunity for the new company's shareholders, employees and customers and will create a formidable combination in the identity solution / management and biometrics sector," said Dr. Joseph J. Atick, CEO of Identix.

Unlocking the Potential of Strong Synergies

Driven by a combined global sales force, the merger unlocks the potential of both organization's strengths in biometrics, credentialing and imaging solutions and offers many natural synergies. For example, Viisage and Identix each have current customer relationships today with the Department of State, with Identix providing biometric facial recognition products for the U.S. VISA program and Viisage acting as the sole source provider for U.S. passports.

The combined technologies are uniquely suited to support multiple identity programs including visa and passport issuance, border control and security, voting program integrity, secure logical access for enterprise and government, and the myriad of government-related access card requirements. In addition, the new company also can successfully meet rigorous government mandates including HSPD12, TWIC, WHTI, US- VISIT, Registered Traveler, HAZMAT, Real ID and ePassport, among others.

The merger positions the new company as a market leader in the biometrics sector. The combined capabilities allow the new company to effectively compete for approximately 80 percent of a market opportunity projected by Frost & Sullivan to reach $3.5 billion by 2008*.

The transaction is expected to close in the second calendar quarter of 2006 and is subject to customary regulatory approvals and other closing conditions, including approval by Viisage and Identix shareholders at their respective stockholder meetings.

Bear, Stearns & Co. Inc. is serving as financial advisor to Viisage, while USBX Advisory Services LLC provided a fairness opinion to the Viisage Board. Janney Montgomery Scott LLC is serving as financial advisor to Identix and has provided a fairness opinion to the Identix Board.

[actr]

Ultralife Batteries, Inc.
12.01.06 21:51 Uhr

12,91 USD

+24,02 % [+2,50]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=ULBI.NAS&lColors=0x000000&sSym=ULBI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=ULBI.NAS&lColors=0x000000&sSym=ULBI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=ULBI.NAS&lColors=0x000000&sSym=ULBI.NAS&hcmask=

Börse
NASDAQ

Aktuell
12,93 USD

Zeit
12.01.06 21:52

Diff. Vortag
+24,21 %

Tages-Vol.
16,67 Mio.

Gehandelte Stück
1,4 Mio.


Ultralife Batteries Receives $1.4 Million Production Order from General Dynamics for Land Warrior Batteries and Chargers

NEWARK, N.Y., Jan 12, 2006 (BUSINESS WIRE) -- Ultralife Batteries, Inc. (NASDAQ: ULBI) has received a battery and charger production order from General Dynamics C4 Systems valued at approximately $1.4 million. The contract is for lithium ion rechargeable batteries as well as vehicle, bulk and individual Soldier-based chargers, part of the equipment being delivered to General Dynamics for use in a Stryker battalion operational assessment.
Land Warrior is an integrated, modular fighting system that uses technology to enhance individual soldiers' close-combat tactical awareness, lethality and survivability. The system includes weapon-mounted sensors, an integrated helmet assembly, a communications-navigation computer system and software for friendly-force tracking and command/control programs. Featuring seamless connectivity to the General Dynamics Stryker combat vehicle, the Land Warrior - Stryker Interoperable portion of the program will undergo a comprehensive operational assessment and a Limited User Test this summer.

In February 2004, Ultralife received a $2.7 million development contract from General Dynamics to design and develop the batteries and chargers to equip Land Warrior ensembles with an advanced man-portable power system. Deliveries against the new production order will begin this month and be completed by the end of March.

John D. Kavazanjian, Ultralife's president and chief executive officer said, "Our power systems engineering services capabilities, combined with our superb track record of developing and supplying industry-leading battery and charger designs demonstrates our ability to move highly-engineered products from design into production. These capabilities are proving to be a key competitive advantage for us as the demand for our products continues to grow."

The products being supplied include: Ultralife's UBBL06 (LI-145) Rechargeable battery, which is a lightweight, rugged, high-energy 16.8 volt, 9.4 Ah lithium ion rechargeable SMBus v1.1 compliant smart battery with a state-of-charge indicator; the CH0006 3-Bay Vehicle Based Charger, which is a 3-battery rugged Smart Level-3 charger mounted in different variants of the Stryker Vehicle; the CH0008 Individual Soldier Based Charger Kit, which is a rugged Smart Level-2 charger with global input voltage and frequency capability; and the CH0017 12-Bay Bulk Charger Kit, which is a 12-battery rugged Smart Level-3 charger with AC and DC power source options, having the capability for various field uses, on a vehicle or in a depot setting.

About Ultralife Batteries, Inc.

Ultralife is a global provider of high-energy power systems for diverse applications. The company develops, manufactures and markets a wide range of non-rechargeable and rechargeable batteries, charging systems and accessories for use in military, industrial and consumer portable electronic products. Through its portfolio of standard products and engineered solutions, Ultralife is at the forefront of providing the next generation of power systems. Industrial, retail and government customers include General Dynamics, Philips Medical Systems, General Motors, Energizer, Kidde Safety, Lowe's, Radio Shack and the national defense agencies of the United States, United Kingdom, Germany and Australia, among others.

Ultralife's headquarters, principal manufacturing and research facilities are in Newark, New York, near Rochester. Ultralife Batteries (UK) Ltd., a second manufacturing facility, is located in Abingdon, England. Both facilities are ISO-9001 certified. Detailed information on Ultralife is available at the Company's web site, www.ultralifebatteries.com.

[actr]

Bad Ticker

By Lawrence Carrel
January 12, 2006


--------------------------------------------------------------------------------
Apogee Technology Inc. (ATA1)

--------------------------------------------------------------------------------
Share price as of Wednesday`s close: $1.65
Share price now: $1.92
Change: 16.4%
Volume: 494,600 shares, daily average 31,500 shares
Last time this high: April 26, 2005
52-week high: $4.39
52-week low: 70 cents
Forward P/E before news: n/a
Forward P/E after news: n/a

--------------------------------------------------------------------------------

DUE DILIGENCE FOR investors ought to include finding the right ticker symbols before buying stocks.
Apogee Technology (ATA2) shares jumped another 16% to $1.92 Thursday, making the tiny sensor maker`s shares a three-day double. Not bad for a company under threat of delisting from the American Stock Exchange. Through Monday the stock had plunged 80% from the beginning of 2005 to close at 91 cents.

But buyers may not be getting what they think.

According to Streetinsider.com, a Birmingham, Mich., news analysis service that follows momentum stocks and tracks rumors, "the run-up in Apogee Technology is related to a Jim Cramer recommendation on ATS Automation Tooling Systems, which trades under the same symbol in Canada. Traders are apparently buying ATA on the Amex thinking it is the correct company, but it is not." Cramer hosts a popular CNBC stock-picking show called "Mad Money."

"Just look at the volume," says Lon Juricic, president of StreetInsider.com. "On Monday, Apogee`s volume was 2,700 shares. Then Cramer comes on and recommends the other stock and the volume surges to 733,000 on Tuesday. There`s no news, so to me it seems pretty obvious people got confused. But, it`s weird the stock keeps going up. You`d think someone, the company, Cramer or the Amex would put out a statement."

On Monday`s program, Cramer advised viewers to buy solar energy stocks, and one in particular. "I think you should buy ATS Automation Tooling Systems. That`s ATA.CN [on the Canadian Stock Exchange]," said Cramer, according to a transcript of the show. "It trades in Canada. That`s where you should buy it. I don`t want you buying the [American Depositary Receipt] on this one, because it trades on the pink sheets."

Based in Cambridge, Ontario, ATS Automation Tooling Systems makes mechanized manufacturing and test systems, as well as energy cells and modules. Solar products accounted for 18% of revenues for the year ended March 2005, according to James Bradford, an analyst with Toronto broker Blackmont Capital, who initiated coverage of the stock last week with a Buy recommendation.

"I think ATS will experience a turnaround in the core automation business," says Bradford. "Also the solar group is expected to grow stronger in terms of revenue and there`s the potential for unlocking shareholder value by spinning off the solar group."
For its fiscal second quarter ended Sept. 30 ATS posted a loss of $3.3 million Canadian dollars on revenues of C$154.5 million, compared with a year-earlier profit of C$432,000 on sales of C$180.3 million. The company blamed the loss on a sluggish U.S. automotive industry, which supplies a large part of the company`s revenues. ($1 equals 1.16 Canadian dollars.)

Shares of ATS, which closed at C$16.25 on the Toronto Stock Exchange Monday, added 3% on Tuesday. On Thursday, the stock rose to C$17.10.

Until October, Apogee had made semiconductors used in audio amplification. Now it makes pressure sensors for the automotive, consumer and medical markets with a proprietary technology it calls Micro-Electromechanical Systems, or MEMS.

For the third quarter the Norwood, Mass., company posted a net loss of $1.6 million compared with a year-earlier loss $449,000. Revenues fell 24% to $1.5 million. The company has posted just one annual profit in the past five years. As of Sept. 30 it had $812,485 in cash, down from $1.9 million at the end of 2004. In October the company sold its SigmaTel audio division, which included the amplifier technology, for $9.4 million and paid off $2.6 million in debt.

In early October, Price Target Research, an independent firm in Chicago, downgraded its rating on the stock to Unfavorable from Neutral.

"Our ratings are mainly driven by a [proprietary valuation] ratio on the potential for further appreciation," says Phillip Hofmann, senior vice president of Price Target Research. "This ratio has not been favorable for Apogee and we haven`t seen anything that would cause that assessment to be changed. Based on a quantitative view of their fundamental position, there is nothing that has happened this week to change our view."

For most of 2005 the company was under the threat of delisting from the Amex for failing to file its 2004 annual report and results for the March 2005 quarter. It filed those reports in August, but it`s unclear whether the delisting threat has been lifted. The Amex did not respond by press time.

So are investors buying Apogee in a wave of confusion? The company hasn`t released significant news since its November earnings results. Its last press release, dated Dec. 6, merely announced an exhibition of its new line of sensors.

Apogee officials couldn`t be reached for comment.

"This is a company with a lot of moving parts," says Adam Lowensteiner, managing director of Microcapreport.com, an online newsletter focusing on microcaps based in Bergenfield, N.J. "The micro-electromechanical systems is an interesting technology with multiple applications that can be used in consumer and medical markets. They are miniature pressure sensors with multiple advantages over other technologies on the market. After selling the amplifier division it has about $8 million in working capital, which should prevent it from being delisted."

Quote:
"Do they have an obligation to come out and talk about the stock price and do they actually know that this is occurring? We`re not sure," says Joe Romo, a regulatory analyst at the NASD/Amex Regulation Division. "It`s not like Apogee put out a press release. The NASD will conduct a thorough review of this situation."



http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&€cy=&&lSyms=ATA.ASE&lColors=0x000000&sSym=ATA.ASE&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&€cy=&&lSyms=ATA.ASE&lColors=0x000000&sSym=ATA.ASE&hcmask=

http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=MACD&ind2=RSI&€cy=&lSyms=ATA.ASE&lColors=0x000000&sSym=ATA.ASE&hcmask=

[actr]

DRAXIS Receives FDA Approval for Diagnostic Iodine I-131 Capsules Product will supplement existing line of products for treating thyroid cancer

MISSISSAUGA, ON, Jan 13, 2006 /PRNewswire-FirstCall via COMTEX/ -- The radiopharmaceutical business unit of DRAXIS Health Inc. (TSX: DAX) (NASDAQ: DRAX) has received approval from the U.S. Food and Drug Administration (FDA) regarding its supplemental new drug application for Sodium Iodide I-131 Capsules USP, Diagnostic - Oral.
These diagnostic sodium iodide I-131 capsules are intended to be used by physicians to perform the radioactive iodide (RAI) uptake test to evaluate thyroid function prior to treatment with stronger therapeutic doses of sodium iodide I-131. Diagnostic doses of sodium iodide I-131 may also be employed in localizing metastases associated with thyroid malignancies. The diagnostic capsules, which are supplied in a gelatin capsule for oral administration, will be produced by DRAXIMAGE, a division of DRAXIS Specialty Pharmaceuticals Inc., the Montreal-based subsidiary that serves as the operating arm of DRAXIS Health Inc.

DRAXIMAGE plans to introduce the new diagnostic capsules into the U.S. market during the first half of 2006, targeting qualified, approved nuclear physicians and/or radiopharmacists. The DRAXIMAGE sodium iodide I-131 diagnostic capsules will be supplied in several different strengths of radioactivity and DRAXIMAGE will employ a system of color-coding to allow each patient to be administered the precise dose of radioactive iodine prescribed by their physician.

The Sodium Iodide I-131 Capsules USP, Diagnostic - Oral are a further addition to the existing line of I-131 radiopharmaceutical products produced by DRAXIMAGE, including its widely used kit for the preparation of Sodium Iodide I-131 Capsules and Oral Solution for the treatment of thyroid cancer and hyperthyroidism. The FDA-approved kit product for therapeutic use was introduced to the U.S. market in 2003.

Thyroid Cancer

--------------

The thyroid gland is at the base of the throat and makes important hormones that help the body function normally. According to the website of the American Cancer Society (www.cancer.org) thyroid cancer is one of the most common endocrine cancers and is one of the few cancers for which incidence rates in the U.S. have increased over the past several years at a rate of approximately 2 percent per 100,000 people per year. They further estimate that in the year 2005 about 25,690 new cases of thyroid cancer will be diagnosed in the United States. The website states that thyroid cancer would seem to be much more common in women (approximately 75% of new cases) than in men and it mainly affects younger people, between the ages of 20 and 56. According to the same source, thyroid cancer is one of the least deadly cancers with a 5-year survival rate of nearly 97% for all cases.

About DRAXIS Health Inc.

DRAXIS Health, through its wholly owned operating subsidiary, DRAXIS Specialty Pharmaceuticals Inc., provides products in three categories. Sterile products include liquid and freeze-dried (lyophilized) injectables plus sterile ointments and creams. Non-sterile products are produced as solid oral and semi-solid dosage forms. Radiopharmaceuticals are used for both therapeutic and diagnostic molecular imaging applications. Pharmaceutical contract manufacturing services are provided through the DRAXIS Pharma division and radiopharmaceuticals are developed, produced, and sold through the DRAXIMAGE division. DRAXIS Specialty Pharmaceuticals Inc. employs over 500 staff in its Montreal facility.


http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=DRAX.NAS&lColors=0x000000&sSym=DRAX.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=DRAX.NAS&lColors=0x000000&sSym=DRAX.NAS&hcmask=

http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=DRAX.NAS&lColors=0x000000&sSym=DRAX.NAS&hcmask=

[actr]

PHAZAR CORP
13.01.06 20:37 Uhr

16,97 USD

+61,31 % [+6,45]

http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=ANTP.NAS&lColors=0x000000&sSym=ANTP.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=ANTP.NAS&lColors=0x000000&sSym=ANTP.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=ANTP.NAS&lColors=0x000000&sSym=ANTP.NAS&hcmask=

Börse
NASDAQ

Aktuell
16,96 USD

Zeit
13.01.06 20:38

Diff. Vortag
+61,22 %

Tages-Vol.
77,97 Mio.

Gehandelte Stück
5,1 Mio.

Phazar Edging Back from Fresh Extended-Hours Highs in Pre-Market

Boston, Jan 13, 2006 (MidnightTrader via COMTEX) -- Phazar (ANTP) is recently edging back from a pre-market high of 14.70, but still maintaining lofty upside momentum near 14 to 14.30.
Today's early strength above the 14 level firmly outpaces an after-hours high of 13.86 recorded Thursday night after the company posted an increase in Q2 results. It closed last night's session up 28.3% at 13.50.

Second quarter financial results announced by PHAZAR CORP

Jan 13, 2006 (M2 EQUITYBITES via COMTEX) -- PHAZAR CORP (Nasdaq: ANTP) announced on 12 January the results of operations for the quarter and six months ended 30 November 2005.
Net sales for the second quarter of 2005 were USD3.76m, as compared to USD3.29m for the corresponding quarter of 2004.

Net income for the second quarter of 2005 was USD0.69m or USD0.31 per share, as compared with net income of USD0.51m or USD0.22 per share for the corresponding period in 2004.

Net sales for the six months ended 30 November 2005 were USD6.944m, as compared with USD7.578m for the corresponding six months of 2004.

For the six months ended 30 November 2005 the company reported net income of USD1.22m or USD0.54 per share, as compared with net income of USD1.364m or USD0.61 per share for the corresponding six months of 2004.


(C)2006 M2 COMMUNICATIONS

[actr]

TYCO INTL LTD
13.01.06 21:07 Uhr

27,06 USD

-10,72 % [-3,25]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=TYC.NYS&lColors=0x000000&sSym=TYC.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=TYC.NYS&lColors=0x000000&sSym=TYC.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=TYC.NYS&lColors=0x000000&sSym=TYC.NYS&hcmask=

Börse
NYSE

Aktuell
27,0699 USD

Zeit
13.01.06 21:07

Diff. Vortag
-10,69 %

Tages-Vol.
1,85 Mrd.

Gehandelte Stück
75 Mio.


Tyco Announces Intent to Separate Into Three Publicly Traded Companies

PEMBROKE, Bermuda, Jan 13, 2006 /PRNewswire-FirstCall via COMTEX/ -- Tyco International Ltd. (NYSE: TYC; BSX: TYC) today announced that its Board of Directors has approved a plan to separate the company's current portfolio of diverse businesses into three separate, publicly traded companies - Tyco Healthcare, one of the world's leading diversified healthcare companies; Tyco Electronics, the world's largest passive electronic components manufacturer, and the combination of Tyco Fire & Security and Engineered Products & Services (TFS/TEPS), a global business with leading positions in residential and commercial security, fire protection and industrial products and services.
The company intends to accomplish the separation through tax-free stock dividends to Tyco shareholders, after which they will own 100% of the equity in three publicly traded companies. Each company will have its own independent Board of Directors and strong corporate governance standards. Tyco expects to complete the transactions during the first quarter of calendar 2007.

According to Tyco Chairman and Chief Executive Officer Ed Breen, "In the past several years, Tyco has come a long way. Our balance sheet and cash flows are strong and many legacy financial and legal issues have been resolved. We are fortunate to have a great mix of businesses with market- leading positions. After a thorough review of strategic options with our Board of Directors, we have determined that separating into three independent companies is the best approach to enable these businesses to achieve their full potential. Healthcare, Electronics and TFS/TEPS will be able to move faster and more aggressively -- and ultimately create more value for our shareholders -- by pursuing their own growth strategies as independent companies."

Tyco's Board of Directors and senior leadership have evaluated a broad range of strategic alternatives, including continuation of Tyco's current operating strategy, sales of select businesses, and separation of only one of the businesses. The company and Board concluded that separating into three businesses is the best way to position these market-leading companies for sustained growth and value creation.

Three Leading Global Companies

TYCO HEALTHCARE

With 2005 revenue of nearly $10 billion, Tyco Healthcare is one of the foremost global providers of healthcare products and services. The company is well-positioned to capitalize on the attractive dynamics of the healthcare industry and to realize more robust growth. Its product portfolio includes advanced surgical instruments and supplies, respiratory care products, contrast media and diagnostic imaging products, needles and syringes, vascular therapies, sutures and wound care products, and generic pharmaceuticals. Healthcare has more than 40,000 employees.

This proposed separation will create a leading stand-alone healthcare company, which is expected to benefit from a focused and independent healthcare culture to help attract top industry talent and strategic partners, as well as increasing access to emerging healthcare-related technologies. This business will continue to be led by current Tyco Healthcare President Rich Meelia, who will become the company's Chief Executive Officer. Chief Operating Officer Kevin Gould and Chief Financial Officer Chuck Dockendorff will also continue in their current leadership positions with the company.

TYCO ELECTRONICS

Tyco Electronics is one of the world's largest suppliers of electronic components, including connectors, switches, relays, circuit protection devices, touch screens, magnetics, resistors, wire and cable, as well as fiber-optic and wireless components and systems. Electronics has 88,000 employees worldwide.

As a $12 billion stand-alone enterprise, Tyco Electronics will be positioned to move quickly and strategically as competition requires, and will be better able to participate in ongoing electronics industry consolidation. The company's Chief Executive Officer will be Tom Lynch -- current President of Tyco's Engineered Products & Services segment -- who brings broad experience in the communications and electronics industries. Dr. Juergen Gromer, who has led Tyco Electronics since 1999, will continue as President, and will also assume additional responsibilities as Vice Chairman. Jacki Heisse will continue to serve as the company's Chief Financial Officer.

TYCO FIRE & SECURITY/ENGINEERED PRODUCTS & SERVICES

TFS/TEPS will be led by Tyco International Chairman and CEO Ed Breen as well as Tyco International's Chief Financial Officer, Chris Coughlin. TFS/TEPS is an $18 billion world leader in electronic security solutions for residential, business, and governmental customers, fire protection and sprinkler systems, and industrial valves and controls. With more than 118,000 employees, TFS/TEPS has a large, stable recurring revenue base and generates strong cash flow. Dave Robinson will continue to serve as President of Tyco Fire & Security. Naren Gursahaney will succeed Tom Lynch as President of Engineered Products & Services.

Breen added, "We believe this separation is a logical next step in Tyco's evolution and we are absolutely convinced that this is the right decision for the long-term success of our businesses, employees and shareholders."

[actr]

SULPHCO INC
13.01.06 21:24 Uhr

16,60 USD

+10,67 % [+1,60]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=

http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=

http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=

Börse
AMEX

Aktuell
16,60 USD

Zeit
13.01.06 21:24

Diff. Vortag
+10,67 %

Tages-Vol.
32,28 Mio.

Gehandelte Stück
2 Mio.

SulphCo Expands Management Team

Jan 11, 2006 (financialwire.net via COMTEX) -- January 11, 2006 (FinancialWire) SulphCo Inc. (AMEX: SUF), whose rivals include NATCO Group Inc (NYSE: NTG), has expanded its management team with the appointment of Michael Applegate as chief operating officer, responsible for overseeing day-to-day operations at the company.
Peter Gunnerman, who held the title of COO, continues as president of the company, focusing on strategy, implementation of the company's recently announced ventures and on the commercialization of SulphCo's ultrasound desulfurization process worldwide.

Applegate spent the majority of his career at Applegate Drayage Co., a tractor-trailer fleet operator in California, Nevada and Utah. The company employed more than 100 drivers, dock workers, mechanics and administrative staff. Applegate served as president, a position he held since 1988. Applegate has served as both president and chairman of the board of the California Trucking Association, the largest state trucking association in the United States. He also served on the board of the Nevada Motor Transportation Association.

"Mike has extensive management experience, which will prove valuable to our company," said Rudolf Gunnerman, SulphCo chief executive officer. "Expanding SulphCo's senior management team is an important priority for the company which we intend to address in 2006

[actr]

Phazar Locked on Stun

By Lawrence Carrel
January 13, 2006


--------------------------------------------------------------------------------
Phazar Corp. (ANTP1)

--------------------------------------------------------------------------------
Share price as of Thursday's close: $10.52
Share price now: $16.09
Change: 53.0%
Volume: 6.0 million shares, daily average 148,300 shares
Last time this high: Oct. 3, 2005
52-week high: $34.00
52-week low: $8.63
Forward P/E before announcement: n/a
Forward P/E after announcement: n/a

--------------------------------------------------------------------------------

AN ANTENNA MAKER'S earnings announcement got quite a reception.
Shares of Phazar (ANTP2) soared 53% to $16.09 Friday after the Fort Worth, Texas, company reported a 38% surge in fiscal second-quarter profits. Fueling the results were a pair of $2 million wireless communications contracts completed during the quarter for BAE Systems, Europe's largest defense contractor and Phazar's primary customer.

"Phazar is in a very good space in a very good industry, delivering the infrastructure for the wireless industry," says Michael Voellinger, vice president of wireless services for Telwares, a Pleasanton, Calif., consultant to the industry. "There are a lot of players involved and a lot of intelligent money is being invested in this space. It all boils down to wireless, from Bluetooth to WiMax to Mobile-Fi."

For its fiscal second quarter ended Nov. 30, Phazar posted late Thursday a profit of $698,773, or 31 cents a share, up from $504,753, or 22 cents, a year earlier. Operating income leapt 55% to $1.0 million as revenues climbed 14% to $3.8 million.

Phazar makes and installs antenna systems, towers and communication accessories. Most of the company's sales come from the U.S. government and its military contractors, such as BAE Systems. Formerly called British Aerospace, BAE is one of the Pentagon's top 10 suppliers, and contributed two-thirds of Phazar's sales for the six months ended Nov. 30, up from 53% of total sales for the fiscal year ended May 2005. Canada's Department of National Defence is Phazar's second-largest customer at 11% of total revenues. The U.S. government's direct purchases comprise 8% of sales.

The company said it's slowly adding private-sector customers. Still, with orders for equipment pending or in backlog, BAE Systems and the U.S. government are expected to remain major clients in 2006.

In Securities and Exchange Commission filings the 33-year-old company said: "We believe that Antenna Products enjoys a reputation for building quality products at a competitive price, because we continue to be asked to bid for new work. Because of our size and lack of significant liquid assets we are at a competitive disadvantage to larger companies that have greater resources to be able to bid a job at lower margins... On the other hand, our customers know us, know our personnel and can rely on us to build the antennas or towers or masts, etc., according to their specifications. We, therefore, compete on the basis of our reputation and history of building quality products at reasonable prices."

Cash provided from operating activities for the six months ended Nov. 30 was $1.1 million, vs. $2.7 million for the same time period in 2004. But accounts receivable as of Nov. 30 rose to $1.6 million from $663,098 as of May 31, primarily because of second-quarter sales to BAE Systems. Excluding the BAE Systems contracts, the company's order backlog stood at $1.6 million on Nov. 30. It has no debt and $3.8 million in cash.

"Phazar has good financials and some good contracts," says Telwares's Voellinger. "The opportunity is being in infrastructure and delivering wireless technology. That is huge. It is playing a piece in the infrastructure of wireless. Chips are another piece and security is another. I would rather be an infrastructure guy. It's much safer, and there's more money to be made."

Phazar announced in December the addition of four new mobile directional antennas to its instrument scientific medical (ISM) antenna product line. The ISM antennas are key components in the control systems used to operate automated rapid transit systems and monorails for urban and airport applications. These antennas are currently being deployed at DFW International Airport and San Francisco International Airport. The company added that this year it will provide antennas for the new terminal at Barajas International Airport in Madrid for the longest automated airport transportation system of its kind in Europe. It will also provide transit system antennas for the first driverless transit system in South Korea.

Phazar also reported in November that it added two multiport omni-directional antennas to its cellular and PCS product line. The dual models are capable of supporting up to four service providers per antenna at a site and the quad models are capable of supporting up to eight service providers per antenna at a site.

Phazar received notice on Nov. 3 from the Nasdaq that it was under threat of delisting. It had failed to comply with marketplace rules over the nomination of its board of directors. Six days later Phazar remedied the situation and the delisting threat was withdrawn.

The company's tiny float of two million shares likely contributed to Friday's run-up, as six million shares changed hands. Phazar management didn't return phone calls seeking comment.

Quote:
"Phazar seems to have a solid footing in this industry," says Telwares's Voellinger. "Some of the rapid growth and some of the market reaction is for companies across the board in this space. These companies will put up really good numbers as their revenues keep growing. This is your new bubble. Wireless technology is exploding. And anything that provides the infrastructure is exploding."

[actr]

Blodget’s Gedanken zu Google

Erinnert sich noch jemand an Henry Blodget? Als Analyst von Oppenheimer & Co. gab er der Aktie von Amazon.com im Dezember 1998 ein Kursziel von 400 Dollar, wurde alsbald zum Hohepriester des Internet und später zum Symbol der Internet-Blase. Jetzt warnt ausgerechnet Blodget vor allzu hohem Optimismus gegenüber Google.

Henry Blodget hat offenbar einiges gelernt in den letzten Jahren. Zum Beispiel, dass Aktien nicht grenzenlos in den Himmerl wachsen können. Und dass Fundamentaldaten wichtiger sind als Optimismus und Momentum am Aktienmarkt. Blodget sieht viele Aktien heute mit anderen Augen, und mit seiner Meinung hält er nicht hinterm Berg. Da ihm wegen übertriebenen Empfehlungen für schwache Aktien ein lebenslanges Berufsverbot im Wertpapierbereich auferlegt wurde, berichtet er lediglich nicht mehr als Insider über den Markt, sondern als „InternetOutsider“ – so der Name seines Blogs.

In diesem Blog hat sich Blodget nun den größten Internetgewinner der letzten Monate vorgeknöpft: Google. Und während die Aktie von acht Jahren vermutlich eine Kaufempfehlung nach der anderen bekommen hätte, postet der Ex-Analyst heute das Foto eines Furcht einflößenden Bören zu seinem Text. Auf dem Foto ist, wohlgemerkt, nur ein einzelner Bär zu sehen, was der Situation an der Börse ziemlich genau entspricht. Denn zumindest unter den Google-Beobachtern wimmelt es nach wie vor von Bullen: Im eben angebrochenen Jahr haebn schon fünf Analysten das Kursziel für die Suchmaschine angehoben, Mark Stahlman von Caris & Co. zuletzt auf – festhalten! – 2000 Dollar.

Das ist bekanntes Terrain für Blodget, der Google ein Kursziel von 100 Dollar gibt – nicht kurzfristig, wie er selbst schreibt, aber möglicherweise irgendwann.

Das Hauptrisiko für Google sieht Blodget im einseitigen Umsatzfluss. Dass der Verkauf von einzelnen Wörtern als Suchbegriffe fast den kompletten Umsatz für die Suchmaschine einbringt, sei gefährlich. Dass Google zahlreiche andere Produkte habe, verbessere die Situation nicht, denn Google Earth, die Bücherei und der neu vorgestellte Videodienst trügen kaum zum Ergebnis bei.

Blodget widmet sich in seinen Beobachtungen also allein dem Verkauf von Suchbegriffen. Dass für winzelne Wörter immer mehr bezahlt werde, ist für den Internet-Experten ein kurzfristiger Trend, der irgendwann auslaufen werde. Doch sieht Blodget nicht nur den Preis pro Wort rückläufig, sondern eines Tages auch die Investitionen der Unternehmen in Online-Werbung.

Welchen Schaden sinkende Einnahmen anrichten könnte, zeigt Blodget im Vergleich mit der Kostenstruktur bei Google aus. Das Unternehmen habe einen ungewöhnlich hohen Anteil an Fixkosten, so dass sinkende Einnahmen umso stärker auf die Bilanz durchschlagen könnten.

Mit einem Szenario, das Blodget für Google ebenso vorsieht, kennt sich der Ex-Analyst bestens aus: Betrug. Dass Internet-Unternehmen für Betrügereien besonders anfällig sind, ist bekannt, schließlich fällt eine Beurteilung von Aktiva schwer, wo nicht mit Waren, sondern mit Information und Hinweisen gehandelt wird. Käme es aber zu Betrugsfällen bei Google, würden Unternehmen und Aktie umso ärger getroffen, je höher sie zur Zeit gejubelt würden.

Um Google-Anleger nun nicht in alle Winde zu verjagen, macht Blodget in seinem Blog eines klar: Ob und wann sich die Schreckensszenarien für die Suchmaschine einstellen, wisse er nicht. Investment-Hinweise wolle – und per Gericht darf – er darüber hinaus auch nicht geben, und so bleibt der Blog einfach eine von vielen Meinungen. Allerdings immer noch die Meinung von einem, der die Sonnen- und die Schattenseite der Internet-Aktien besser kennt als alle anderen.

Lars Halter

[actr]

Zacks.com announces that Donald Rowe highlights the following stocks: AAR Corporation, Administaff, Inc., NetLogic Microsystems, Inc. and UbiquiTel, Inc.

CHICAGO, Jan 16, 2006 (BUSINESS WIRE) -- Donald Rowe, editor of the Wall Street Digest newsletter, says 2006 will be a super year for the economy and the stock market, and he recommends AAR Corporation (NYSE:AIR), Administaff, Inc. (NYSE:ASF), NetLogic Microsystems, Inc. (Nasdaq: NETL) and UbiquiTel, Inc (Nasdaq: UPCS)


Sampling of Buy Recommendations:

AAR Corporation (NYSE:AIR) is a worldwide leader in supplying aftermarket products and services to the global aerospace/aviation industry. It provides aircraft, engines and engine parts; airframe and accessories products; overhaul, repair and maintenance services and company-manufactured products to customers in all segments of this industry.

Administaff, Inc. (NYSE:ASF) is a leading personnel management company that serves as a full-service human resources department for small and medium-sized businesses throughout the United States.

NetLogic Microsystems, Inc. (Nasdaq: NETL) is a semiconductor company that designs, develops and markets high performance knowledge-based processors for a variety of advanced Internet, corporate and other networking systems, such as routers, switches, network access equipment and networked storage devices.

UbiquiTel, Inc. (Nasdaq: UPCS) is the exclusive provider of Sprint PCS digital wireless personal communications services to four midsize and smaller markets in the western and midwestern United States. The company's business strategy includes the following elements: capitalize on affiliation with Sprint PCS, capitalize on experienced management team, execute optimal network build-out plan, utilize strategic third party relationships in network build-out, implement effective operating structure with a focus on customer service, and focus on midsize and smaller markets.

Read Donald Rowe's commentary regarding the 2006 economy and stock market. Then discover more stocks by clicking: http://at.zacks.com/?id=85

[actr]

Reynolds and Reynolds Enhances CRM Solution to Increase Compatibility, Functionality Contact Management 3.2 Answers Dealers' Call for DMS-Neutral Technology

DAYTON, Ohio, Jan 16, 2006 /PRNewswire-FirstCall via COMTEX/ -- The Reynolds and Reynolds Company (NYSE: REY), a leading provider of software and services to the automotive retailing industry, has launched an enhanced version of its Web- based customer relationship management (CRM) solution.
Contact Management 3.2 now empowers dealers, regardless of their dealer management system provider, to manage the sales process through one CRM provider from inquiry to close -- and at every touch point with the consumer -- whether the customer is on the Web, on the phone, in the showroom or in the service lane.

"Our customers have shared with us their desire to work with a single CRM partner to provide a comprehensive suite of CRM solutions, allowing them to move away from multiple point products that do not work seamlessly with each other," said Jill Gehrhardt, CRM solutions executive, Reynolds and Reynolds. "Contact Management enables dealerships to automate their sales activities with CRM tools and conduct timely follow up and targeted marketing campaigns to build loyalty and repeat business."

With Reynolds Contact Management, dealerships can leverage each interaction with the customer and log that customer immediately into follow-up steps and processes. It helps dealerships to move customers from the Web into the showroom and through the sales process.


Key upgrades to Reynolds Contact Management solution include:


- DMS Neutral: Empowers larger dealer groups with multiple DMS providers

throughout their locations to leverage Contact Management across the

enterprise and derive more consistent reporting. Dealers can choose to

import existing customer data, such as demographic information and

sales and service history, into Contact Management.


- Desk Log Function: Equips the sales management team with a tool to

monitor floor traffic and personalize visits for prospects. Through an

on-screen dashboard, sales managers have a view of dealership sales

activity. Dashboard functions enable managers to access client records,

assign salespersons, add vehicles, update sales steps, add and edit

notes, and create a deal. The function provides key metrics such as

prospect count and sales steps completed.


- Call Tracking: Captures inbound and outbound phone calls to produce

reports that help management monitor sales activity and can improve

employee productivity. Additionally, this optional feature aids sales

managers in coaching their sales team on how to effectively call

customers. The product interfaces with a majority of private telephone

switch (PBX) systems.

Contact Management's architecture combines the advantages of ASP delivery and advanced technology to make the application flexible and easy-to-use.

Reynolds is an automotive retail CRM market leader. Reynolds has more than 10,000 deployed CRM applications across its Reynolds Web Solutions, Contact Management and other lead management solutions.

About Reynolds

Reynolds and Reynolds (http://www.reyrey.com) helps automobile dealers sell cars and take care of customers. Serving dealers since 1927, it is the leading provider of dealer management systems in the U.S. and Canada. The company's award-winning product, service and training solutions include a full range of retail Web and Customer Relationship Management solutions, e-learning and consulting services, documents, data management and integration, networking and support and leasing services. Reynolds serves automotive retailers and OEMs globally through its incadea solution and a worldwide partner network, as well as through its consulting practice.

[actr]

Protox receives FDA clearance to begin Phase I prostate cancer trial

VANCOUVER, Jan. 16, 2006 (Canada NewsWire via COMTEX) -- Protox Therapeutics Inc. announced today that the Investigational New Drug (IND) application for PRX302, the Company's lead product for the treatment of recurrent localized prostate cancer, has been cleared by the US Food and Drug Administration (FDA). As reported previously, the IND application was filed in December, 2005 and its clearance means that the Company may now proceed with the initiation of its Phase I clinical trial. PRX302 is the first of a novel class of targeted prodrugs based on the Company's PORxin(TM) platform. It is a therapeutic pore-forming toxin designed to be activated by prostate specific antigen (PSA), an enzyme which is produced and is active only in the prostate.
"Receiving FDA approval to proceed with our first Phase I clinical trial is a significant and exciting milestone for the growth of Protox and its clinical development programme," stated Dr. Fahar Merchant, President and CEO of Protox. "This milestone underscores the potential therapeutic benefit of our targeted PORxin(TM) platform originally developed by Dr. Tom Buckley, our Chief Scientific Officer."

Dr Merchant added that, "our ability to successfully reach this important goal was due to the commitment and considerable effort by Rosemina Merchant, our Vice President for Development and Regulatory Affairs, and the support from our development partners. We expect to leverage our advances with PRX302 to file an additional IND this year for the treatment of benign prostatic hyperplasia (BPH or enlarged prostate), an indication that is not adequately served by current treatments."

The Phase I clinical trial will be an open-label, dose-escalation study of PRX302 in patients with locally recurrent prostate cancer. Patient enrollment will commence in the next few weeks. The Phase I trial will be conducted at Scott & White Memorial Hospital in Temple, Texas and at least one additional site in the United States. The trial is expected to enroll approximately 24 patients and has been designed to determine safety, tolerability and therapeutic activity of PRX302.

About Prostate Cancer

Prostate cancer is one of the most common malignancies in North American men. It is estimated that nearly 250,000 men in North America will be diagnosed with prostate cancer this year. Every year, more then 30,000 men die of prostate cancer in the US alone.

Current treatment options for localized prostate cancer include surgery (radical prostatectomy), brachytherapy (implantation of radioactive seeds), and external beam irradiation. Unfortunately each of these therapies can result in erectile dysfunction, incontinence, urinary toxicity and rectal toxicity. PRX302 is being developed for the treatment of localized recurrent prostate cancer. At present there are no licensed drugs available for salvage therapy of purely local recurrence of prostate cancer.

About Protox Therapeutics

Protox Therapeutics Inc. is developing novel targeted cancer therapeutics based on engineered protein toxins. Its lead programme (PORxin(TM)) is based on pore forming protoxins such as modified proaerolysin. PORxins(TM) are inactive pro-drugs that are preferentially activated at the tumour site into potent toxins by cancer specific proteases, thereby causing cancer cell death. The Company works in partnership with research groups at the University of Victoria, Johns Hopkins University, Scott & White Hospital and other research institutions.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this press release. This press release contains certain forward-looking statements respecting the Company's business, capital, research and development, and potential future products, which statements can be identified by the use of forward looking terminology, such as "expect", "to generate", "moving forward", "intends", "committed to", "moving", "developing", "believe" or the negative thereof or any other variations thereon or, or that events or conditions "will,", "can", "to", "may," "could" or "should" occur, or comparable terminology referring to future events or results. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of numerous factors, including, without limitation, the need for extensive additional research and development, which is costly and time-consuming and may not produce anticipated or useful results; scientific research and development risks; the risk of technical obsolescence; intellectual property risks; manufacturing and marketing risks; partnership/strategic alliance risks; the effect of competition; the need for regulatory approvals, including without limitation, FDA approvals, which is not assured; product liability and insurance risks; the need for future human clinical trials, the occurrence and success of which is not assured; changes in business strategy or development plans; and the need for additional capital, which may not be obtained; and the fact that the Company may not produce any products or if it does, that such products may not be commercially successful; any of which could cause actual results to vary materially from current results or the Company's anticipated future results. See the Company's prospectus and other documents filed with the TSX Venture Exchange and the Canadian Securities Administrators at www.sedar.com from time to time for a further discussion of these and other important risks and uncertainties that could cause actual results to differ materially from results referred to in forward-looking statements. The Company assumes no obligation to update the information contained in this press release.

[actr]

At the Request of the TSX Venture Exchange, China Diamond Corp. Clarifies Certain Disclosure Information on Its Exploration Projects in China

LONDON, ON, Jan. 16, 2006 (Canada NewsWire via COMTEX) -- China Diamond Corp., (TSX-V: CDC) has amended the disclosure in its January 3, 2006 news release, which relates to the Company's exploration and mine expansion programs for 2005 and its corporate development plans for 2006, in order to clarify and expand on the disclosure that was contained within.
The 701 Changma Diamond Mine Expansion Plan

-------------------------------------------

In December 2004 the Company initiated a major underground capital development program at the Mine by deepening the main decline to the -40 metre level (the bottom-most development horizon for mining Indicated Mineral Resources). The Company is pleased to announce that this program has now been completed. Tonnes processed at the Mine have steadily increased since August 2005, and are now at normal production levels of approximately 10,000 tonnes per month. It is anticipated that 2006 mine throughput will be approximately 118,000 tonnes producing close to 82,000 carats.

Since new management took over the helm of the Company in late 2003, it believes that the value of the diamonds produced at the Mine is not realized to its full potential until the existing processing plant facilities are improved. To this end, the Company commissioned an engineering study to evaluate a processing plant improvement and at the same time, assess a mine expansion scenario to improve the economics of the Mine. The study was completed in December 2005 by the Beijing General Research Institute of Mining and Metallurgy ("BGRIMM"), a First Class Engineering certificate holder in China. The study recommends that annual throughput be increased to 168,300 tonnes, which would result in the recovery of approximately 120,000 carats of diamonds per annum. Additionally, a dense medium separator ("DMS") and x-ray circuit has been recommended for installation in the processing plant. This circuit will update the plant with state-of-the-art technology, resulting in increased recovery of diamonds and better control over security aspects. The installation of inertia cone crushers to replace the existing ball mills is expected to reduce fragmentation of diamonds, and reduce electricity consumption and mine operating costs.

Total capital investment over the life of the Mine is estimated at US$2.9 million, with US$1.5 million required in the next two years. Funds after the next two years are required for continued underground mine development and sustaining capital, which will be financed from after-tax profits. The Company is planning to have an independent 43-101 technical report completed on the property during the first quarter of 2006.



Exploration Projects

--------------------


Diamond Portfolio


702 Diamond Project


During 2005, the Company and its joint venture partner have been actively pursuing the necessary permits and licenses to complete a bulk sampling program and future mining of the 702 deposit. Although an independent engineering study was completed by a Chinese engineering firm during 2005 that indicated the positive aspects of this project, the Company considers that it is prudent to collect a relatively large bulk sample to ascertain the valuation of the diamonds prior to any mine production decision. This will not only provide the necessary confidence in the diamond value but will also provide the necessary information for detailing the optimal mining and processing scenarios for future mine operations. The Company is currently assessing the optimal way to proceed with the bulk sample and once the method and costs are determined, may require additional financing.

703 Diamond Project

Exploration on the 703 project throughout 2005 identified a number of circular magnetic anomalies thought to represent the possible kimberlite source of the diamonds and kimberlite indicator minerals previously recovered from surface soil and stream sediment sampling. In addition, the Company initiated a detailed soil sampling survey and resistivity survey immediately over top of and down slope of the Dajingtou (A1) anomaly. The detailed soil sampling recovered 6 diamonds and over 1,200 kimberlite indicator minerals. To date, six holes have been drilled into this area that have so far recovered a number of pyrope garnets, chrome diopside and chromite grains, all of which are indicative of a kimberlite source rock (October 12 news release). However, due the complex nature of the geology, which hosts a number of cross-cutting faults that may have caused displacement of the original kimberlite rock, core drilling has yet to intersect the kimberlite source rock for the diamonds. However, given the extensive soil sampling and the obvious cluster of diamonds in a relatively small area of less than 2km2, the Company remains confident in the potential of this area hosting a diamondiferous kimberlite, and as such, continues to aggressively explore this area with soil sampling, geophysics and core drilling, which is currently ongoing.

The Company expects to receive 4 other exploration licenses early in 2006 that are in the proximity of the Dajingtou License where exploration work is currently ongoing. The exploration program for 2006, for the Dajingtou license as well as the remaining four licenses (once received) is currently funded in entirety.



Gold Portfolio


Huixian Gold-Copper Project


During 2005, the Company successfully discovered four gold-copper mineralized zones on the Huixian Project with associated alteration and sulfide mineralization, similar to that of the Huixian Mine (September 19, 2005 news release).

The Company is continuing detailed surface exploration on the newly discovered zones, consisting of trenching and ground geophysics to better define the geometry of the mineralized zones beneath the surface to target mineralized zones for future core drilling. In addition, the Company is planning to commence drilling on the Huixian Mine mineralization in order to collect additional information of the gold-copper mineralization at depth prior to updating the estimate of Mineral Resources. The surface work for the project is funded and ongoing, while the core drilling program expected to commence later in 2006 will require additional financing, the amount of which will be determined upon completion of the surface exploration.

In the past two months, a total of 40 surface muck pile samples were collected from the area of the past producing Huixian Mine. The assays (see following Table 1) provide an indication of the high grade gold-copper values within the deposit that correlate well with the known average grade of the deposit.



<<

[actr]

16.01.2006 15:11
Presse: General Motors hebt Einsparziel an
Der amerikanische Automobilkonzern General Motors Corp. (ISIN US3704421052 (Nachrichten/Aktienkurs)/ WKN 850000) hat Presseangaben zufolge sein Einsparungsziel weiter erhöht.

Wie die "Financial Times Deutschland" unter Berufung von Aussagen des Konzernchefs Rick Wagoner bei einer Rede vor Analysten berichtet, will der angeschlagene Automobilhersteller seine Kosten bis zum Jahr 2010 um insgesamt 14 Mrd. Dollar senken. Bislang lag das ursprüngliche Ziel bei Kosteneinssparungen von 7 Mrd. Dollar bis zum Jahr 2008. Gleichzeitig betonte Wagoner laut dem Bericht, dass die Sanierung des Nordamerikageschäfts mit einem extremen Gefühl der Dringlichkeit durchgeführt werden soll. Dabei dürfte die bereits angekündigte Streichung von 30.000 Stellen bei General Motors wohl erst der Anfang gewesen sein, hieß es weiter.

Der CEO des weltgrößten Automobilkonzerns steht derzeit angesichts wachsender Kritik der Aktionäre und Analysten zunehmend unter Druck. Durch das neue Einsparungsziel will Wagnoer diesen Vorgaben nun gerecht werden. Vor dem Hintergrund der derzeitigen tarifrechtlichen Rahmenbedingungen müssen jedoch Werksschließungen mit der Automobilgewerkschaft UAW abgestimmt werden. Der Abbau von Stellen ist derzeit laut dem Bericht aufgrund der aktuellen Tarifverträge nahezu unmöglich.

Ein Insolvenzverfahren stellt in diesem Zusammenhang nach Meinung einiger Beobachter einen Ausweg aus der Misere dar. Für Wagoner ist das keine Lösung, weil bei einem Insolvenzantrag die Konsumenten keine GM-Autos mehr kaufen würden: "Die geben bis zu 40.000 Dollar für ein Auto aus, das sie in den nächsten fünf Jahren verwenden wollen", wird Wagoner zitiert. Seiner Meinung nach zählt für Kunden Verlässlichkeit "bei der Garantie oder beim Rückverkauf".

Die Aktie von General Motors notierte zuletzt bei 20,37 Dollar.

[actr]

Altair Nanotechnologies Inc.
17.01.06 22:00 Uhr

3,25 USD

+38,89 % [+0,91]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=ALTI.NAS&lColors=0x000000&sSym=ALTI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=ALTI.NAS&lColors=0x000000&sSym=ALTI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=ALTI.NAS&lColors=0x000000&sSym=ALTI.NAS&hcmask=

Börse
NASDAQ

Aktuell
3,25 USD

Zeit
17.01.06 22:00

Diff. Vortag
+38,89 %

Tages-Vol.
50,40 Mio.

Gehandelte Stück
16 Mio.

Altair Nanotechnologies Lithium Ion Battery Cells Exceed HEV Power Requirements of U.S. FreedomCAR

RENO, NV, Jan 17, 2006 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies Inc. (NASDAQ: ALTI) today announced that its battery research and development team successfully completed a testing program for lithium ion battery cells containing Altairnano's nano-structured lithium titanate electrode materials.
"The test results demonstrated that the performance of these lithium ion battery cells exceed the system-level power requirements set forth by the U.S. Council for Automotive Research FreedomCAR Energy Storage System Performance Goals for hybrid electric vehicle (HEVs), as well as those requirements published by major U.S. automakers," said Evan House, Ph.D., Program Director, Altairnano's Advanced Materials & Power Systems business unit. These power requirements can be viewed at: www.uscar.org/consortia&teams/consortiahomepages/con-usabc.htm

The battery cells using Altairnano's nano-structured lithium titanate electrode materials in battery cell tests developed for HEV applications demonstrate a useable state-of-charge range twice that of conventional nickel metal hydride (NiMH) batteries presently used in hybrid electric vehicles. Nano-structured lithium titanate electrode materials offer a near-term promise of lithium ion batteries that exhibit rapid charge and discharge, longer cycle life and more inherently safe performance than either currently available nickel metal hydride or lithium ion batteries. These results support the feasibility of a power lithium ion battery pack half the size of those currently being tested for HEV applications.

"We believe this phase of our testing program provides enough data to demonstrate that lithium-ion batteries utilizing our nano-structured battery electrode materials can have both the energy and power densities that exceed those of the nickel metal hydride (NiMH) batteries currently being used in HEVs," commented Altairnano President and CEO Alan J. Gotcher, Ph.D. "In our meetings with members of the automotive industry in the U.S. and abroad, we have been told that power-based lithium-ion batteries with the ability to discharge and charge rapidly, combined with greater cycle life and abuse tolerance, are desirable for the future of hybrid vehicles.

"This assessment," continued Dr. Gotcher, "was validated in the October 24, 2005, issue of Automotive News, when Japan's largest maker of nickel metal hydride batteries, used by Ford Motor Company and other carmakers of hybrid vehicles, stated that the future belongs to lithium-ion batteries. This sentiment was echoed in the article by Sanyo Electric Company, Toyota Motor Corporation, General Motors and Ford Motor Company executives."

The power of Altair's cell was first demonstrated and published in the September 2004 edition of the advanced energy industry standard, Journal of Power Sources. In that paper, authored by Dr. Du Pasquier and colleagues of the Rutgers University Energy Storage Group, battery cells using Altairnano's nano-structured battery electrodes demonstrated a three-minute full recharge and more than 9,000 cycles of sequential three-minute, 100 percent, recharges and discharges, validating the superior cycle life characteristics of Altairnano's nano-materials, when compared to traditional lithium ion batteries with a cycle life of 300 to 500 recharges and discharges.

The battery testing programs for applications targeting HEVs and electric vehicles are underway at a specially equipped facility located in the company's corporate headquarters in Reno, NV. Located in Anderson, Indiana, Altairnano's battery product application labs, with rapid prototyping and battery testing capabilities, is expected to be fully equipped and operational and to have its first battery cells manufactured by the end of January.

ABOUT ALTAIR NANOTECHNOLOGIES INC.

Altairnano is a leading supplier and innovator of advanced ceramic nanomaterial technology. Based in Reno, Nevada, Altairnano has assembled a unique team of materials scientists who, coupled in collaborative ventures with industry partners and leading academic centers, have pioneered an array of intellectual property and products.

Altairnano's robust proprietary technology platforms produce a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. The company has scalable manufacturing capability to meet emerging nanomaterials demands. Altairnano's two divisions, Life Sciences and Performance Materials, are focused on applications where the company's nanotechnology may enable new high growth markets. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials and other medical markets. The Performance Materials Division is focused on market applications in advanced materials for paints and coatings; air and water treatment, environmental sensing, and alternative energy -- including new lithium ion battery electrode materials. For additional information on Altairnano and its nanomaterials, visit www.altairnano.com.

[actr]

BioCryst Pharmaceuticals, Inc.
17.01.06 22:00 Uhr

22,41 USD

+17,70 % [+3,37]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=BCRX.NAS&lColors=0x000000&sSym=BCRX.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=BCRX.NAS&lColors=0x000000&sSym=BCRX.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=BCRX.NAS&lColors=0x000000&sSym=BCRX.NAS&hcmask=

Börse
NASDAQ

Aktuell
22,41 USD

Zeit
17.01.06 22:00

Diff. Vortag
+17,70 %

Tages-Vol.
382,44 Mio.

Gehandelte Stück
19 Mio.

BioCryst Receives FDA Fast Track Designation for Peramivir

Jan 17, 2006 /PRNewswire-FirstCall via COMTEX/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the U.S Food and Drug Administration (FDA) has granted "fast track" designation for peramivir injection in the treatment of influenza infections, including highly virulent, life-threatening strains of influenza. Peramivir is an influenza neuraminidase inhibitor that, in preclinical studies, has shown potent, broad- spectrum activity against multiple strains of flu, including the H5N1 virus. On December 22, 2005, BioCryst announced that the FDA had given the company approval to begin human clinical trials using injectable peramivir.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030414/BIOCRYSTLOGO )

The fast track programs of the FDA are designed to facilitate the development and expedite the review of new drugs that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. In correspondence with BioCryst, the FDA said that it agrees that the use of peramivir in the proposed indication of treatment of influenza infections, including highly virulent, life-threatening strains, meets the criterion of treating a serious life-threatening condition. Based on this conclusion, the FDA designated peramivir injection for influenza infection as a fast track product.

"The FDA's decision supports our belief in the potential of peramivir as an effective therapy for the treatment of influenza, including highly virulent, life-threatening strains like those associated with avian influenza," said Charles E. Bugg, Ph.D., Chairman and Chief Executive Officer of BioCryst. "We are initially developing the intravenous formulation of peramivir for the treatment of acutely ill influenza-infected patients and anticipate beginning Phase I clinical testing of the intravenous formulation early this quarter, at the NIH Clinical Center in Bethesda, Maryland. In addition, we are also conducting preclinical studies with intramuscular formulations, which will be directed initially at patients with seasonal influenza infections. We are pursuing both of these development programs in close collaboration with research groups at the National Institutes of Allergy and Infectious Diseases (NIAID) at the National Institute of Health (NIH)."

About BioCryst

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections. BioCryst integrates the necessary disciplines of biology, crystallography, medicinal chemistry and computer modeling to effectively use structure-based drug design to discover and develop small molecule pharmaceuticals.

BioCryst's lead product candidate, Fodosine(TM), is a transition-state analog inhibitor of the target enzyme purine nucleoside phosphorylase (PNP). The drug is currently in a Phase IIa trial for patients with T-cell leukemia and a combination IV and oral Phase I pharmacokinetic trial in healthy volunteers was recently completed. Results of the Phase IIa and the Phase I pharmacokinetic trial will assist in the design of a planned combination IV and oral Phase IIb pivotal clinical trial in patients with T-cell leukemia. The Company has requested a Special Protocol Assessment from the FDA for this planned trial. Additionally, Fodosine(TM) is currently being studied in a Phase I trial with an oral formulation in cutaneous T-cell lymphoma (CTCL), a Phase II trial in chronic lymphocytic leukemia (CLL) and a Phase I/II trial in B-cell acute lymphoblastic leukemia (B-ALL). Fodosine(TM) has been granted Orphan Drug status by the U.S. Food and Drug Administration for three indications: T-cell non-Hodgkin's lymphoma, including CTCL; CLL and related leukemias including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for treatment of B-cell acute lymphoblastic leukemia (ALL). Additionally the FDA has granted "fast track" status to the development of Fodosine(TM) for the treatment of relapsed or refractory T-cell leukemia.

In August, 2005, BioCryst initiated a Phase Ib study with its second- generation PNP inhibitor, BCX-4208, to evaluate the safety, tolerability and pharmacokinetics of multiple oral doses of BCX-4208. In November, 2005 BioCryst announced it had entered into an exclusive licensing agreement with Roche to develop and commercialize BCX-4208 for the prevention of acute rejection in transplantation and for the treatment of autoimmune diseases.

Additionally, BioCryst has re-initiated clinical development of peramivir, an inhibitor of influenza neuraminidase, with a focus on intravenous and intramuscular delivery. Also, BioCryst has identified a clinical candidate, BCX-4678, in its hepatitis C polymerase inhibitor program, and is advancing this compound through preclinical testing with the goal of filing an IND in 2006. For more information about BioCryst, please visit the company's web site at http://www.biocryst.com.

[actr]

DANA CP
17.01.06 22:01 Uhr

5,40 USD

-20,59 % [-1,40]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=DCN.NYS&lColors=0x000000&sSym=DCN.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=DCN.NYS&lColors=0x000000&sSym=DCN.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=DCN.NYS&lColors=0x000000&sSym=DCN.NYS&hcmask=

Börse
NYSE

Aktuell
5,40 USD

Zeit
17.01.06 22:01

Diff. Vortag
-20,59 %

Tages-Vol.
42,33 Mio.

Gehandelte Stück
7,5 Mio.


Dana Corporation Reports Third-Quarter 2005 Results

Jan 17, 2006 /PRNewswire-FirstCall via COMTEX/ -- Dana Corporation (NYSE: DCN) today reported financial results for both the quarter and nine months ended Sept. 30, 2005, and announced that it will file its Form 10-Q for the third quarter of 2005 later today. The filing and delivery of this report will eliminate any defaults related to late filing of the third-quarter financial statements under the company's financing agreements.
(Logo: http://www.newscom.com/cgi-bin/prnh/19990903/DANA )

Sales for the third quarter of 2005 were $2,396 million, compared to $2,114 million during the same period in 2004. The company recorded a net loss of $1,272 million, or $8.50 per share, for the quarter, compared to net income of $42 million, or 28 cents per share in the third quarter of 2004. Results for the quarter and nine months ended Sept. 30, 2004 have been restated, as previously disclosed in the 2004 Form 10-K/A filed on Dec. 30, 2005.


About Dana Corporation

Dana people design and manufacture products for every major vehicle producer in the world. Dana is focused on being an essential partner to automotive, commercial, and off-highway vehicle customers, which collectively produce more than 60 million vehicles annually. A leading supplier of axle, driveshaft, engine, frame, chassis, and transmission technologies, Dana employs 46,000 people in 28 countries. Based in Toledo, Ohio, the company reported sales of $9 billion in 2004. Dana's Internet address is: http://www.dana.com.

[actr]

If It Doesn't Fit...

By Lawrence Carrel
January 17, 2006


--------------------------------------------------------------------------------
AHPC Holdings, Inc. (GLOV1)

--------------------------------------------------------------------------------
Share price as of Friday's close: $3.00
Share price now: $3.62
Change: 20.7%
Volume: 343,154 shares, daily average 4,800 shares
Last time this high: Oct. 18, 2005
52-week high: $5.65
52-week low: $2.32
Forward P/E before announcement: n/a
Forward P/E after announcement: n/a

--------------------------------------------------------------------------------

THE ONLY THING missing from a disposable glove maker's rags-to-riches announcement is, well, riches.
Shares of AHPC Holdings (GLOV2) jumped 21% to $3.62 Tuesday after the maker of latex gloves reported winning a five-year federal supply contract. Financial details3 of the pact weren't disclosed by the Glendale Heights, Ill., company.

"The company solidified a deal that's good for five years," says Adam Lowensteiner, managing director of Microcapreport.com, an online newsletter based in Bergenfield, N.J. "That's why a lot of companies like working with the government. The feds give out long contracts that are easier on your sales cycles. The big questions are: How big is the deal, and does it take AHPC to profitability?"

The answers, from the looks of it, are "not very" and "unlikely," based on information we pieced together from the General Services Administration, the federal procurement agency that doles out contracts on behalf of government agencies, and the company's regulatory filings. AHPC didn't return phone calls seeking comment.

"The contract is worth a potential value of $125,000 over five years," says GSA spokeswoman Viki Reath. According to the GSA, there are no preferences or guarantees in the agreement, and AHPC will compete against other government contractors to win sales among federal agencies. For the fiscal year ended June 30, AHPC's revenues totaled $26.6 million.

Formerly known as WRP Corp., AHPC sells gloves for the food service, medical, dental, nursing home and retail industries through its wholly owned subsidiary, American Health Products. AHPC markets latex, vinyl and synthetic disposable gloves under the brand names DermaSafe, Glovetex and SafePrep. Latex-powdered gloves comprise 28% of revenues, while latex powder-free gloves bring in 27% and nonlatex gloves, 36%

The contract, which runs from Dec. 1, 2005, to Nov. 30, 2010, is for DermaSafe and Glovetex examination and specialty latex gloves.

"If it's a real contract why didn't the company tell us the dollar amount?" says Peter Cohan, president of Peter S. Cohan & Associates, a management-consulting and venture-capital firm in Marlborough, Mass. "It seems if the company knew the dollar amount of the contract, it would disclose it. That would add to the credibility of the announcement and give investors a view into how much it's worth."

Recent earnings statements show lackluster results. For the fiscal first quarter ended Sept. 30, AHPC posted a net loss of $498,556, or 41 cents a share, vs. a net loss of $373,649, or 39 cents, for the year-earlier period. Revenues climbed 5.7% to $6.9 million. A 29% revenue increase in the company's health-care business was offset by increased costs for raw materials, primarily latex and low-density polyethylene. Gross margins fell to 20.7% from 23.2% a year earlier.

The company has produced a profit in just one of its past five quarters, and that came from a one-time gain from the sale of its Indonesian manufacturing business. And while annual losses have steadily decreased over the past two years, so have annual sales — they're half of what they were in 2001.

Other concerns loom. In its 2005 annual report AHPC said "during the process of responding to a recent SEC comment letter, the company's management identified an error which led to the identification of a material weakness within the company's financial reporting and disclosure controls." The error related to the reporting of net loss per share after a January 2004 3-for-1 reverse stock split, and forced the company to restate two years' worth of earnings.

"This whole thing brings up the question of whether any of the numbers are real," says Cohan, the venture capitalist. "It seems like it has no cash and it doesn't generate any cash. It survives by convincing credit companies and private investors to give them cash. It's borrowing against receivables."

From June 2004 to June 2005, AHPC's cash balance fell to $16,434 from $359,012. By September it had climbed to $60,000, despite the company posting negative operating cash flow of $755,000 for the quarter.

In September 2004 GE Capital terminated its credit facility with AHPC. This forced the company to work with a privately held commercial financing company called Greenfield Commercial Credit. Greenfield gave the company a $5 million line of credit five months ago and helped with an October private placement of $1.2 million in 7% subordinated promissory notes.

In AHPC's annual report, its accounting firm, Grant Thornton, issued a so-called going concern qualification, meant to warn investors when a company is at risk for eventual insolvency. Last week AHPC fired Grant Thornton and hired independent accounting firm Plante & Moran.

Quote:
"This company reminds me of the company Vandalay Industries, made famous by the 'Seinfeld' TV show," says Cohan. "George, who is trying to get a job, gives Jerry's number for a recommendation, pretending it's a latex firm, Vandalay Industries. The phone rings. Kramer picks it up. George comes out of the bathroom in his underwear screaming, 'Answer Vandalay Industries,' but Kramer says this isn't a company — it's an apartment. Seinfeld then walks in, sees George on the floor in his underwear and says, 'And you want to be my latex salesman?' I think this company has as much a chance of making it as Vandalay Industries."


http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=GLOV.NAS&lColors=0x000000&sSym=GLOV.NAS&hcmask=

http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=GLOV.NAS&lColors=0x000000&sSym=GLOV.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=GLOV.NAS&lColors=0x000000&sSym=GLOV.NAS&hcmask=

[actr]

18.01.2006 08:50
Intel verfehlt im Schlussquartal 05 ... (zwei)
Die niedriger als erwartete Marge begründete Intel (Nachrichten/Aktienkurs) mit der schwächeren Umsatzentwicklung im vierten Quartal. Zudem verwies das Unternehmen auch auf den "leichten Wechsel" im gesamten Produktmix hin zu Produkten, die nicht aus dem Mikroprozessorenbereich stammen sowie auf die Neubewertung bei einem Teil der Lagerbestände. Die effektive Steuerrate sei dagegen mit 29,1% niedriger als erwartet ausgefallen. Intel war von einer Rate von rund 31% ausgegangen.

Die Umsatzentwicklung im Schlussquartal ist den Angaben zufolge vor allem auf geringer als erwartete Auslieferungen und Preise bei Desktop-Prozessoren zurückzuführen. Der Chief Financial Officer des Konzerns, Andy Bryant, sagte im Anschluss an die Ergebnispräsentation, dass sich weitere Faktoren negativ auf das Intel-Geschäft ausgewirkt hätten. So habe es bei der Versorgung mit so genannten Chip Sets Engpässe gegeben.

Bryant zufolge verlor Intel im Schlussquartal geringfügig Marktanteile an Konkurrent Advanced Micro Devices Inc (AMD).

DJG/DJN/abe/nas

[actr]

MORNING UPDATE: Seven Summits Research Issues Alerts for INTC, IBM, YHOO, JPM, and LUV

CHICAGO, Jan 18, 2006 /PRNewswire via COMTEX/ -- Seven Summits Research issues the following Morning Update at 8:30 AM EST with new PriceWatch Alerts for key stocks.
Before the open... PriceWatch Alerts for INTC, IBM, YHOO, JPM, and LUV, Market Overview, News Leaders and Laggards, Today's Economic Calendar, and the Quote Of The Day.

QUOTE OF THE DAY

"We are looking for a new record high in the U.S. trade deficit. The triggers for dollar weakness may come from structural indicators."


-- Todd Elmer, Currency Strategist, Citigroup


New PriceWatch Alerts INTC, IBM, YHOO, JPM, and LUV...

PRICEWATCH ALERTS -- HIGH RETURN COVERED CALL OPTIONS --

-- Intel Corp. (Nasdaq: INTC)

Last Price 25.52 - APR 25.00 CALL OPTION@ $1.70 -> 5.0 % Return assigned*

-- International Business Machines Corp. (NYSE: IBM)

Last Price 83.00 - JUN 80.00 CALL OPTION@ $6.90 -> 5.1 % Return assigned*

-- Yahoo! Inc. (Nasdaq: YHOO)

Last Price 40.11 - FEB 40.00 CALL OPTION@ $2.05 -> 5.1 % Return assigned*

-- JP Morgan Chase & Co. (NYSE: JPM)

Last Price 39.71 - JUN 40.00 CALL OPTION@ $1.70 -> 5.2 % Return assigned*

-- Southwest Airlines Co. (NYSE: LUV)

Last Price 15.87 - JUN 15.00 CALL OPTION@ $1.85-> 7.0 % Return assigned*


MARKET OVERVIEW

Things are looking a bit ugly overseas, as none of the foreign markets we track are in positive territory. Tokyo Stock Exchange officials had to step in and halt trading 20 minutes earlier than normal as a glut of orders threatened to exceed the systems' 4 million-order capacity. This is only the second time that officials have shut down trading early, and it caused many of the major Asian markets to post losses. European shares also moved lower on Wednesday, thanks in part to the situation in Asia and rising oil prices. Every component of the main French and German indices dropped. Oil stocks comprised the scant amount of companies posting gains in Europe.

The February crude contract surged past $66 per barrel yesterday, closing at their highest level since late September. Supply concerns were the main driver for the high prices, as news from Iran and Nigeria sparked worries. The news out of Iran consists of the resumption of its nuclear program. The country denies that it is planning to develop nuclear weapons, but Europe and the United States are trying to call an emergency meeting of the International Atomic Energy Agency, which could result in sanctions against Iran. The country warned that sanctions against it could lead to higher oil prices. In Nigeria, militants have threatened further attacks against the oil industry in the country, which is the world's eighth-largest oil exporter. A glut of attacks against Royal Dutch Shell facilities have caused the company to cut output and withdraw staff from four oil production platforms.


2006 has started well for the OPEC oil nations -- the cartel that controls about 40% of the world's oil output. And according to the US Department of Energy, it's set to increase its revenues by 10% to a record US$522 billion this year. They barely look worse off in 2007, with revenues projected to drop only slightly to US$495 billion. Elsewhere on the power-generating topic, General Electric, Siemens and Alstom have released a combined report detailing how they believe the world is about to experience a power shift from gas to coal. Their research, obtained by the Financial Times, shows that they expect 40% of the new orders for electric turbines over the next decade to be for coal-powered systems. Meanwhile, demand for gas-based systems is expected to drop some 25-30%. So why the shift? Well, there are several reasons. Unsurprisingly, the biggest concern is that gas is becoming increasingly expensive because of supply concerns. Proof of this was seen just recently, as Russia and the Ukraine became embroiled in a dispute over pricing. In addition, new technological advances mean coal is now less of a pollutant that before. Over in Japan, the prospects for more sustained growth are looking brighter. In its new report outlining the state of the country's economy, the Bank of Japan said that all nine regions announced positive data for the final quarter of 2005. Back in October, six of the nine upgraded their outlooks. Conclusion? That, coupled with a statement from Governor Toshihiko Fukui last week that the country is emerging from its prolonged black hole of deflation, Japan's economy has turned the corner.

Read more economic/market/stock analysis from the Taipan Group and 247Profits.com every trading day with the FREE 247Profits Dynamic Market Alert. Featuring: insightful economic commentary from the US and worldwide... profitable investment recommendations...and full access to the leading team of financial experts. Register for free here: http://www.247profits.com/enter.html

NEWS LEADERS AND LAGGARDS

So far today, J.P. Morgan Chase, Southwest Airlines, and Mellon Financial lead the list of companies with the most news stories while SunTrust Banks and Sony Ericsson Mobile are showing a spike in news. CIT Group, International Business Machines, and Johnson & Johnson have the highest srtIndex scores to top the list of companies with positive news while Intel and Yahoo! lead the list of companies with negative news reports. Bank of New York has popped up with a high positive news sraIndex score.


TODAY'S ECONOMIC CALENDAR

7:00 a.m. Jan 13 MBA Refinancing Index

7:45 a.m. Jan 14 ICSC Store Sales Index

8:30 a.m. Dec CPI

8:30 a.m. Dec CPI, ex-food and energy

8:55 a.m. Jan 14 Redbook Retail Sales Index

9:00 a.m. Nov Treasury Intl Capital Flows

12:15 p.m. Richmond Fed Pres Lacker speaks in Baltimore

1:00 p.m. Jan NAHB Housing Index

2:00 p.m. Federal Reserve Beige Book

[actr]

Ivanhoe Energy, Inc. - Common Shares
18.01.06 19:40 Uhr

2,87 USD

+20,59 % [+0,49
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=

Börse
NASDAQ

Aktuell
2,87 USD

Zeit
18.01.06 19:40

Diff. Vortag
+20,59 %

Tages-Vol.
129,31 Mio.

Gehandelte Stück
48 Mio.

Conference Call Wednesday, January 18, to discuss Ivanhoe Energy's Heavy-to-Light Oil process

BAKERSFIELD, CA, Jan 18, 2006 /PRNewswire-FirstCall via COMTEX/ -- Ivanhoe Energy Inc. (NASDAQ: IVAN and TSX: IE, IE.U) will host a telephone conference call for investors and analysts today, Wednesday, January 18, at 4:00 p.m. EST (1:00 p.m. PST).
Briefings will be provided on the successful attainment of performance objectives by the company's Commercial Demonstration Facility in Southern California that is showcasing Ivanhoe's revolutionary heavy-oil upgrading technology (HTL). Ivanhoe Energy now is preparing to test crudes from potential partners, with an initial focus on heavy crudes from California and Western Canada, including bitumen from Canada's Athabasca Tar Sands region.


Ivanhoe Energy is an independent international oil and gas exploration and development company building long-term growth in its reserve base and production. Ivanhoe Energy is a leader in technologically innovative methods designed to significantly improve reserves of oil and gas through the upgrading of heavy oil to light oil, state-of-the-art drilling techniques, enhanced oil recovery (EOR) and the conversion of natural gas to liquids (GTL). Core operations are in the United States and China, with business development opportunities worldwide.

Ivanhoe Energy trades on the NASDAQ Capital Market with the ticker symbol IVAN and on the Toronto Stock Exchange (TSX) with the symbol IE.

[actr]

NAUTILUS INC
18.01.06 20:11 Uhr

13,969 USD

-24,61 % [-4,561]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=NLS.NYS&lColors=0x000000&sSym=NLS.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=NLS.NYS&lColors=0x000000&sSym=NLS.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=NLS.NYS&lColors=0x000000&sSym=NLS.NYS&hcmask=

Börse
NYSE

Aktuell
13,969 USD

Zeit
18.01.06 20:11

Diff. Vortag
-24,61 %

Tages-Vol.
119,15 Mio.

Gehandelte Stück
9,1 Mio.



Nautilus, Inc. Announces Preliminary Fourth Quarter 2005 Results

VANCOUVER, Wash., Jan 18, 2006 (BUSINESS WIRE) -- Nautilus, Inc. (NYSE:NLS), a leading marketer, developer, and manufacturer of branded health and fitness products, today provided preliminary fourth quarter 2005 results, and announced the date of its next quarterly conference call with investors.
Based upon preliminary information, the Company announced that it expects fourth quarter 2005 net sales in the range of $179-183 million, with corresponding earnings per share in the $0.07-0.12 range. The Company's previous fourth quarter 2005 guidance presented on November 2, 2005, estimated net sales of $210 million and earnings per share in the $0.44-0.48 range.

"Our innovation-centered business model generated increasing consumer interest in our products again in the fourth quarter, helping us achieve net sales growth of 21 percent in fiscal 2005," said Gregg Hammann, Chairman and Chief Executive Officer. "However, we are experiencing growing pains in ramping innovation through the manufacturing side of our business, which resulted in delays in the introduction of new products that were expected to have significant sales and earnings in the fourth quarter. We are continuing to make progress in improving our manufacturing and operational capacity as we adjust to a fast pace of product innovation. We are closing gaps and improving efficiencies in each stage of our go-to-market process."

The Company continues to expect 15-20 percent annualized sales growth, and 20-30 percent annualized earnings growth, through its 2006-08 strategic business plan.

The fourth quarter 2005 conference call is scheduled for 5 p.m. EST (2 p.m. PST) February 1, 2006. It will be broadcast live over the Internet hosted at www.nautilusinc.com/events and will be archived online within one hour after completion of the call. In addition, listeners may call 800-729-5806 from anywhere in North America, and 212-676-4919 from outside North America. Participants will include: Gregg Hammann, Chairman and Chief Executive Officer; Bill Meadowcroft, Chief Financial Officer; and Tim Hawkins, Chief Customer Officer and Chief Marketing Officer.

A telephonic playback will be available from 7:00 p.m. PST February 1 through 7:00 p.m. PST, February 10, 2006. North American callers can dial 800-633-8284 and other international callers can dial 402-977-9140 to hear the playback. The passcode is 21282027.

About Nautilus, Inc.

Headquartered in Vancouver, Wash., Nautilus, Inc. (NYSE:NLS) is a pure fitness company that provides tools and education necessary to help people achieve a fit and healthy lifestyle. With a brand portfolio that includes Nautilus(R), Bowflex(R), Schwinn(R)Fitness, StairMaster(R), Trimline(R) and Pearl iZUMi(R), Nautilus manufactures and markets a complete line of innovative health and fitness products through direct, commercial, retail, specialty and international channels. The Company was formed in 1986 and had sales of $524 million in 2004. It has 1,400 employees and operations in Washington, Oregon, Colorado, Oklahoma, Texas, Illinois, Virginia, Canada, Switzerland, Germany, United Kingdom, Italy, China, and other locations around the world. More information is at www.nautilusinc.com.

[actr]

Intel Corporation
18.01.06 21:10 Uhr

22,51 USD

-11,79 % [-3,01]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=INTC.NAS&lColors=0x000000&sSym=INTC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=INTC.NAS&lColors=0x000000&sSym=INTC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=INTC.NAS&lColors=0x000000&sSym=INTC.NAS&hcmask=

Börse
NASDAQ

Aktuell
22,51 USD

Zeit
18.01.06 21:10

Diff. Vortag
-11,79 %

Tages-Vol.
4,93 Mrd.

Gehandelte Stück
244 Mio.

Despite its third straight year of double-digit earnings growth, Intel reportedly disappointed many Wall Street analysts that expected better numbers from the world's leading computer chip maker.

[actr]

Yahoo! Inc.
18.01.06 21:18 Uhr

35,24 USD

-12,14 % [-4,87]
KGVe:
46,99

http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=YHOO.NAS&lColors=0x000000&sSym=YHOO.NAS&hcmask=

Börse
NASDAQ

Aktuell
35,26 USD

Zeit
18.01.06 21:19

Diff. Vortag
-12,09 %

Tages-Vol.
3,38 Mrd.

Gehandelte Stück
103 Mio

Yahoo Profit Jumps; Shares Slide

United States, Jan 18, 2006 (Newsbytes via COMTEX) -- Yahoo Inc. said yesterday that its fourth-quarter profit nearly doubled and revenue was up almost 40 percent, but Wall Street viewed the earnings report as disappointing and sent the Web portal's stock tumbling by more than 13 percent in after-hours trading.
For the quarter that ended Dec. 31, Yahoo said it earned $683.2 million, compared with $372.5 million for the comparable period in 2004. For the 2005 fiscal year, the Sunnyvale, Calif.-based company earned $1.9 billion, compared with $839.6 million the previous year.

Yahoo executives credited the increase to advertisers moving to the Internet and said advertiser spending could double for the company within the next two years.

Analysts agreed that online advertising sales in the United States would probably see substantial increases, with the fastest growth coming from search-based ads. In that arena, Yahoo's market share slipped to 19 percent in November from 27 percent a year earlier. Google Inc. saw its share jump to 60 percent from 47 percent.

Financial analysts had expected earnings of 17 cents per share, excluding one-time gains and tax benefits. Yahoo missed that forecast by a penny, and its stock plummeted $5.15 in after-hours trading to $34.96.

Simply, analysts said, Yahoo's quarter wasn't good enough to wow Wall Street.

"What's disappointing about it is they didn't really trump people's expectations," said Oppenheimer & Co. analyst Sasa Zorovic. "People are now saying: 'Look, I was anticipating more. I didn't get what I anticipated, so I'm going to scale back.'

"For Yahoo, people always hope they will become more like Google, and this quarter was not Google-like," he said. "Google definitely beats and raises expectations. Yahoo was more ho-hum in that sense

[actr]

Stereotaxis, Inc.
18.01.06 21:24 Uhr

13,33 USD

+14,62 % [+1,70]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=STXS.NAS&lColors=0x000000&sSym=STXS.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=STXS.NAS&lColors=0x000000&sSym=STXS.NAS&hcmask= http://isht.comdirect.de/charts/large.chart?hist=10d&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=STXS.NAS&lColors=0x000000&sSym=STXS.NAS&hcmask=

Börse
NASDAQ

Aktuell
13,33 USD

Zeit
18.01.06 21:24

Diff. Vortag
+14,62 %

Tages-Vol.
13,44 Mio.

Gehandelte Stück
1,1 Mio.

Stereotaxis Announces Initial U.S. Clinical Usages of Cardiac Ablation Catheter With Company's Niobe(R) System - Significant Milestone Achieved With Successful Complex Ablations Completed at Three Leading U.S. Electrophysiology Centers Utilizing the

ST. LOUIS, Mo., Jan 12, 2006 /PRNewswire-FirstCall via COMTEX/ -- Stereotaxis, Inc. (Nasdaq: STXS) today announced the achievement of a significant milestone with three leading electrophysiology sites becoming the first U.S. centers to successfully treat cardiac arrhythmias using the Celsius(R) RMT Diagnostic and Ablation Catheter. This proprietary catheter, which was co-developed by Stereotaxis and Biosense Webster, recently received FDA approval for use with the Stereotaxis Niobe(R) Magnetic Navigation System. This expands applications of the Stereotaxis Niobe System in the U.S. from diagnostic and device delivery procedures into the major therapeutic market for minimally invasive endocardial ablation treatment of cardiac arrhythmias. The worldwide market for these procedures is experiencing rapid growth and Stereotaxis estimates that the market currently comprises more than 400,000 procedures per year, of which approximately 70% are conducted in the U.S.
During the week of January 2, Cleveland Clinic, Baptist Memorial Hospital-Memphis and St. Elizabeth's Medical Center of Boston completed a total of 15 procedures with the Stereotaxis Niobe system, including successful completion of complex AVNRT ablation, AV node ablation, Atrial Tachycardia Ablation and treatment of Wolff-Parkinson-White Syndrome, as well as a number of Bi-Ventricular pacing lead placements for treatment of Congestive Heart Failure. The Cleveland Clinic procedures, which included a complex atrial tachycardia, were successfully completed in the Cleveland Clinic's department of Cardiovascular Medicine, section of Electrophysiology and Pacing, which is co-chaired by Dr. Andrea Natale, M.D., and Patrick Tchou, M.D. Dr. Tchou performed the ablation utilizing Stereotaxis' Niobe Magnetic Navigation system to successfully complete the ablation.

"The Stereotaxis system marks a fundamental change in the way we can treat cardiac arrhythmias," said Dr. Tchou. "During the successful treatment of a patient with an atrial tachycardia, we were able to precisely and easily adjust the tip of the Celsius RMT Diagnostic and Ablation Catheter using computer control. The catheter maintained an extraordinarily consistent contact with the tissue during the application of energy that is not generally achieved in manual ablation. Consistent contact is a critical element to the success of the ablation."

"Until today, in order to map and ablate arrhythmia, it was necessary to manually advance and rotate a fairly stiff catheter in an effort to reach specific points within the heart," said Dr. Natale. "Adding computer control and automation to precisely steer soft, magnetically enabled catheters offers the potential to improve the treatment of complex arrhythmia. We look forward to treating a wide range of arrhythmias with this enhanced technology."

Eric Johnson, M.D., of Baptist Memorial Hospital, successfully completed two AV node ablations with the Stereotaxis system in combination with the Celsius RMT Diagnostic and Ablation Catheter. "The decreased procedure time and increased efficiency seen in our initial experiences using the Stereotaxis system in combination with the Celsius RMT Diagnostic and Ablation Catheter are rarely achieved when relying on manual ablation," said Dr. Johnson. "At a community hospital, speed and efficiency are obviously critical to the center's ability to increase patient volume, and I believe that leveraging this technology could be helpful in increasing patient flow."

Charles I. Hafajee, M.D., of St. Elizabeth's Medical Center commented, after completing successful ablation procedures with the Celsius RMT Diagnostic and Ablation Catheter, "I am very impressed with the combination of the Stereotaxis system and the new mapping and ablation catheters. The system is intuitive, user-friendly and enables us to reproduce accurate and detailed maps of cardiac anatomy."

Physicians in Europe have been able to utilize the Celsius RMT Ablation Catheter with the Niobe system since CE Mark authorization was received in March 2005 and have conducted successful ablation procedures for a variety of arrhythmias, including Wolff-Parkinson-White Syndrome, AVNRT and AVRT.

The Niobe system utilizes a computer-controlled magnetic field to remotely steer a magnetic catheter or other device through the vasculature to the target therapy site and to apply therapy with precision and efficiency, utilizing sophisticated integration of major imaging technologies. Additionally, clinical feedback indicates that use of the Niobe system reduces physician exposure to imaging radiation during procedures and that the system enhances patient safety because the consistent, "soft-touch" contact with the heart wall unique to magnetically enabled catheters may reduce the risk of vessel or other tissue perforation during procedures. The core components of the Stereotaxis system have received regulatory clearance in the U.S. and Europe.

"The use of magnetic navigation to precisely control the therapeutic tip of soft ablation catheters is a fundamental improvement over the existing practice of physicians manually controlling devices that are difficult to manipulate," said Bevil Hogg, President and CEO of Stereotaxis. "We firmly believe that Stereotaxis has the potential to become the new standard of care for both routine and highly complex ablation and other cardiac procedures."

[actr]

One Rep Too Many

By Lawrence Carrel
January 18, 2006


--------------------------------------------------------------------------------
Nautilus, Inc. (NLS1)

--------------------------------------------------------------------------------
Share price as of Tuesday's close: $18.53
Share price now: $13.91
Change: -24.9%
Volume: 11.6 million shares, daily average 693,500 shares
Last time this low: Jan. 29, 2004
52-week high: $29.65
52-week low: $16.70
Forward P/E before announcement: 15.4 (based on $1.20 a share)
Forward P/E after announcement: 16.2 (based on 86 cents a share)

--------------------------------------------------------------------------------

THE PRICE OF NAUTILUS (NLS2) stock plummeted like a weight stack with a slipped pin Wednesday.
Shares of the manufacturer of health and fitness products fell 25% to a two-year low of $13.91 after the Vancouver, Wash., company warned manufacturing problems would cause fourth-quarter earnings to come in 75% below its previous guidance. Despite plenty of consumer interest for its new products, Ron Arp, Nautilus's director of communications, says production bottlenecks put a damper on results.

" The ramp-out in terms of quantity available for sale proceeded much more slowly than expected; therein lies the shortfall," says Arp. " I would present this as growing pains in a company that seeks to grow its product offerings. It's about a commitment to get it right the first time, and we ended up not selling the kind of volume we expected, despite the fact there was strong consumer interest. We just couldn't meet demand."

The reason Nautilus didn't see the shortfall earlier in the quarter, says Arp, was because half of all fourth-quarter sales occur in December, with a large part coming right before Christmas through New Year's Day, as people make resolutions to exercise more. And while the company may have lost some sales to competitors, Arp says products have a three- to four-year life cycle and that " the market place is hungry for new fitness equipment."

Nautilus now expects fourth-quarter earnings to total between seven cents and 12 cents a share on net sales of $179 million to $183 million. That bears little similarity to the company's November guidance of profits between 44 cents and 48 cents on $210 million in revenues. Thomson First Call had a consensus estimate of 46 cents. The November guidance, too, was the result of a warning; previously the company had said it would earn 55 cents to 57 cents a share. In the year-ago fourth quarter Nautilus earned $14.2 million, or 42 cents, on sales of $169.6 million.

" The company didn't hold a conference call, so it's very hard to get a hold of what caused a $25 million to $30 million top-line shortfall," says Marc Bettinger, an analyst at Stanford Group, an investment bank based in Boca Raton, Fla. " I understand we're talking about a manufacturing issue related to new products, but why this occurred and the planning involved remains unanswered. What steps are being taken to resolve it?" On Wednesday, Bettinger cut his rating on the stock to Hold from Buy.

Nautilus said it was in the process of improving manufacturing and operational capacity, but spokesman Arp declined to offer specifics. Among the 20-year-old company's fitness products are its namesake brand of commercial gym machines, Bowflex home gym equipment, Schwinn Fitness exercise bikes, StairMaster step machines, Trimline treadmills and Pearl iZUMi sports apparel, as well as nutritional supplements. In 2004 Nautilus posted sales of $524 million.

" Management clearly will need to enact significant changes to the company's supply chain to not only address such a lack of operational efficiency in the near term, but to also ensure such problems do not arise in the future," wrote Rommel Dionisio, an analyst at Los Angeles investment bank Wedbush Morgan Securities, on Wednesday. " We still believe that management has done an impressive job of growing the top line in recent quarters, through gaining important new retail customers as well as successful new product introductions. However, it now becomes clear that the company's supply chain and production infrastructure were not up to the challenge of keeping pace with such increased demand."
Dionisio said typically when such significant operational challenges occur in the consumer-products industry, it requires at least two quarters to fix the problems. Accordingly, he cut his rating on the stock to Hold from Buy.

Despite the fourth-quarter stumble, Nautilus reiterated its forecast for 20% to 30% annualized earnings growth on 15% to 20% annualized sales growth from 2006 through 2008. The company expects to release final results on Feb. 1.

In 2002, Nautilus posted record earnings of $98 million. But investors who bought shares at the start of that year had lost 55% two years later. For most of 20033 sales and earnings plunged on what the company called a " challenging business environment4."

The company said it completed a turnaround in 2004 and that 2005 was expected to be a year of growth and investment in the future. But with the stock down nearly 60% from its midyear high of $29.65, some might say the company is still in turnaround mode.

Part of the past year's selloff related to Nautilus being found liable for falsely advertising its Bowflex home gym over a 17-year period. In November, a jury in federal court in Salt Lake City found the company misled customers by saying Bowflex had " patented power rods," when it really was a patented product that used power-rod technologies. A judge is currently reviewing the $7.8 million judgment.

Quote:
" If demand wasn't there I would be concerned, but demand is strong," says Eric Wold, an analyst at San Francisco investment bank Merriman Curhan Ford & Co. " The problem is Nautilus is launching too many new products in too short a period of time. Also, I think there is a big misunderstanding from the press release. The company is expected to earn 70 cents in fiscal 2005 and people are forecasting 2006 earnings of 85 cents to 90 cents. However, management thinks the manufacturing problem is a one-time thing. So, the 30-cent earnings hit for 2005 should be added back in, for a total of $1 a share, before looking for 20% to 30% earnings growth. That means 2006 should see earnings between $1.20 and $1.30 a share."

[actr]

Dynavax's Ragweed Allergy Therapy, TOLAMBA(TM), Achieves Primary Efficacy and Safety Endpoints in Phase 2/3 Trial Statistical Significance Achieved in Primary Endpoint (p=0.024) and Major Secondary Endpoints; Pivotal Phase 3 Trial Anticipated to Begi

BERKELEY, Calif., Jan 18, 2006 /PRNewswire-FirstCall via COMTEX/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) announced that results from a two-year Phase 2/3 clinical trial of TOLAMBA, a ragweed allergy immunotherapeutic, showed that patients treated with TOLAMBA experienced a statistically significant reduction in total nasal symptom scores (TNSS) compared to placebo-treated patients in the second year of the trial, the primary efficacy endpoint of the study (p=0.024). Results also showed significant clinical benefit relative to secondary endpoints, including composite hay fever symptoms and ocular effects, and a significant reduction in antihistamine use (p=0.01). These results were achieved after a single short course of therapy prior to the first ragweed season (2004), and demonstrated that a booster dose prior to the second season (2005) was not required to achieve clinical benefit. Unlike the TOLAMBA-treated group, the boosted group did not achieve statistical significance relative to the primary efficacy endpoint compared to placebo. The safety profile of TOLAMBA was favorable. Systemic side effects were indistinguishable from placebo and local injection site tenderness was minor and transient.
Based on these results Dynavax anticipates initiating a large-scale pivotal Phase 3 clinical trial of TOLAMBA in the first half of 2006 and pursuing discussions with the US Food & Drug Administration (FDA) concerning the potential registration strategy for TOLAMBA. Dynavax intends to present the detailed clinical results of the Phase 2/3 trial at the upcoming meeting of the American Association of Allergy, Asthma and Immunology (AAAAI), March 3-7, in Miami, Florida. Dr. William W. Busse, MD, Professor of Medicine, University of Wisconsin-Madison, Clinical Science Center, and principal investigator for the study, will make the presentation at AAAAI. A separate company announcement will provide details of that presentation.

"We believe that the positive outcome in this allergy trial represents a major success for Dynavax and its shareholders and expands our leadership in the TLR-9 agonist space. This achievement provides important validation of our ISS technology's potential to modify disease through immune system reprogramming and complements the positive results shown to date with HEPLISAV(TM), our hepatitis B vaccine," said Dino Dina, MD, president and chief executive officer.

Continued Dr. Dina: "We are fully committed to the development of TOLAMBA and believe this product could represent the cornerstone of our strategy to establish a valuable allergy franchise. We are preparing to initiate our pivotal Phase 3 trial within the next few months and will look forward to upcoming discussions with the FDA concerning key parameters in this study and our regulatory strategy. In addition, our ongoing clinical trial in ragweed allergic children is progressing well and should yield primary endpoint results following the 2006 ragweed season. We sincerely appreciate the support and enthusiasm of our many clinical investigators in the Phase 2/3 trial, and will look forward to building on these relationships as we implement our pivotal Phase 3 trial."

TOLAMBA represents the foundation of a comprehensive allergy franchise for Dynavax, and has the potential to be a novel entrant in the multibillion-dollar global allergy market. In the US alone, approximately 40 million people suffer from allergic rhinitis. Ragweed is the single most common seasonal allergen, affecting up to 75% of those with allergic rhinitis, or 30 million Americans. Current therapeutic options are mainly limited to symptomatic therapies and conventional allergy immunotherapy, which generally requires 60-90 shots over three to five years and represents a significant treatment burden for allergy sufferers. TOLAMBA has the potential to offer a safe, efficacious and convenient alternative for patients suffering from ragweed allergy.

"The results of the Phase 2/3 clinical trial are encouraging, clearly demonstrating that TOLAMBA has a meaningful clinical benefit in reducing the symptoms of ragweed allergy and has an attractive safety profile," said Dr. Busse. "TOLAMBA could represent an entirely novel approach to allergy immunotherapy and has the potential to offer allergy sufferers with severe as well as moderate or mild disease an effective, convenient and safe alternative to conventional treatment."

Phase 2/3 Trial Design

The Phase 2/3 TOLAMBA clinical trial, initiated in early 2004, was a two-year, randomized, double-blind, placebo-controlled study conducted at 29 sites in the midwestern, southwestern and eastern US. The trial involved 462 subjects, aged 18 to 55 years, with moderate to severe ragweed allergy (hay fever). Prior to the 2004 ragweed season, which generally lasts from August through October, subjects received six weekly doses of either placebo or escalating doses of up to 30 micrograms of TOLAMBA, in a two-to-one randomization, TOLAMBA to placebo group. Prior to the 2005 ragweed season, one half of the TOLAMBA-treated subjects received two additional booster shots. The other half of the TOLAMBA-treated group received placebo injections and the original placebo-treated group received placebo injections. The trial protocol permitted subjects to self-administer pseudoephedrine hydrochloride (Sudafed(R), Pfizer, Inc.) and fexofenadine hydrochloride (Allegra(R), sanofi-aventis), as needed.

The primary objective of the trial was to assess the treatment difference in a subject-rated 24-hour total nasal symptom score. The primary efficacy endpoint was the change from baseline in TNSS during the peak period of the 2005 ragweed season of the TOLAMBA-treated groups compared to the placebo group. TNSS includes nasal symptoms (congestion, sneezing, itching and runny nose) rated on a four-point scale. Patients recorded their symptoms electronically on a daily basis. Results were analyzed comparing the TOLAMBA-to-TOLAMBA and TOLAMBA-to-placebo groups to the placebo-to-placebo treatment group over the two-week peak period of the 2005 ragweed season. Secondary objectives included the change in hay fever symptoms (visual analog score or VAS, recorded electronically on a weekly basis), eye symptoms, aggregate hay fever scores, quality of life, medication use, the change in serum IgG and IgE antibody response to Amb a 1, and safety.

About ISS Technology and TOLAMBA

Immunostimulatory sequences (ISS) are short synthetic DNA molecules that stimulate a Th1 immune response while suppressing Th2 immune responses. ISS contain specialized sequences that activate the innate immune system. ISS are recognized by a specialized subset of dendritic cells containing a unique receptor called Toll-Like Receptor 9, or TLR-9. The interaction of TLR-9 with ISS triggers the biological events that lead to the suppression of the Th2 immune response and the enhancement of the Th1 immune response.

TOLAMBA consists of Dynavax's proprietary ISS molecule linked to the purified major allergen of ragweed, called Amb a 1. TOLAMBA is designed to target the underlying cause of seasonal allergic rhinitis caused by ragweed. The conjugation of ISS to Amb a 1 ensures that both ISS and ragweed allergen are presented simultaneously to the same immune cells, producing a highly specific and potent inhibitory effect and suppressing the Th2 cells responsible for inflammation associated with ragweed allergy.

Dynavax was founded in August 1996 by Dr. Dennis A. Carson, Dr. Eyal Raz, and Dr. Lawrence M. Lichtenstein, based on work done at the University of California at San Diego. Dr. Raz and Dr. Carson co-invented the conjugation technology linking ISS to allergens and other antigens that is a key aspect of TOLAMBA's mechanism of action.


Dynavax Technologies Corporation
19.01.06 16:47 Uhr

5,62 USD

+29,20 % [+1,27]

Typ: Aktie WKN: 2698737

Börse: NASDAQ



http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=DVAX.NAS&lColors=0x000000&sSym=DVAX.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=DVAX.NAS&lColors=0x000000&sSym=DVAX.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=log&dsc=abs&avgtype=exp&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=DVAX.NAS&lColors=0x000000&sSym=DVAX.NAS&hcmask=

NASDAQ

Aktuell 5,62 USD

Zeit 19.01.06 16:47

Diff. Vortag +29,20 %

Tages-Vol. 4,23 Mio.

Gehandelte Stück 895.323

Geld 5,61

Brief 5,64

Zeit 19.01.06 16:47

[actr]

JDS Uniphase Corporation
19.01.06 17:11 Uhr

3,09 USD

+7,30 % [+0,2101]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=JDSU.NAS&lColors=0x000000&sSym=JDSU.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=JDSU.NAS&lColors=0x000000&sSym=JDSU.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=JDSU.NAS&lColors=0x000000&sSym=JDSU.NAS&hcmask=

Börse
NASDAQ

Aktuell
3,09 USD

Zeit
19.01.06 17:11

Diff. Vortag
+7,30 %

Tages-Vol.
98,87 Mio.

Gehandelte Stück
33 Mio.

[actr]

Millicom International Cellular S.A.
19.01.06 18:59 Uhr

36,86 USD

+32,30 % [+9,00]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=MICC.NAS&lColors=0x000000&sSym=MICC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=MICC.NAS&lColors=0x000000&sSym=MICC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=MICC.NAS&lColors=0x000000&sSym=MICC.NAS&hcmask=

Börse
NASDAQ

Aktuell
36,75 USD

Zeit
19.01.06 18:39

Diff. Vortag
+31,91 %

Tages-Vol.
81,40 Mio.

Gehandelte Stück
3,1 Mio.

Millicom International Cellular S.A. announces review of strategic options

Jan 19, 2006 (NORDIC BUSINESS REPORT via COMTEX) -- The Swedish-controlled international telecomms investor Millicom International Cellular S.A. said on Thursday (19 January) that due to the recent receipt of a high number of unsolicited approaches its board of directors had decided to conduct a review of strategic options for the company.
The company has appointed Morgan Stanley as financial advisor.

Millicom said that it remains confident in its current strategy and growth prospects and the outcome of the review may not lead to any transaction.

Swedish investment company Investment AB Kinnevik said in a separate statement that, as the largest shareholder in Millicom, it supports the decision to review strategic options for the company.

[actr]

Charlotte Russe Holding, Inc.
19.01.06 19:15 Uhr

16,38 USD

-16,00 % [-3,12]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=CHIC.NAS&lColors=0x000000&sSym=CHIC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=CHIC.NAS&lColors=0x000000&sSym=CHIC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=CHIC.NAS&lColors=0x000000&sSym=CHIC.NAS&hcmask=

Börse
NASDAQ

Aktuell
16,36 USD

Zeit
19.01.06 19:16

Diff. Vortag
-16,10 %

Tages-Vol.
53,67 Mio.

Gehandelte Stück
3,4 Mio.


Charlotte Russe Announces First Quarter Results * First Quarter Sales Rose 34.3% With Same Store Sales Increase of 15.6% * EPS of 29 Cents Per Share Increases 222% Over Same Quarter Last Year * 14 New Stores Opened in Quarter, 35 New Stores Planned f

SAN DIEGO, Jan 19, 2006 /PRNewswire-FirstCall via COMTEX/ -- Charlotte Russe Holding, Inc. (Nasdaq: CHIC), a growing mall-based specialty retailer of fashionable, value-priced apparel and accessories targeting young women in their teens and twenties, today reported financial results for the first quarter of fiscal 2006 ended December 24, 2005.

Mark Hoffman, Chief Executive Officer, remarked: "Our comparable store sales improvement in this first quarter reflects significant progress made in both brands to reclaim market share. Charlotte Russe recorded positive comp sales trends in apparel which was complemented by continued strength in our accessory categories. Rampage, while posting double digit comp sales growth, continues to be a work in process with its brand repositioning."

"At the quarter-end," Mr. Hoffman continued, "inventory levels at comparable stores were up 20% over prior year levels due, in part, to the earlier receipts of transitional Spring merchandise this year. As a result, we were well positioned following Christmas and thereafter. In fact, comparable store sales for the first three weeks of January have been running double-digit during this clearance period. Going into the fourth week of January, inventories at comparable stores were up high teens over the same week last year, and we feel very confident about the fashion Spring content and quality of our merchandise. Our new Spring floor sets should be complete by the second week of February in both brands."

Mr. Hoffman added: "The Charlotte Russe brand continues to trend positively. With respect to the Rampage repositioning, during 2004 we experienced significant negative comp sales until Spring 2005 when the elevated product and price points gained support from our targeted customer base. While we have achieved a rebound in sales, it was partially due to a stronger promotional strategy and higher markdown expense. During the first quarter of fiscal 2006, we continued to build average store volumes for the Rampage chain; however, markdowns ran high and the store-level financial performance was not much better than the same time last year. In summary, we have been successful in rebuilding in part our Rampage store volumes; however, more progress is needed with our product gross margins. For the coming two quarters, we expect that the high level of promotional activities will continue and that, at the store-level, Rampage is expected to show a loss in the second quarter of fiscal 2006 with a projected profit in the subsequent third quarter."

"The continuation of elevated promotional strategies for market share, higher charges for stock options and bonuses this year, and the calendar shift of a later Easter will all impact the second quarter which is the lowest volume period of the year. Because of the calendar shift, we feel that the next two quarters should be viewed together; therefore, for this reason and for this quarter only, we are providing investors with financial guidance for the next two quarters. Assuming no significant change in the overall retailing environment, we would guide investors to expect low double-digit positive comparable store sales in the second and third quarters of fiscal 2006 with a loss of 3 to 7 cents per share for the second quarter, compared to a loss of 3 cents last year, and diluted earnings per share of 20 to 24 cents for the third quarter, compared to 14 cents last year," Mr. Hoffman concluded.

As has been the company's policy, this guidance does not include the potential of any business risks, opportunities or developments that may occur after January 19, 2006. Management does not expect to report on its second quarter financial performance, or to comment on it to the investment community, until after the financial results for the second quarter have been released on or about April 20, 2006.

Financial Results:

Net sales for the first quarter increased 34.3% to $201.5 million from $150.0 million for the first quarter last year. Comparable store sales increased 15.6% during the quarter, compared to a decrease of 9.9% for the first quarter of fiscal 2005.

Operating income for the first quarter was $11.4 million as compared to $3.5 million for the same quarter last year. Net income increased 227% to $7.1 million from $2.2 million during the same quarter last year. Diluted earnings per share of 29 cents for the quarter compared to 9 cents for the same quarter of the prior year, an increase of 222%.

Included in the quarterly results was a $0.6 million pre-tax charge, which represented a 1.5-cent impact on diluted earnings per share, associated with the new requirement to recognize compensation expense for the company's stock option plan. The average number of shares outstanding during the recent quarter was 24.5 million on a diluted basis.

Charlotte Russe Holding, Inc. is a growing mall-based specialty retailer of fashionable, value-priced apparel and accessories targeting young women in their teens and twenties. The company operated a total of 422 stores in 43 states and Puerto Rico, as of December 24, 2005, comprised of 356 Charlotte Russe stores and 66 Rampage stores. The company expects to open up to 35 new Charlotte Russe stores during the fiscal year ending in September 2006.

The "Charlotte Russe" stores offer fashionable, affordable apparel and accessories that have been tested and accepted by the marketplace, thus appealing to women who prefer established fashion trends. The "Rampage" stores feature trendsetting apparel and accessories and thus appeal to women with a flair for making fashion statements and who want runway-inspired fashion, quality and value.

[actr]

Lifeline Systems, Inc.
19.01.06 19:34 Uhr

46,95 USD

+18,89 % [+7,46]
KGVe:
39,45

http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=LIFE.NAS&lColors=0x000000&sSym=LIFE.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=LIFE.NAS&lColors=0x000000&sSym=LIFE.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=LIFE.NAS&lColors=0x000000&sSym=LIFE.NAS&hcmask=

Börse
NASDAQ

Aktuell
46,95 USD

Zeit
19.01.06 19:34

Diff. Vortag
+18,89 %

Tages-Vol.
63,34 Mio.

Gehandelte Stück
1,5 Mio.

Lifeline Systems to be Acquired by Royal Philips Electronics; Lifeline Shareholders to Receive $47.75 per Share in Cash

FRAMINGHAM, Mass., Jan 19, 2006 (CCNMatthews via COMTEX) -- Lifeline Systems Inc. (NASDAQ: LIFE) announced today that it has signed a definitive merger agreement with Royal Philips Electronics (NYSE:PHG, AEX:PHI) under which Philips will acquire Lifeline, a leader in personal emergency response services. Philips has agreed to acquire Lifeline for $47.75 per share or a total equity value of $750 million (equaling an aggregate value of $690 million net of $60 million cash and cash equivalents) in a transaction that has been unanimously approved by the Board of Directors of Lifeline. Completion of the transaction is subject to the terms and conditions of the merger agreement, which contains customary closing conditions and is subject to the approval of Lifeline's shareholders.
"The acquisition of Lifeline is an important step on our roadmap for growth in healthcare," says Gerard Kleisterlee, President and CEO of Royal Philips Electronics. "By targeting seniors and other people who want to continue living independently and exerting more control over their health and lifestyle," he added, "we aim to become a global player in the evolving home healthcare market."

The aging of the population provides strong underlying market growth for home healthcare solutions such as those offered by Lifeline. Today, seniors represent around 15% of the population in the developed world and are expected to almost double in size over the next 25 years. At the same time they are becoming increasingly active in managing their own health and wellness. Personal response services are already the largest category of home healthcare solutions purchased out-of-pocket by older adults and their caregivers. Still, penetration in the age group 65 years and older is just 2-3%, allowing for significant future growth.

Lifeline's revenues in 2005 are expected to be approximately $150 million, representing a 15% increase over 2004. A large part of the revenues are recurring in nature. Lifeline's operating margins in 2005 are expected to be approximately 15%. The company has a broad market presence in United States and Canada. The company markets its services through a network of more than 2,500 hospitals and other healthcare providers and serves a subscriber base of nearly 470,000.

Lifeline's twenty-four hours a day service gives independently minded seniors the confidence to maintain an active life at home, knowing if they suddenly need help, they can send an alert to a call-center that indicates they need assistance. Two-way communication allows a caring and extensively trained operator - who has instant access to the pertinent health history and personal profile of the caller - to establish the nature of the problem. Appropriate action can then be taken, including notifying a neighbor or family member, or summoning emergency services.

"Our many years of understanding consumers and their needs have led us to identify 'healthcare at home' as a key sector for us," stated Ivo Lurvink, CEO of Philips Consumer Health & Wellness. "Lifeline is a market-leader that offers us a platform for other home healthcare products and services. As such it complements our existing presence in telemedicine, showcased in Motiva, our advanced interactive healthcare system. We believe our brand, global presence, technology and innovation capabilities will accelerate the growth of the company and we're very much looking forward to working with their experienced management team and talented employees."

Lifeline President and CEO Ron Feinstein said, "Philips' acquisition of Lifeline represents the next phase in the continued evolution and growth of our company. This combination of two industry leaders opens up numerous product and technology synergies, as well as growth opportunities designed to both further and broaden Lifeline's founding mission of providing personal emergency response and support services to the at-risk elderly and their families to enhance their independence and quality of life."

[actr]

Lam Research Corporation
19.01.06 21:02 Uhr

43,54 USD

+13,62 % [+5,22]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=LRCX.NAS&lColors=0x000000&sSym=LRCX.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=LRCX.NAS&lColors=0x000000&sSym=LRCX.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=LRCX.NAS&lColors=0x000000&sSym=LRCX.NAS&hcmask=

Börse
NASDAQ

Aktuell
43,54 USD

Zeit
19.01.06 21:02

Diff. Vortag
+13,62 %

Tages-Vol.
429,30 Mio.

Gehandelte Stück
10 Mio.


BUYINS.NET: LAM Research (LRCX) SqueezeTrigger Price Is $29.45. Short Sellers Are Down Approximately $73 Million After Company Beats Earnings Estimates.

Jan 19, 2006 (M2 PRESSWIRE via COMTEX) -- www.buyins.net, announced today that the 5.51 million shares declared short on LAM Research Corp. (NASDAQ: LRCX) have a SqueezeTrigger Price of $29.45 per share. Lam Research Corp. said on Wednesday that second-quarter earnings slipped 7 percent, but results easily beat analysts' estimates, sending shares up in after-hours activity. The developer of semiconductor processing equipment said net income for the quarter ended Dec. 25 was $77.8 million, or 55 cents per share, down from $83.6 million, or 59 cents per share last year. Revenue for the quarter was $358.2 million, down from $379.8 million. Analysts polled by Thomson Financial expected the company to earn, on average, 39 cents per share for the quarter on $344.1 million in revenue. Short sellers are down approximately $73 million as the stock is currently trading near $42.84. To access SqueezeTrigger Prices ahead of short squeezes beginning, visit http://www.buyins.net/squeezetrigger.pdf.
From January to December of 2005, an aggregate amount of 227,021,056 shares of LRCX have been shorted for a total dollar value of $6.68 billion. The LRCX SqueezeTrigger price of $29.45 is the volume weighted average price that all shorts are short in shares of LRCX. Since crossing above the SqueezeTrigger Price, shares of STX are up nearly 45%. There is still approximately $235 million worth of potential short covering in shares of LRCX.

Lam Research Corporation (NASDAQ: LRCX) engages in the design, manufacture, marketing, and service of semiconductor processing equipment used in the fabrication of integrated circuits. Its products include etch systems, including dielectric etch products, conductor etch products, and resist strip products, as well as synergy cleaning products. The company markets its products and services primarily to companies involved in the production of semiconductors in the United States, Europe, Asia Pacific, Korea, and Japan. Lam Research Corporation was founded in 1980 and is headquartered in Fremont, California.

[actr]

Cashing In on Chips

By Lawrence Carrel
January 19, 2005


--------------------------------------------------------------------------------
Fairchild Semiconductor International, Inc. (FCS1)

--------------------------------------------------------------------------------
Share price as of Wednesday's close: $17.85
Share price now: $19.64
Change: 10.0%
Volume: 5.0 million shares, daily average 1.1 million shares
Last time this high: May 28, 2004
52-week high: $18.62
52-week low: $12.80
Forward P/E before news: 33.7 (based on 53 cents a share)
Forward P/E after news: 28.5 (based on 69 cents a share)

--------------------------------------------------------------------------------

AN EARNINGS MISS FOR INTEL (INTC2) no longer signals doom for the entire chip industry, it seems.
Shares of Fairchild Semiconductor International (FCS3) climbed 10% to a new 52-week high of $19.64 after the maker of chips for consumer electronics, PCs and industrial equipment reported fourth-quarter results grew substantially over the previous quarter and predicted the trend will continue into the new year.

That stands in sharp contrast to the 11% tumble Intel shares took Wednesday after the company failed to meet its midquarter guidance.

"The industry doesn't march to Intel's beat anymore as the consumer end-market becomes a bigger driver," says Ramesh Misra, an analyst at New York investment bank C.E. Unterberg Towbin. "In general, we are in the early stages of an upswing in the semiconductor cycle. When that happens, the companies that benefit most are often the ones supplying the commodity products, because pricing leverage for those products tends to be the greatest. That's helping Fairchild in the near term."

Fairchild's fourth-quarter results fell well short of year-ago numbers, but showed marked improvement over the third quarter. Adjusted earnings totaled $13.6 million, or 11 cents a share, compared with a year-earlier $24.8 million, or 21 cents. Analysts were looking for seven cents, according to Thomson First Call. Even on an adjusted basis, Fairchild posted posted a net loss of $3 million, or three cents a share in the third quarter.

Revenues climbed 7% sequentially to $370.8 million in the fourth quarter, but fell 2% from the fourth quarter of 2004. Gross margin jumped 3.4 percentage points sequentially, but fell 1.4 percentage points year-over-year.

"Fairchild has gone through a multiquarter process of reducing channel inventories and internal inventories," says Craig Berger, an analyst at Wedbush Morgan Securities, a Los Angeles investment bank. "Its inventory levels drive production, and production amounts drive gross margin. Over the past three quarters it has drained the inventory channels so sales can bounce back."

Fairchild said it reduced internal inventories by more than 20% and channel inventories about 16% compared with 2004. Tighter channel management increased fourth-quarter sell-through by about 4% sequentially, the highest level in more than four years.

Intel's earnings miss was especially disappointing considering the strength of the personal computer market. According to technology research firm Gartner, world-wide PC unit shipments grew an estimated 16% in the fourth quarter on strong holiday sales. Merrill Lynch analyst Richard Farmer wrote on Thursday that he now expects world-wide PC units to grow 10.5% for 2006, up from his previous estimate of 8.5%. Microsoft's (MSFT4) new operating system, Vista, is due out in the fourth quarter of 2006.

Market watchers say Intel's problems don't look industry-specific, but rather company-specific5. Advanced Micro Devices (AMD6), Intel's chief rival, is grabbing market share from the chip giant. Both companies primarily manufacture central processors for PCs. AMD's stock gained 4% on Wednesday.

"I think overall the chip sector is healthy," says Tore Svanberg, an analyst at Minneapolis investment bank Piper Jaffray. "We have to look at the two companies and compare what they do. Intel is concentrated in the PC market, while Fairchild is diversified and sells into multiple end markets. Whether Intel loses market share or not, that doesn't affect Fairchild. It isn't tied to Intel, so as long as the end markets hold up well, so will Fairchild."

Fairchild doesn't make central processors, but the South Portland, Maine, company derives 26% of its sales from the PC industry. Consumer devices like DVD players, game consoles, cameras and personal digital assistants make up 22% of sales. Cellphones bring in 13%, and industrial power supplies, 28%. The rest of sales come from cars, televisions and monitors.

"I don't think that there is the industry disconnect that a superficial analysis of the headlines suggests there is," says Mark Thompson, Fairchild's president and chief executive. "Intel grew in the same range that we grew. It just wasn't as much as their own forecasts. So, when I look at the entire industry, I don't see that disconnect."

Thompson says Fairchild's channel inventories increased significantly in 2004 because demand didn't materialize. But during 2005, Fairchild began selling off inventory, improving its cash flow in the process. The company used the funds to pay down its debt to a record low $100.7 million.

Sales were solid across all the end markets with particular strength in products supporting computing, consumer and industrial applications, said Thompson. He added that bookings outpaced the strong fourth-quarter sales growth, and that the company expects the trend to continue. With a higher backlog position and shipping at levels in line with end-market demand, first-quarter sales are expected to grow 5% to 7% sequentially. Gross margins are forecast to increase another two to three percentage points sequentially.

Quote:
"With the stock up 12% today, I would recommend that people not chase it," says Piper Jaffray's Svanberg. "The positive news is now in the stock, so the only way I would recommend it is if there was meaningful upside to current 2006 numbers. There could be, but it's too early to tell."




http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=FCS.NYS&lColors=0x000000&sSym=FCS.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=FCS.NYS&lColors=0x000000&sSym=FCS.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=FCS.NYS&lColors=0x000000&sSym=FCS.NYS&hcmask=

[actr]

CITIC Securities Expected to See Net Profit Up by Over 50%

BEIJING, Jan 20, 2006 (SinoCast via COMTEX) -- CITIC Securities Co., Ltd. (SHSE: 600030) expects to see its net profit for 2005 jump by over 50 percent compared with the previous year.
Most of Chinese securities firms were experiencing restructuring in 2005. But, CITIC Securities, the nation's largest listed brokerage, seized the opportunity to commence its expansion in a large scale. It successively acquired operations from several securities firms, including Wantong Securities, Huaxia Securities and Gold Stone Securities.

The series of acquisition and regrouping vaulted CITIC Securities into the leader in brokerage and investment banking fields. So, the company could achieve the outstanding performance in 2005, said industry insiders.

CITIC Securities is a subsidiary of China International Trust and Investment Corp. (CITIC), the largest financial conglomerate in the country. Compared with majority of the nation's securities firms that incur losses, CITIC Securities is regarded as one of the better players in the industry.

[actr]

Nitches, Inc. 10.60 +4.5501 (+75.21 %)

Sedol: 2087885 Exch: NASDAQ Sym: NICH 20/01 14:41
http://focus.squaregain.co.uk/_common/informer/lib/chart/middlechart.chart?minYear=820022400&sSymbol=NICH.NAS&sTimeframe=iD&sTimestamp=iD+iD+820022400

http://focus.squaregain.co.uk/_common/informer/lib/chart/middlechart.chart?hiddenTimeFrame=1&iInd0=na&iInd1=2&iInd2=na&iIndcount=1&iType=1&minYear=820022400&sAv1=na&sAv2=200&sAv2count=1&sBench1=na&sBench2count=1&sBenchcount=1&sMarket=NICH.NAS&sOrdType=price&sScale=linear&sSettings=na&sSymbol=NICH.NAS&sTimeframe=5D&sTimestamp=1137164100+1137768900+820022400
http://focus.squaregain.co.uk/_common/informer/lib/chart/largechart.chart?iInd0=1&iInd1=2&iInd2=5&iIndcount=1&iType=4&minYear=820022400&sAv1=na&sAv2=200&sAv2count=1&sBench1=na&sBench2count=1&sBenchcount=1&sMarket=NICH.NAS&sOrdType=price&sScale=linear&sSettings=na&sSymbol=NICH.NAS&sTimeframe=3M&sTimestamp=1129991400+1137767400+820022400


Price Time Trades 212

Latest 10.50 14:42 20/01 Traded Shares 82,710

Bid 10.40 14:42 20/01 Trading Volume 868,455.00

Offer 10.65 14:43 20/01 52W High 8.20

Open 10.94 20/01 52W Low 3.192

High 12.72 20/01 1Y High 8.20

Low 10.12 20/01 1Y Low 5.23

Close 6.0499 18:14 19/01 Split (05.05.98) 1 : 2



Nitches, Inc. Announces First Quarter Fiscal 2006 Results:

SAN DIEGO, CA, Jan 20, 2006 (MARKET WIRE via COMTEX) -- Nitches, Inc. (NASDAQ: NICH)

-- Earnings per share of $.42 reverses year ago loss


-- Net Sales increase 132% to $14.7 million


-- Order backlog up 80% to $23.4 million

Nitches, Inc. (NASDAQ: NICH) announced today its results for the three months ended November 30, 2005. The Company earned consolidated net income of $520,000 for the first quarter of fiscal 2006, reversing a $12,000 loss in the year ago period. First quarter earnings per share were $.42 versus a loss of $.01 for the first quarter of fiscal 2005. Earnings were negatively impacted due to one time, non-cash adjustments related to the acquisition. Consolidated pretax income before the effect of these one time charges was $1.6 million and net income was $936,000 or $.75 per share. Earnings per share for the current period reflect the effect of 180,000 shares issued for the acquisition of Designer Intimates.

On October 24, 2005, Nitches acquired the remaining seventy-two percent (72%) of Designer Intimates, Inc. which it did not own, resulting in the Company owning one hundred percent (100%) of Designer Intimates. The primary reason for the acquisition was to acquire the trademarks and brand licenses held by Designer Intimates to complement the Company's broad production base and provide a platform for future revenue growth. Nitches currently distributes men's casual lifestyle clothing by Newport Blue(R), Dockers(R) men's swimwear and t-shirts, golf apparel by The Skins Game, women's sleepwear and loungewear by Body Drama(R) and women's western wear by Adobe Rose(R), Saguaro(R) and Southwest Canyon(R). With the recent acquisition of Designer Intimates, the Company markets sleepwear, robes, loungewear, and daywear under the following brands: Argentovivo(R), Derek Rose(R), Princesse tam tam(R), Crabtree & Evelyn(R), The Anne Lewin(R) Collection, The Bill Blass(R) Lifestyle Collection, The Dockers(R) Collection, The Claire Murray(R) Collection and The Vassarette(R) Collection. Products are sold to better department stores, specialty boutiques, moderate department stores, and national and regional discount department stores and chains. The Company also develops and manufactures private label products for many leading retailers and catalogs.

Consolidated net sales for the first quarter of fiscal 2006 increased 132% to $14.7 million versus $6.3 million for the first quarter of 2005. Net sales contributed by the Company's newly acquired Designer Intimates business totaled $6.4 million. At November 30, 2005, the Company had unfilled customer orders of $23.4 million compared to $13.0 million at the same time last year, with such orders generally scheduled for delivery by May 2006 and May 2005, respectively. The increase of $10.4 million is due primarily to the additional orders being reported as a result of the acquisition of Designer Intimates. The amount of unfilled orders at any given time is affected by a number of factors, including the timing of the receipt and processing of customer orders and the scheduling of the manufacture and shipping of the product, which may be dependent on customer requirements.

Nitches, Inc. has been designing and marketing quality apparel for niche markets since 1971. The Company is headquartered in San Diego, California, with offices in Los Angeles, New York City, Hong Kong and Istanbul. The Company's shares are traded on the NASDAQ Capital Market under the symbol NICH. Visit our web site at http://www.nitches.com.

Backlog amounts include both confirmed orders and unconfirmed orders that the Company believes, based on industry practice and past experience, will be confirmed. While cancellations, rejections and returns have generally not been material in the past, there can be no assurance that such action by customers will not reduce the amount of sales realized from the backlog of orders at November 30, 2005.

[actr]

AVI BioPharma, Inc.
20.01.06 18:29 Uhr

8,23 USD

+39,73 % [+2,34]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=AVII.NAS&lColors=0x000000&sSym=AVII.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=AVII.NAS&lColors=0x000000&sSym=AVII.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=AVII.NAS&lColors=0x000000&sSym=AVII.NAS&hcmask=

Börse
NASDAQ

Aktuell
8,22 USD

Zeit
20.01.06 18:30

Diff. Vortag
+39,56 %

Tages-Vol.
214,07 Mio.

Gehandelte Stück
29 Mio.

AVI BioPharma Reports Confirmation of Efficacy against Influenza Strains; NEUGENE Antisense Efficacy against Influenza Strains, Including Avian Influenza, to Lead to IND Filing with the FDA

PORTLAND, Ore., Jan 20, 2006 (BUSINESS WIRE) -- AVI BioPharma, Inc. (Nasdaq: AVII) today announced confirmation from three independent laboratories of NEUGENE(R) antisense efficacy in preclinical experiments against multiple strains of influenza, including avian influenza strain H5N1.
-- Dr. P. Puthavathana at Mahidol University in Bangkok, Thailand, confirmed NEUGENE antisense efficacy against an H5N1 viral isolate in her assay system.

-- Dr. Darwyn Kobasa at the Public Health Agency of Canada in Winnipeg, Manitoba, completed an initial dose-response study in cell culture demonstrating NEUGENE efficacy against both the H1N1 and H3N2 strains.

-- Dr. Manoj Pastey at Oregon State University in Corvallis, Ore., confirmed efficacy using the same NEUGENE antisense agents against the H7N7 and H3N8 strains.

Taken together, these data confirm efficacy observed with the H1N1 strain previously reported from Drs. Jianzhu and Chen Qin Ge at Massachusetts Institute of Technology in Boston and now represent positive reports from four laboratories using different endpoints and methodologies.

"These confirmations validate our approach to blocking replication of influenza viruses. We now believe that a single NEUGENE drug could be effective against most influenza subtypes, including the H5N1 avian strain," said Patrick L. Iversen, Ph.D., senior vice president of research and development at AVI. "By targeting regions of the viral genetic code that are common to all influenza A subtypes, we expect that our NEUGENE drugs will be effective against avian flu and the far more common influenza A viruses, which kill an average of 35,000 Americans every year."

AVI is also conducting collaborative animal studies evaluating NEUGENE efficacy against influenza strains at Tulane University in New Orleans and at the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID) in Frederick, Maryland.

"Based on these recent findings and other results from additional studies, AVI now plans to file an Investigative New Drug (IND) application with the FDA for the treatment of influenza A virus with NEUGENE antisense drugs," said Denis R Burger, Ph.D., chief executive officer of AVI. "We feel confident in the safety, efficacy and potency of our NEUGENE drugs targeting influenza and plan to move forward into the clinical trial process later this year."

AVI's NEUGENE antisense drug development program against the influenza A virus specifically targets genetic regions of the virus that are highly conserved between six viral subtypes that cause human disease. These include three subtypes that caused pandemics in the 20th century -- the 1918 Spanish flu (H1N1), the 1957 Asian flu (H2N2) and the 1968 Hong Kong flu (H3N2) -- and three subtypes of avian flu that have been reported to cause disease in humans (H5N1, H7N7 and H9N2).

AVI's Antiviral Program

AVI's proprietary NEUGENE antisense drug candidates have demonstrated efficacy in preclinical studies against SARS coronavirus, West Nile virus (WNV), hepatitis C virus (HCV), dengue virus, Ebola virus, and Marburg virus. AVI has filed IND applications with the U.S. Food and Drug Administration and has ongoing clinical trials in WNV and HCV.

Showing how versatile NEUGENE drugs can be across viral subtypes, AVI demonstrated in its collaboration with the Centers for Disease Control and Prevention that NEUGENE agents are efficacious against all four immunologically distinct subtypes of the dengue virus. This outcome was achieved by targeting a highly conserved region of the dengue viral genetic code. In collaborative work with the USAMRIID targeting the Ebola virus, NEUGENE drugs protected three animal species from lethal challenges with this virus (see PloS Pathog 2(1): e1). Additional clinical development efforts targeting dengue virus and Ebola virus are planned for 2006.

The speed with which effective NEUGENE drugs can be designed and manufactured exceeds any other modern drug development timeframe. For example, NEUGENE compounds targeting SARS, WNV and Ebola were developed within days to weeks of obtaining the appropriate genetic sequences for the viruses.

AVI's Clinical Experience

AVI's NEUGENE antisense drugs have a well-defined safety record in human clinical trials. Approximately 300 patients have been dosed with NEUGENE drug candidates targeting host and viral gene targets in 12 clinical studies under multiple INDs. Five routes of administration have been employed in AVI's clinical studies, and doses up to 450 mg have been administered without a single drug-related, serious adverse event. The combination of AVI's NEUGENE chemistry with conserved viral targets that are not expressed in the human genome makes a strong case for the potential for success in the development of candidates to address influenza, including the possible emergence of a transmittable avian flu.

About Influenza A Viruses

Influenza, or flu, is a contagious respiratory illness caused by influenza viruses. On average 5 percent to 20 percent of the U.S. population is infected with the flu each year. Influenza A virus is an enveloped negative-strand RNA virus, with eight genome segments that code for 10 proteins. Influenza strains are subtyped according to the antigenic and genetic nature of their surface glycoproteins: hemagglutinin (HA or H) and neuraminidase (NA or N). Fifteen H and nine N subtypes have been identified, with three associated with widespread human disease (H1N1, H2N2 and H3N2). In addition, several subtypes of avian influenza virus -- H5N1, H7N7 and H9N2 -- can infect and cause disease in humans.

The current influenza pandemic in birds throughout Asia, Eastern Europe and Turkey is caused by the H5N1 subtype. It is thought that co-infection of humans or certain animals (such as pigs) with both H1N1 and H5N1 can lead to a reassortment or recombination of viral particles, resulting in the emergence of a virus with dangerous public health properties, namely one to which the human population has no natural immunity and which has the ability to spread easily from person to person. It is believed that emergence of avian flu by this general mechanism may have led to the worldwide pandemics of 1918, 1957 and 1968.

About AVI BioPharma

AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs. AVI's lead NEUGENE antisense compound is designed to target cell proliferation disorders, including cardiovascular restenosis, cancer and polycystic kidney disease. In addition to targeting specific genes in the body, AVI's antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus and Ebola virus. AVI has introduced a NEUGENE-based exon-skipping technology called ESPRIT therapy. More information about AVI is available on the company's Web site at http://www.avibio.com.

[actr]

Hoku Scientific, Inc.
20.01.06 19:00 Uhr

10,25 USD

+12,02 % [+1,10]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&€cy=&&lSyms=HOKU.NAS&lColors=0x000000&sSym=HOKU.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&€cy=&&lSyms=HOKU.NAS&lColors=0x000000&sSym=HOKU.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&€cy=&lSyms=HOKU.NAS&lColors=0x000000&sSym=HOKU.NAS&hcmask=

Börse
NASDAQ

Aktuell
10,25 USD

Zeit
20.01.06 19:00

Diff. Vortag
+12,02 %

Tages-Vol.
13,02 Mio.

Gehandelte Stück
1,6 Mio.

Hoku Scientific, Inc. Reports Third Quarter 2006 Results

KAPOLEI, HI, Jan 19, 2006 (MARKET WIRE via COMTEX) -- Hoku Scientific, Inc. (NASDAQ: HOKU)

Highlights:

-- Quarterly revenue increases to $1.7 million compared to $75,000 in the

year ago period; For nine month period, revenue increases to $4.1 million

compared to $175,000 in the year ago period


-- Net income increases to $0.01 per diluted share from a loss of $0.11

per diluted share in the prior year; For the nine month period, net income

increases to $0.06 per diluted share from a loss of $0.40 per diluted share

in the year ago period


-- Fourth consecutive profitable quarter


-- Hoku successfully completes milestones in contract with Nissan Motor

Co., Ltd.


-- Hoku and Sanyo Electric Company, Ltd. enter into new joint testing

agreement


-- Hoku and IdaTech LLC begin manufacturing 11 fuel cell systems for the

U.S. Navy

Hoku Scientific, Inc. (NASDAQ: HOKU), a designer, developer and manufacturer of membrane electrode assemblies (MEAs) and membranes for proton exchange membrane (PEM) fuel cells, today announced its financial results for its third quarter ended December 31, 2005 and provided a general update on its business. The Company also announced that it has successfully completed all technical milestones in its contract with Nissan, and entered into a new joint testing agreement with Sanyo Electric Co., Ltd. to provide for Sanyo`s testing and integration of the Company`s next generation MEA products at Sanyo`s R&D facility in Japan. Furthermore, the Company conveyed that it successfully completed the remaining milestones in its initial contract with the U.S. Navy and, in coordination with IdaTech LLC, has begun manufacturing eleven fuel cell systems.

Revenue for the quarter ended December 31, 2005, was $1.7 million, compared to $75,000 in the quarter ended December 31, 2004. Revenue for the nine months ended December 31, 2005 was $4.1 million, compared to $175,000 for the same nine months in 2004. Total deferred revenue, which is attributable to contracts with the U.S. Navy and Sanyo Electric Company, Ltd. of $2.1 million and $260,000, respectively, declined to $2.4 million at December 31, 2005 compared to $4.2 million at March 31, 2005 primarily due to the recognition of $4.1 million of deferred revenue during the nine months ended December 31, 2005 related to contracts with Nissan Motor Co., Ltd.

Net income, computed in accordance with GAAP, for the quarter ended December 31, 2005 was $202,000, or $0.01 per diluted share, compared to a net loss, computed in accordance with GAAP, of $650,000, or $0.11 per diluted share for the quarter ended December 31, 2004. Net income, computed in accordance with GAAP, for the nine months ended December 31, 2005 was $836,000, or $0.06 per diluted share, compared to a net loss, computed in accordance with GAAP, of $2.1 million, or $0.40 per diluted share for the same nine months in 2004.

Non-GAAP net income for the quarter ended December 31, 2005 was $447,000, or $0.03 per diluted share, compared to a non-GAAP net loss of $336,000, or $0.06 per diluted share for the quarter ended December 31, 2004. Non-GAAP net income (loss) for the quarters ended December 31, 2005 and 2004 excludes non-cash stock-based compensation of $245,000 and $314,000, respectively. Non-GAAP net income for the nine months ended December 31, 2005 was $1.6 million, or $0.11 per diluted share, compared to a non-GAAP net loss of $1.2 million, or $0.23 per diluted share for the nine months ended December 31, 2004. Non-GAAP net income (loss) for the nine months ended December 31, 2005 and 2004 excludes non-cash stock-based compensation of $773,000 and $898,000, respectively. The accompanying schedules provide a reconciliation of net income (loss) and net income (loss) per share computed on a GAAP basis to net income (loss) and net income (loss) per share computed on a non-GAAP basis.

Dustin Shindo, chairman, president and chief executive officer of Hoku Scientific, said, "We achieved our fourth consecutive profitable quarter, with revenue and profit growth compared to the same period last year. We continue to execute on the contracts we already have in place with an impressive list of customers. We have successfully completed key technical milestones on or ahead of schedule, while also building out our pipeline of potential customers. Recently, we signed a new contract with Sanyo and successfully achieved all technical milestones in our contract with Nissan. We also moved forward with the first option under our contract with the U.S. Navy.

"During the quarter we installed and tested our new manufacturing equipment making our production line ready for full operations. We also continue to install and test other new manufacturing equipment in an effort to expand our capacity to meet potential future customer demands. We are pleased with the progress of our technology development and the status of our various customer relationships, and remain optimistic about the growth of the fuel cell industry and our competitive position within this growing industry."

Forward Guidance

The Company`s policy is only to provide guidance for the next fiscal quarter. Fluctuations in quarterly revenue are expected to continue in future periods due to uncertainty regarding the level and the timing of revenue from customer contracts and achievement of contract milestones. Based on its current outlook, the Company expects revenue for the fourth quarter ending March 31, 2006 to be in the range of $1.7 to $2.0 million. In addition, the Company expects that it will need to increase its efforts in supporting its new and existing contracts, in developing the Company`s next generation products and in growing its customer base. The result is that the Company expects its costs to increase significantly. Based upon projections, the Company expects net income to be in the range of a loss to break even or slightly profitable. Except as required by law, the Company assumes no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

[actr]

Supertex, Inc.
20.01.06 20:04 Uhr

32,21 USD

-25,53 % [-11,04]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=SUPX.NAS&lColors=0x000000&sSym=SUPX.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=SUPX.NAS&lColors=0x000000&sSym=SUPX.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=SUPX.NAS&lColors=0x000000&sSym=SUPX.NAS&hcmask=


Börse
NASDAQ

Aktuell
32,21 USD

Zeit
20.01.06 20:04

Diff. Vortag
-25,53 %

Tages-Vol.
139,00 Mio.

Gehandelte Stück
4,9 Mio.


Supertex Reports Third Fiscal Quarter Results

SUNNYVALE, CA, Jan 19, 2006 (MARKET WIRE via COMTEX) -- Supertex, Inc. (NASDAQ: SUPX) today reported net sales of $19,915,000 for the third fiscal quarter ended December 31, 2005, a 33% increase from the $14,925,000 reported for the same quarter of the prior fiscal year, and a 2% decrease compared with the prior quarter of $20,226,000. Net income for the quarter increased 64% to $3,689,000 or $0.26 per share on a diluted basis from $2,250,000 or $0.17 on a diluted basis for the same quarter of the prior fiscal year, and decreased 13% from $4,247,000 or $0.31 per share on a diluted basis when compared with the prior quarter.
For the nine-month period ended December 31, 2005 compared to the same period of the prior fiscal year, net sales increased 26% from $44,715,000 to $56,134,000, and net income increased 78% from $6,026,000 to $10,755,000.

Dr. Henry C. Pao, President and CEO, commented, "Our net sales decreased by 2% sequentially in our third fiscal quarter, but increased 33% year over year. Our gross margin dropped 2% to 54%, from the prior fiscal quarter mostly due to our slightly lower sales this quarter and operating inefficiencies during the quarter caused by numerous holidays and our production facilities being shutdown in the last week for annual maintenance and upgrade work. Inventory went up by $635,000, partly due to increased inventory at a customer's hub and at some foreign distributors where we found that some of the volume products we shipped to them per their order schedules during the last two weeks of the quarter were not shipped to their end-customers as quickly as is typical. Since we only recognize revenue on shipments to distributors upon their resale of our product, even for our foreign distributors, this caused our revenue to be less than our shipments for the quarter and caused our inventory to increase correspondingly. However, when we checked the inventory at these distributors on January 9, 2006, it had all been shipped to the end customers. In fact, this week we received several big orders to replenish their inventory of the same products. Cash flow was positive in the quarter. Cash, cash equivalents, and short-term investments increased by $6,667,000 to $102,966,000 during the quarter. Our research and development expenses in the quarter increased $194,000 from prior quarter to $2,792,000 due to increasing activities in new product development. Our sales and marketing expenses decreased by $53,000, or less than 3% from the prior quarter, resulting from the decrease of 2% in net sales compared to the prior quarter. Based on our backlog and forecast from our customers, we are projecting a good sequential top line growth and improvement in our gross margin for our fourth fiscal quarter and the next fiscal year over the previous quarter and fiscal year respectively."

[actr]

FARO Technologies, Inc.
20.01.06 20:34 Uhr

14,83 USD

-28,36 % [-5,87]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&€cy=&&lSyms=FARO.NAS&lColors=0x000000&sSym=FARO.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&€cy=&&lSyms=FARO.NAS&lColors=0x000000&sSym=FARO.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&€cy=&lSyms=FARO.NAS&lColors=0x000000&sSym=FARO.NAS&hcmask=

Börse
NASDAQ

Aktuell
14,83 USD

Zeit
20.01.06 20:34

Diff. Vortag
-28,36 %

Tages-Vol.
32,55 Mio.

Gehandelte Stück
2,2 Mio.

FARO Maintains Sales Guidance and Lowers Earnings Guidance for Q4

Jan 19, 2006 /PRNewswire-FirstCall via COMTEX/ -- FARO Technologies, Inc. (Nasdaq: FARO) today announced that for the fourth quarter ended December 31, 2005, it expects to report sales of approximately $34.6 million, a 21.4% increase from $28.5 million in the fourth quarter of 2004, and within the $33-$35 million range given by the company on November 3, 2005. Earnings are now expected to be in the range of $0.03 to $0.05 per diluted share, rather than in the previously expected range of $0.19 to $0.27 per diluted share, and below the current First Call consensus estimate of $0.21 per diluted share.
"Our fourth quarter sales and gross margin are expected to be within our forecasted ranges, as are R&D expenditures. However, SG&A expenses and income tax for the quarter are expected to be substantially higher than forecasted," said Jay Freeland, President and COO. "Selling expenses are expected to be approximately $2.5 million higher than forecasted because of higher commissions ($1.5 million) in part related to payment of incentive bonuses for sales people who exceeded their annual goals, higher headcount ($700,000), and higher marketing costs ($300,000). General and Administrative expenses are expected to be approximately $700,000 higher than forecasted due to legal expenses, including patent litigation and our insurance deductible related to a class action suit brought against the Company in December ($450,000), and ramp up costs in our new Singapore headquarters ($250,000). Our income tax rate for the quarter is expected to be approximately 25% vs. our estimate of 15-17% due to higher than expected sales in the Americas and lower than expected sales in Europe, the latter which is a lower tax jurisdiction for the Company. The net impact of higher taxes to the company in the fourth quarter is expected to be approximately $100,000."

"Our expected fourth quarter results will bring annual sales to approximately $125.7 million for fiscal 2005, a 29.6% increase from $97.0 million in fiscal 2004," said Simon Raab, CEO. "Gross margin is expected to be approximately 58% for 2005, and we expect to report net income of approximately $8.5-$8.8 million or approximately 6.8%-7.0% of sales (approximately $0.59-$0.61 per share). The 2005 year was marked with significant positioning investments through geographic expansion and an acquisition, along with high legal expenses related to litigation and a more normalized tax rate of approximately 17.0%. We expect some additional headcount and other expansion expenses to spill over into the first half of 2006, and a continuation of legal costs related to litigation. However, I am optimistic that we will begin to leverage our growth-related expenses into improved operating margins by the second half of 2006."

The company expects to release earnings for the fourth quarter of 2005 on Tuesday, February 21, 2006, before the market opens and will host a conference call at 11:00 a.m. eastern time the same day.

About FARO

With more than 9,100 installations and 4,100 customers globally, FARO Technologies, Inc. (Nasdaq: FARO) and its international subsidiaries design, develop, and market software and portable, computerized measurement devices. The Company's products allow manufacturers to perform 3-D inspections of parts and assemblies on the shop floor. This helps eliminate manufacturing errors, and thereby increases productivity and profitability for a variety of industries in FARO's worldwide customer base. Principal products include the FARO TrackArm; FARO Laser ScanArm; FARO Laser Scanner LS; FARO Gage and Gage- PLUS; Platinum, Digital Template, Titanium, Advantage FaroArms; the FARO Laser Tracker X and Xi; and the CAM2 family of advanced CAD-based measurement and reporting software. FARO Technologies is ISO 9001 certified and ISO-17025 laboratory registered.

[actr]

A Full Measure of Disappointment

By Lawrence Carrel
January 20, 2006


--------------------------------------------------------------------------------
Faro Technologies, Inc. (FARO1)

--------------------------------------------------------------------------------
Share price as of Thursday's close: $20.70
Share price now: $15.40
Change: -25.6%
Volume: 2.8 million shares, daily average 340,600 shares
Last time this low: Oct. 9, 2003
52-week high: $31.20
52-week low: $16.42
Forward P/E before announcement: 23.5 (based on 88 cents a share)
Forward P/E after announcement: 29.6 (based on 52 cents a share)

--------------------------------------------------------------------------------

FARO TECHNOLOGIES (FARO2) MAKES laser-based measurement equipment that can spot a thousandth-of-an-inch error from 230 feet away. But when it comes to earnings forecasts the company shows the precision of a chimpanzee calligrapher.
Shares of the Lake Mary, Fla., company sank 26% to a two-year low of $15.40 Friday after management warned that fourth-quarter earnings would miss its previous estimates by as much as 84% due to higher-than-expected expenses.

" This doesn't surprise us at all," says Jonathan Dorsheimer, an analyst at Boston investment bank Canaccord Adams. " This is the third warning since August."

Faro announced late Thursday that it now foresees fourth-quarter earnings shrinking to between three cents and five cents a share, vs. the company's November guidance of 19 cents to 27 cents. Thomson First Call had a consensus estimate of 21 cents. Sales should increase 21% to $34.6 million, in line with its previous forecast range of $33 million to $35 million. In its second and third quarters, Faro missed analysts' earnings estimates by 24% and 28% respectively.

The company makes robotic arms with laser systems that measure components that go into cars, airplanes, factories and more. By performing 3-D inspections of parts and assemblies on the shop floor, the tools help customers increase productivity and profits by eliminating manufacturing errors.

Faro said fourth-quarter gross margin and research-and-development expenditures should land within previously forecasted ranges. However, the company now anticipates a sharp increase in selling, general and administrative expenses, which include the cost of things like salaries, commissions, executive travel and advertising. Specifically, selling costs are expected to top projections by $2.5 million, of which $1.5 million is attributable to commissions, $700,000 comes from staff additions and $300,000 is due to marketing costs. General and administrative costs are seen exceeding forecasts by $700,000, including $450,000 for legal costs — the company is involved in a patent dispute with rival Hexagon Metrology over laser-scanning technology — and $250,000 for ramping up a new manufacturing facility in Singapore.

The company also expects its income tax rate for the quarter to hit 25%, rather than its earlier forecast of 15% to 17%. This it blamed on higher-than-expected sales in the Americas and lower-than-expected sales in Europe.

" One positive is that 2005 is closed and is now history," wrote A.G. Edwards analyst Mark Jordan in a Friday note reiterating his Buy rating. " What caused the higher operating expenses? Major sales-force and Pacific Rim expansion materially lowered profits; the acquisition of IQvolution [a German laser-scanner maker bought in early 2005] likely cost the company approximately 10 cents per share; and litigation costs associated with the class-action lawsuit and patent litigation probably cost the company six to 10 cents a share. The higher commissions cited in the press release appear to be the result of outperformance on the part of some salespeople."

Separate from the patent dispute with Hexagon, Faro faces numerous class-action suits over alleged violations of federal securities laws. The central allegation is that certain of the company's public disclosures between May 6, 2004 and Nov. 3, 2005, were materially false or misleading. The company " adamantly denies" that any of its public disclosures violated any federal securities law and said the lawsuits are baseless.

Jordan was pleased that sales and gross margin hit their targets. As for the higher-than-expected expenses, he wrote, " these appear not to be ongoing in nature and could be described as an anomaly." Following that logic, Jordan anticipates the company will regain normal margins in the second half of 2006 as sales increase 23% to $155 million. Together, these factors should cause earnings to rebound. Jordan also expects Faro to increase its sales by 20% to 25% in 2007, and boost its operating margin to the 15% it experienced in 2004.

" I am optimistic that we will begin to leverage our growth-related expenses into improved operating margins by the second half of 2006," said Faro President and Chief Operating Officer Jay Freeland in a written statement. The company, which plans to release finalized fourth-quarter results on Feb. 21, didn't return phone calls seeking comment.

Quote:
" Our take on this is that management is currently tied up in the legal battle with Hexagon," says Dorsheimer of Canaccord Adams. " This has distracted management for the past two quarters. The real surprise here is not that SG&A expenses are high — we had been anticipating a high level of SG&A due to Faro's sales-force ramp — but the fact that SG&A expenses are so far out of proportion to the firm's revenue run rate. While we continue to like the Faro story longer term, in the near term we feel the current lawsuit with Hexagon, combined with sharp increases in headcount, are weighing on the company's ability to leverage its business model. We would become more constructive at lower prices, or when the current patent lawsuit is settled and management is able to focus its full attention on growing the business."

[actr]

20.01.2006 22:35
Google erlebt historischen Sell off
Google (Nachrichten/Aktienkurs) hat am Freitag einen veritablen Rücksetzer hinnehmen müssen. Der Titel verbilligte sich um knapp 9% auf 399,46 Dollar und erlebte damit seinen bisher größten Kurssturz binnen eines Tages. Gleichzeitig vollzog sich der Ausverkauf bei einem Rekordvolumen. Noch nie, seit der Titel börsennotiert ist, wechselten binnen eines Tages so viele Stücke den Besitzer. 40 Millionen Aktien wurden gehandelt, mehr als bei der Börseneinführung der Suchmaschine.

Zuletzt verlor Google in ähnlicher Größenordnung am 5.November 2004, als die Aktie 8,3% auf 169 Dollar nachgab. Seinerzeit hatte ein UBS-Analyst sich kritisch über die Aussichten des Unternehmens geäußert.

Nachbörslich kann sich der Titel derzeit weitgehend stabilisieren und notiert bei 399,24 Dollar (-0,06%).

[actr]

Google-Aktien auf Talfahrt


http://kurier.at/mmedia/17.12.2005/1134816933_3.jpg

Der Gesamtwert der Microsoft-Aktien ist derzeit mit 281 Milliarden Dollar mehr als doppelt so hoch wie der der Google-Aktien.
Die Aktien des weltgrößten Internetsuchmaschinen-Betreibers und Wall-Street-Lieblings Google sind am Freitag um fast 8,5 Prozent auf 399,46 Dollar (331,01 Euro) eingebrochen. Sie haben damit innerhalb eines Tages fast elf Milliarden Dollar an Wert verloren. Das US-Justizministerium will Google zur Herausgabe von Millionen Suchanfrage-Daten aus einer Woche zwingen. Dies hat Google abgelehnt. Die Wall Street sorgte sich über die Reaktionen von Internet-Nutzern auf die Forderungen Washingtons.

Hinzu kam die Enttäuschung über die in dieser Woche vorgelegten Geschäftsergebnisse des Google-Hauptkonkurrenten Yahoo. Dies ließ an der Wall Street teilweise Befürchtungen über die Google-Zahlen für das Schlussquartal 2005 aufkommen. Sie werden am 31. Jänner vorgelegt.

Weit vom Tief 2005 entfernt

Seit dem am 11. Jänner verbuchten Höchststand von 475,11 Dollar haben die Google-Aktien fast 16 Prozent an Wert verloren. Der Gesamtwert der Aktien fiel seither um rund 22 Milliarden auf derzeit etwa 118 Milliarden Dollar. Der Google-Aktienkurs ist jedoch mit 399,46 Dollar noch mehr als doppelt so hoch wie das Zwölfmonatstief von 172,57 Dollar vom März 2005.

Google liegt beim Gesamtwert seiner Aktien auch weit vor anderen Internet-Riesen wie dem Online-Auktionshaus eBay (Börsenwert 63 Mrd Dollar), Yahoo (47,9) und dem weltgrößten Online-Einzelhändler Amazon.com (18). Die Aktien des weltgrößten Computerkonzerns IBM, deren Gesamtwert hinter Google gerutscht war, sind inzwischen mit 128,5 Milliarden Dollar wieder mehr wert als die von Google.



Artikel vom 21.01.2006 |apa

[actr]

The Banc Corporation Announces Fourth Quarter 2005 Results

Jan 23, 2006 /PRNewswire-FirstCall via COMTEX/ -- The Banc Corporation (Nasdaq: TBNC) announced today its 2005 fourth quarter results of operations. The Banc Corporation reported net income for the quarter ended December 31, 2005 of $1,196,000, compared to a net loss of $275,000 for the quarter ended December 31, 2004.
CEO Stan Bailey stated, "During 2005, The Banc Corporation successfully addressed the major priorities established by the new management team - transaction deposit growth, wholesale funding reduction, improved credit quality, recruitment of experienced bankers and new investments in key growth markets in northeast Alabama and Florida. These successes are reflected in a 37% enhancement in shareholder value since year-end 2004 and will continue to be our primary areas of emphasis in 2006 and beyond."

Net income (loss) per common share for the three- and twelve-month periods ended December 31, 2005 and 2004 was as follows:


For the Three-Month For the Twelve-Month

Period Ended Period Ended

December 31, December 31,

(In thousands, except (In thousands, except

per share data) per share data)

2005 2004 2005 2004

Net income (loss) $1,196 $(275) $(6,115) $1,187


Less:

Preferred stock dividends - 228 305 446

Effect of early conversion

of preferred stock - - 2,006 -


Net income (loss) available

to common stockholders $1,196 $(503) $(8,426) $741


Net income (loss) per

common share

Basic $0.06 $(0.03) $(0.44) $0.04

Diluted $0.06 $(0.03) $(0.44) $0.04

The Corporation provided $750,000 to the allowance for loan losses during the fourth quarter. Net charge-offs for the fourth quarter were $763,000. The allowance for loan losses at December 31, 2005 was $12.0 million, or 1.25% of loans, net of unearned income, compared to $12.5 million, or 1.34% of loans, net of unearned income, at December 31, 2004. Non-performing assets ("NPAs") declined to 0.68% of total loans plus NPAs as of December 31, 2005, compared to 1.32% of total loans plus NPAs as of December 31, 2004.

At December 31, 2005, The Banc Corporation had total assets of $1.416 billion, compared to $1.423 billion at December 31, 2004. Loans, net of unearned income, increased $28 million, or 3.04%, to $963 million at December 31, 2005 from $935 million at December 31, 2004. Investment securities decreased $46 million, or 15.9%, to $243 million at December 31, 2005 from $288 million at December 31, 2004. Deposits decreased 2.14%, to $1.044 billion at December 31, 2005 from $1.067 billion at December 31, 2004. These changes reflect the Corporation's continued strategy of deleveraging its balance sheet and focusing on deposit and loan mix realignment, as well as reduction of its brokered certificates of deposit portfolio, which management expects will continue to improve net interest margin. Net interest margin increased to 3.26% for the three-month period ended December 31, 2005 from 3.06% for the three-month period ended September 30, 2005. Stockholders' equity increased $4.2 million, or 4.2%, to $104.7 million at December 31, 2005 from $100.5 million at December 31, 2004.

Recently, there has been considerable discussion within the accounting profession of the proper way to account for certain derivative instruments under Statement of Financial Accounting Standards No. 133 ("SFAS 133"), including interest rate swaps commonly used by financial institutions to hedge their interest rate exposure with respect to brokered certificates of deposit. The Corporation has entered into such swap arrangements from time to time, and has historically accounted for these swaps using an abbreviated method of fair value hedge accounting under SFAS 133, known as the "short-cut" method, which assumes that the hedging transactions are effective.

However, in light of recent informal technical interpretations of accounting for these instruments, the Corporation has determined that these swaps may not have qualified for the short-cut method in prior periods because the related certificates-of-deposit broker placement fee caused the swap not to have a fair value of zero at inception, which is a requirement for use of the short-cut method under SFAS 133. Therefore, after discussions with its independent registered public accounting firm, the Corporation has concluded that any fluctuations in the market value of these interest rate swaps should have been recorded through the Corporation's income statement. Accordingly, while the Corporation believes that the swaps have been and will continue to be highly effective hedges, the Corporation will be amending its previously reported results for the first three quarters of 2005 to reflect the Corporation's determination that such swaps did not qualify for hedge accounting under SFAS 133. The cumulative impact of this revised treatment reduced earnings by $625,000, or $.03 per share, for the year ended 2005. The change had no impact on the Corporation's cash flows and no material impact to prior years. The year-end and fourth quarter results of 2005 reported below reflect such revised treatment of the swaps. The Corporation has re-designated these interest-rate swaps as fair value hedges under the "long-haul'' method in order to qualify them under SFAS 133 for fair value hedge accounting in future periods.

The Banc Corporation is a $1.416 billion community bank holding company headquartered in Birmingham, Alabama. The principal subsidiary of The Banc Corporation is Superior Bank, a southeastern community federal savings bank. Superior Bank has twenty-six branches, with nineteen locations throughout the state of Alabama and seven locations along Florida's eastern panhandle. Superior Bank also has loan production offices in Montgomery, Alabama, Tallahassee, Florida and Panama City, Florida.

[actr]

WebEx Targets $6 Billion IT Systems Management Market With On-Demand System Management Services New WebEx Support Center Service Brings Enterprise-Level System Management to Broader Market Without the Cost, Complexity or Maintenance of Legacy Softwar

Jan 23, 2006 /PRNewswire-FirstCall via COMTEX/ -- WebEx Communications (Nasdaq: WEBX), the leading provider of on-demand collaborative business applications, today launched WebEx System Management Services, an on- demand solution for managing software and hardware assets across LAN, WAN and the Internet. According to Gartner the worldwide system management software spending was $6 billion in 2005 and is expected to grow to $7.3 billion by 2008*.
WebEx System Management Services provides on-demand remote access, and support and maintenance capabilities that enable business owners and IT departments to cost-effectively manage, protect and secure software and hardware investments. Since there is no software to install or maintain, WebEx System Management Services removes the risks and costs traditionally found in complex software implementations.

For the first time, small and mid-sized businesses have a cost-effective way to deliver proactive system management including: rapid access to all remote systems, patch management, easy online backup, streamlined software distribution and licensing compliance, asset management, virus protection and more -- all regardless of physical location. Unlike legacy premise-based solutions, WebEx System Management Services does not require specialized hardware, complex software or expensive IT management and maintenance. WebEx System Management Services gives companies the tools they need to ensure desktop assets are secure while allowing IT to remain productive and focused on core business.

"Before WebEx, these advanced IT management capabilities were beyond the reach of many businesses who didn't have dedicated IT departments or big budgets for system management software," said Gary Griffiths, vice president, product management, WebEx. "We partnered with Everdream, a market leader in on-demand system management, to create an enterprise-grade, easy-to-use system management service that delivers value to businesses of all sizes, for a fraction of the cost of traditional legacy software solutions. Our MediaTone on-demand platform allows us to quickly bring new applications to market and offer seamless integration with third-party application providers."

WebEx System Management Services is the latest extension of the market- leading WebEx Support Center suite. WebEx Support Center provides an integrated suite of on-demand support and system management services. WebEx System Management Services includes:


-- Asset Management -- comprehensive dashboard-driven management

interface with detailed information about the location of the assets

as well as the user assigned to each asset and tracks hardware and

software regardless of location

-- Software Distribution -- automatically tracks software usage and

distributes software to targeted assets

-- Patch Management -- eliminates security holes caused by viruses,

worms and bugs by automatically assessing security threats and

rapidly deploying the latest tested patches to all PCs regardless of

location

-- Virus Protection -- identifies virus vulnerabilities and installs

the latest virus definitions remotely without user intervention

-- Backup Management -- secures business data without taxing employee

productivity


About WebEx Communications

WebEx Communications, Inc. is the global leader of on-demand applications for collaborative business on the web. WebEx applications are used across the enterprise in sales, support, training, marketing, engineering and product design. WebEx delivers its range of applications over the WebEx MediaTone Network, a global network specifically designed for secure delivery of on- demand applications. WebEx Communications is based in Santa Clara, California and has regional headquarters in Europe, Asia and Australia. Please call toll free 877-509-3239 or visit www.webex.com for more information * Forecast: Enterprise Systems Management Software, Worldwide, 2003-2008 (Executive Summary); Gartner Dataquest, 2004

[actr]

AXA and the Caisse de d?pot et placement du Qu?bec strengthen their private equity partnership

MONTREAL, Jan. 23, 2006 (Canada NewsWire via COMTEX) -- The Caisse de dépôt et placement du Québec and AXA, via its subsidiary AXA Private Equity, an AXA Investment Managers company for private equity, which have been partners since 1996, have decided to step up their joint private equity efforts on the key markets of North America, Europe and Asia.
The agreement signed today in Paris between the two groups has several components. First, the two organizations will consolidate their joint position on Europe's mid-sized enterprise market through direct investments, funds of funds or a co-investment fund.

The second component of the agreement calls for development, through AXA Private Equity in Asia, of a fund specializing in the Asian market. AXA Private Equity and the Caisse de dépôt et placement du Québec will be the two main partners in the fund.

AXA Private Equity and the Caisse will also work together to develop an investment structure for the mid-sized market in the United States, through a fund of funds and a co-investment fund.

Finally, the Caisse and AXA Private Equity intend to pool their resources to ensure more effective coverage of market intelligence and will share information on best management practices, especially through exchanges of personnel. It should be noted, however, that both partners will maintain their independence in terms of conduct of business. Together, the two organizations will provide more than (euro) 1.5 billion to implement this agreement.

According to Henri-Paul Rousseau, President and Chief Executive Officer of the Caisse, this agreement will be beneficial for the institution. "Together, our two institutions have the ability to provide substantial amounts of capital and respond quickly to business financing needs". Normand Provost, Executive Vice President, Private Equity, added that "by combining the expertise of our teams, we're convinced that the synergies will swiftly generate added value for both organizations".

Henri de Castries, Chairman of AXA's Management Board and Dominique Senequier, Chief Executive Officer of AXA Private Equity welcome this new stage of AXA Private Equity's development. "We're especially pleased to be able to continue working with the Caisse de dépôt et placement du Québec to promote the exchange of expertise and the professionalism that are the basis for the recognized success of the AXA and Caisse teams."

About the Caisse de dépôt et placement du Québec (www.lacaisse.com)

The Caisse de dépôt et placement du Québec is a financial institution that manages funds primarily for public and private pension and insurance plans. As at December 31, 2004, it held $102.4 billion of net assets. The Caisse invests in the main financial markets as well as in private equity and real estate. The institution partners with dynamic companies in various sectors, offering them a full range of debt and equity financing products. The Caisse partners with dynamic companies in various sectors, offering them a wide range of financing products, mainly equity investments and loans. As at December 31, 2004, the private equity portfolios held more than 600 investments in funds and companies, for $10.2 billion of net assets.

About AXA Group (www.axa.com)

AXA Group is a world leader in financial protection. AXA's operations are geographically diverse, with major operations in Western Europe, North America and the Asia/Pacific area. AXA had (euro) 935 billion of assets under management as at June 30, 2005. In 2004, it had IFRS revenues of (euro) 67 billion and IFRS underlying earnings of (euro) 2,640 million. For the first half of 2005, AXA reported total IFRS revenues of (euro) 37 billion and IFRS underlying earnings of (euro) 1,761 million. AXA's common shares trade on the Paris Stock Exchange under the symbol AXA. In the United States, AXA's American depository shares trade on the NYSE under the ticker AXA.

About AXA Investment Managers (AXA IM- www.axa-im.com)

AXA IM is a multi-expert asset management company within the AXA Group, a world leader in financial protection and wealth management. AXA IM is one of the largest European-based asset managers with approximately (euro) 424.2billion(x) under management. AXA IM employs over 2,100 people(xx) and serves clients in fifteen countries.


(x)Source: AXA IM as at 30 November 2005

(xx)Source: AXA IM as at 30 November 2005


About AXA Private Equity (www.axaprivateequity)


AXA Private Equity, an AXA Investment Managers company, is a management company with an exclusive focus on unlisted investments. It has offices in Paris, Frankfurt, London, New York and Singapore. Its expertise spans all types of private equity: leveraged buyouts, venture capital, expansion and funds of funds. AXA Private Equity manages and/or advises private equity funds with assets in excess of (euro) 7 billion for some of the world's leading investors. With a constant focus on transparency, performance and sustainable profitability, AXA Private Equity is supported by the expertise of its staff and its international experience.

SOURCE: CAISSE DE DEPOT ET PLACEMENT DU QUEBEC

[actr]

THQ Announces Exclusive Worldwide Video Game Rights to Stormbreaker Movie Teen Spy Game Expected to Infiltrate Stores on Handheld Formats in Summer 2006

Jan 23, 2006 /PRNewswire-FirstCall via COMTEX/ -- THQ Inc. (Nasdaq: THQI) today announced the company's exclusive worldwide rights to develop and publish video games based on the forthcoming teen spy movie Stormbreaker. Following award-winning author Anthony Horowitz's series of best-selling Alex Rider books, the movie has attracted top acting talent, including Mickey Rourke, Alicia Silverstone, Bill Nighy, Sophie Okonedo, Robbie Coltrane and Ewan McGregor. The video games, developed by Altron for Nintendo DS(TM) and Razorback Developments for Game Boy(R) Advance, are scheduled for a simultaneous worldwide launch with the movie in Summer 2006.
(Logo: http://www.newscom.com/cgi-bin/prnh/20041118/LATH093LOGO )

"Alex Rider has a huge worldwide following, having sold over nine million books to date," said Jennifer Wyatt-Ambler, senior global brand manager, THQ Inc. "We are excited to work with Anthony Horowitz and Samuelson Productions to bring the Alex Rider movie franchise to a whole new fan base with an exhilarating, action-packed game."

"Our decision to work with THQ to bring the Stormbreaker video game to market was based on the company's vast expertise with leading global licenses," stated Peter Samuelson, who produces the film with his partner, brother Marc Samuelson, Steve Christian and Andreas Grosch. "We look forward to seeing the brand extended into the video game market and allowing consumers the opportunity to be the martial arts, parachuting, scuba diving, 14-year-old action spy who is Alex Rider."

The motion picture Stormbreaker is scheduled for release in the United Kingdom on July 21 by Entertainment Film Distributors, in the United States on August 18 by The Weinstein Company and worldwide throughout summer 2006 by leading local distributors.

About The Stormbreaker Video Game

Players embrace the role of Alex Rider to out-spy, outwit and out-cool evil in this thrilling action adventure on Nintendo DS and Game Boy Advance. Featuring third-person stealth game play, fast-paced racing action, intense fighting and engaging, gadget-based mini-games, players can relive defining moments from the Stormbreaker movie and become the ultimate spy.

About The Stormbreaker Movie

The first of Anthony Horowitz's six best-selling novels about reluctant schoolboy special agent Alex Rider, Stormbreaker was named in a nationwide poll of children as the book they most wanted to see turned into a movie. The action-packed film, directed by Geoffrey Sax from a screenplay by Anthony Horowitz, stars newcomer Alex Pettyfer as Alex Rider, with Sarah Bolger, Robbie Coltrane, Stephen Fry, Damian Lewis, Ewan McGregor, Bill Nighy, Sophie Okonedo, Missi Pyle, Andy Serkis, Alicia Silverstone, Ashley Walters and Mickey Rourke.

About Samuelson Productions

Stormbreaker is produced by Marc Samuelson and Peter Samuelson, whose producing credits include "Arlington Road," "Wilde," "Revenge of the Nerds" and "Tom & Viv" and, as executive producers, "Keeping Mum," "The Libertine" and the forthcoming "Chromophobia."

About THQ

THQ Inc. (Nasdaq: THQI) is a leading worldwide developer and publisher of interactive entertainment software. The company develops its products for all popular game systems, personal computers and wireless devices. Headquartered in Los Angeles County, California, THQ sells product through its global network of offices located throughout North America, Europe and Asia Pacific. More information about THQ and its products may be found at www.thq.com and www.thqwireless.com. THQ, THQ Wireless, and their respective logos are trademarks and/or registered trademarks of THQ Inc.

Nintendo, Game Boy Advance and DS are trademarks or registered trademarks of Nintendo.

[actr]

23.01.2006 14:32
Aktien NYSE/NASDAQ Ausblick: Freundlich - Gemischte Quartalszahlen

Die US-Börsen dürften am Montag nach den deutlichen Verlusten vom Freitag freundlich in den Handel starten. Unterschiedlich ausgefallene Quartalszahlen von Bank of America <BAC.NYS> <NCB.ETR> (Nachrichten/Aktienkurs) (Nachrichten/Aktienkurs) und Ford Motor <F.NYS> <FMC1.FSE> (Nachrichten/Aktienkurs) (Nachrichten/Aktienkurs) sorgten aber für Vorsicht, sagten Händler.

Der Future auf den S&P-500-Index <INX.IND> legte bis 14.15 Uhr um 3,90 Punkte auf 1.268,70 Zähler zu, der NASDAQ-100-Future <NDX.X.IND> stieg um 4,50 Punkte auf 1.690,00 Zähler.

Ford-Aktien <F.NYS> <FMC1.FSE> (Nachrichten/Aktienkurs) (Nachrichten/Aktienkurs) gewannen vorbörslich 6,33 Prozent auf 20,15 US-Dollar. Der Autokonzern hatte im vierten Quartal dank Sondereffekten und der starken Finanzsparte deutlich besser abgeschnitten als vom Markt erwartet. Konkurrent General Motors (GM) <GM.NYS> <GMC.FSE> (Nachrichten/Aktienkurs) legte 0,50 Prozent auf 20,15 Dollar zu.

Bank of America <BAC.NYS> <NCB.ETR> (Nachrichten/Aktienkurs) (Nachrichten/Aktienkurs) verloren hingegen 1,95 Prozent auf 43,33 Dollar. Die zweitgrößte US-Bank hatte im vierten Quartal wegen einer höheren Risikovorsorge sowie einem enttäuschendem Handelsergebnis überraschend etwas weniger verdient als ein Jahr zuvor.

Yahoo-Papiere <YHOO.NAS> <YHO.FSE> (Nachrichten/Aktienkurs) gewannen 2,05 Prozent auf 34,43 Dollar. Bear Stearns hatte die Papiere des Internet-Portalbetreibers von "Peer Perform" auf "Outperform" hoch gestuft. Der jüngste Kursrückgang sei "übertrieben" gewesen, hieß es in einer Analyse.

Albertson's <ABS.NYS> <AOI.BER> (Nachrichten) kletterten um 3,44 Prozent auf 24,94 Dollar. Ein Konsortium um die US-Konkurrenten Supervalu <SVU.NYS> <SJ1.BER> (Nachrichten) und CVS <CVS.NYS> <CVS.FSE> (Nachrichten) sowie einer von Cerberus Capital Management geführten Investorengruppe übernimmt die Supermarktkette für 26,29 Dollar je Aktie./he/tw

AXC0098 2006-01-23/14:26

[actr]

23.01.2006 14:35
Bristol-Myers stellt wegen Rechtsstreit $185 Mio zurück
Der Pharmakonzern Bristol-Myers Squibb Co. (Nachrichten/Aktienkurs) bildet im Zusammenhang mit seinem Herzmedikament Vanlev eine Rücklage von 185 Millionen Dollar. Wie das Unternehmen am Montag weiter mitteilte, wird jener Betrag aufgrund der Erwartung einer möglichen Einigung in einem Rechtsstreit zu jenem Präparat zurückgestellt. So seien beiden Parteien in Finanzfragen und anderen Bereichen zu einer entsprechenden Grundsatzeinigung gelangt. Eine endgültige Einigung sei jedoch noch nicht erzielt. Der an Bristol-Myers gerichtete Vorwurf lautet auf Verletzung von gesetzlichen und behördlichen Sicherheitsvorschriften durch Vanlev.

Bristol-Myers verlieren vorbörslich um 1,2% auf 22,05 Dollar

[actr]

23.01.2006 14:35
Bristol-Myers stellt wegen Rechtsstreit $185 Mio zurück
Der Pharmakonzern Bristol-Myers Squibb Co. (Nachrichten/Aktienkurs) bildet im Zusammenhang mit seinem Herzmedikament Vanlev eine Rücklage von 185 Millionen Dollar. Wie das Unternehmen am Montag weiter mitteilte, wird jener Betrag aufgrund der Erwartung einer möglichen Einigung in einem Rechtsstreit zu jenem Präparat zurückgestellt. So seien beiden Parteien in Finanzfragen und anderen Bereichen zu einer entsprechenden Grundsatzeinigung gelangt. Eine endgültige Einigung sei jedoch noch nicht erzielt. Der an Bristol-Myers gerichtete Vorwurf lautet auf Verletzung von gesetzlichen und behördlichen Sicherheitsvorschriften durch Vanlev.

Bristol-Myers verlieren vorbörslich um 1,2% auf 22,05 Dollar

[actr]

Polycom Integrates Desktop and Group Video Into IBM Collaboration Solutions in Technology Demo at Lotusphere Polycom Brings Business Quality Video to IBM Lotus Web Conferencing; 125 Million IBM Lotus Notes Users to Benefit From Initiating Real-Time V

LOTUSPHERE, ORLANDO, Fla., Jan 23, 2006 /PRNewswire-FirstCall via COMTEX/ -- Polycom, Inc. (Nasdaq: PLCM), a world leader in providing unified collaborative communications solutions, today announced a technology demonstration at Lotusphere(R) in which Polycom's market leading desktop and group video systems and bridges are integrated with IBM(R) Workplace(TM) Collaboration Services, IBM Lotus(R) Sametime(R), and IBM Lotus Notes(R). The joint Polycom and IBM demonstration can be seen at Booth # 418 at Lotusphere.
The demonstration shows how users can initiate a web conference in Lotus Sametime and add TV-like video with near CD quality sound using the Lotus Notes buddy list, which displays both people and the Polycom desktop and group video endpoints associated with them. The calls, which can be initiated in real time and involve participants on a variety of audio and video devices, can be point to point or multipoint, from PC to PC, or PC to conference room video as a result of the Polycom MGC bridge integration with Lotus Sametime, Lotus Notes and Workplace Collaboration Services.

In the Lotusphere demonstration, a Polycom PVX(TM) desktop video and VSX group conference room system have been added as "buddies" on an instant message buddy list in Lotus Notes. Integration of the Polycom MGC conference bridge, which supports the broadest array of PTSN, ISDN, H.320, H.323 and SIP devices, with IBM's collaboration servers enables joint Polycom and IBM customers to initiate multipoint calls connecting any type of endpoint over any network for a truly unified conferencing experience. Because conference room video systems are now integrated with desktop PCs, enterprises can expand the reach of Lotus real time collaboration beyond PCs to be a complete collaborative solution end-to-end both within and between organizations.

"Offering business quality multipoint video to users of IBM's enterprise collaboration solutions can help improve the flow of communication within a business and enhance overall productivity," said Ken Bisconti, vice president, Workplace, Portal and Collaboration products, IBM. "Polycom's demonstration at Lotusphere 2006 is a great opportunity for the over 125 million Lotus Notes users to experience this type of convergence first hand."

"Collaborative communications that include video are compelling to enterprises looking to raise productivity among dispersed workgroups," said Mark Roberts, vice president of market development for Polycom's Network Systems Division. "With today's demo, video now joins audio and web conferencing as an equal partner in delivering effective and efficient collaboration. IBM and Lotus customers are a critical audience to be included as we integrate voice, video, and data seamlessly onto core IP communications networks and integrate PCs and applications with systems found in conference rooms."

Presence-based collaboration involves providing desktop users the choice to initiate on-demand voice, video, data sharing, and instant messaging sessions -- all from a single mouse click. The tech demo at Lotusphere illustrates both companies' commitment to broaden the reach and simplify the usage of video communications as part of IBM collaboration.

About Polycom

Polycom, Inc. is a worldwide leader in unified collaborative communications (UCC) that maximize the efficiency and productivity of people and organizations by integrating the broadest array of video, voice, data and Web solutions to deliver the ultimate communications experience. Polycom's high quality, standards-based conferencing and collaboration solutions are easy to deploy and manage, as well as intuitive to use. Supported by an open architecture, they integrate seamlessly with leading telephony and presence- based networks. With its market driving technologies, best-in-class products, alliance partnerships, and world-class service, Polycom is the smart choice for organizations seeking proven solutions and a competitive advantage in real-time communications and collaboration. For additional information call 1-800-POLYCOM (765-9266) or +1-408-526-9000, or visit the Polycom website at www.polycom.com.

NOTE: Polycom and the Polycom are registered trademarks and VSX, PVX, MGC, are trademarks of Polycom in the U.S. and various countries. All other trademarks are the property of their respective owners.

IBM, Lotus, Lotusphere, Sametime, Lotus Notes, Domino and Workplace are trademarks of International Business Machines Corporation in the United States, other countries, or both. Other company, product or service names may be trademarks or service marks of others.

[actr]

Google Wins Higher User Satisfaction than Baidu in China

BEIJING, Jan 23, 2006 (SinoCast via COMTEX) -- Chinese users are more satisfied with Google than Baidu in Internet search services, according to a survey by Keynote Systems, Inc. (NASDAQ: KEYN), an Internet performance authority Although Baidu.com Inc. (NASDAQ: BIDU) has competitive edges in market share and brand in the Chinese search services market, its customer satisfaction index is lower than that of its strong rival Google.
Jeff Kraatz, directing manager of Keynote Systems Asia-Pacific Region, said the survey entailed visits to Yahoo! China, Baidu.com, Google, and Sohu's Sogou, the top four Chinese-language Internet search service providers, by 1,200 Chinese Internet users, of which 70% came from major Chinese cities.

Keynote Systems appraised the four Internet search service providers in terms of over 250 indices after tracking a series of activities of the 1,200 interviewees, including website searching.

When it comes to the customer experience, Keynote Systems uses 13 indices and Google outnumbered other three peers in 11 indices.


From eNet, Page 1, Friday, January 20, 2006

info@SinoCast.Com

[actr]

23.01.2006 14:59
Rambus stockt Aktienrückkaufprogramm auf
Der Chipentwickler Rambus Inc (Nachrichten) . stockt ein laufendes Aktienrückkaufprogramms auf ein Volumen von 5 Millionen Anteilsscheine auf. Die Erweiterung ist als Beitrag zu einem vorangegangenen Programm und einem daraus resultierenden unerledigten Rückkauf von 1,6 Millionen Aktien zu sehen. Wie das Unternehmen am Montag weiter mitteilte, gestattet die positive Bilanzsituation und die starke Barausstattung eine gleichzeitige Investition in die laufende Geschäftsstruktur als auch in Aktienrückführungen.

Rambus legen vorbörslich um 5,5% auf 34,82 Dollar zu

[actr]

Agilent Technologies Introduces Liquid Chromatography System, Successor to Its Market-Leading 1100 LC; With New Rapid-Resolution Configuration, 1200 Series is World's Fastest, Most Comprehensive LC System

PALO ALTO, Calif., Jan 23, 2006 (BUSINESS WIRE) -- Agilent Technologies Inc. (NYSE:A) today introduced the Agilent 1200 Series LC (liquid chromatography) system, replacing its market-leading 1100 Series LC. Used by more than 250,000 customers worldwide in applications from forensics to food safety, pharmaceuticals and protein research, LC is a measurement technology used to separate, identify, quantify and purify compounds. It represents a $2 billion market and is one of the largest sources of revenue for Agilent's life science and chemical analysis business.
Since introducing the 1100 Series instrument in 1995, Agilent has sold more than 400,000 modules, or roughly 60,000 LC systems, making it the most popular LC in the industry. To protect customer investments, Agilent has made the 1200 reverse-compatible with the 1100. Customers can combine new and existing modules, and can continue using existing methods without costly new method development, revalidation or retraining of operators. Agilent even provides an 1100 Emulation Mode for customers using non-Agilent software until third-party software upgrades are available.

The Agilent 1200 is the most comprehensive LC available. With more than 60 instrument modules, it can be configured for all major LC applications, including a new rapid-resolution format as well as prep-scale, standard, narrow, capillary, nanoflow, and Agilent's revolutionary chip-based liquid chromatography. Now HPLC-Chips are available to apply this technology for both small and large molecule work, with chromatographic separation or just for infusion of samples. Nanospray HPLC-Chip/MS technology can provide customers with more than a 1,000-fold improvement in sensitivity over conventional LC/MS.

The Agilent 1200 Series Rapid Resolution System

The new 1200 Series Rapid Resolution System provides up to 20 times faster analysis and 60 percent higher resolution than conventional LC, making it twice as fast and three times as precise as the competition's best systems. The system can also still run any traditional LC method, making it the most flexible LC on the market. Further, a special high-throughput configuration of the 1200 Rapid Resolution system allows sequential execution of more than 2,000 samples per day on a single system -- without giving up data quality or method flexibility.

The system features more than 70 new Rapid Resolution High Throughput (RRHT) columns and a new high-performance pump that can handle flow rates from 0.05-5 ml/min and up to 600 bar pressure. It also features a new high-performance degasser, autosampler, column compartment and UV and MS detectors. The system can be optimized for highest speed and resolution in both LC/UV and LC/MS applications.

"The Agilent 1200 Series Rapid Resolution system has been designed to deliver the industry's best speed and resolution without dramatically increasing pressure," said Fred Strohmeier, general manager of liquid phase analysis for Agilent's life science and chemical analysis business. "It optimizes performance while minimizing the risks that ultra-high pressure imposes on instrument reliability and longevity as well as the risk of changes in the physical and chemical properties of compounds. In short, it provides customers a truly secure approach to increased lab productivity."

New Agilent ZORBAX 1.8 Micron RRHT Columns

Expanding on the success of Agilent 400 bar Rapid Resolution High Throughput (RRHT) columns, Agilent is introducing extended-range RRHT columns. They permit faster flow rates, increased pressures and higher efficiencies. Columns range from 1 mm to 4.6 mm internal diameter and from 20 to 150 mm length, and come in more than six bonded phases at 5, 3.5 and 1.8 micron particle sizes. These include:

-- ZORBAX Eclipse XDB (C8 and C18), a general-purpose bonded phase for use up to 60 degrees C.

-- ZORBAX StableBond (C18, C8 and CN), good for low pH and high-temperature applications for faster analysis; temperature resistant to 90 C.

-- ZORBAX Extend (C18), for extended high pH, up to pH 11.5. Temperature resistant to 60 C.

The 1200: A Comprehensive Approach to Performance

The Agilent 1200 Series features improvements in design, manufacturing, software and associated services to provide measurable gains in performance, ease of use and uptime. System specifications vary depending on the complete configuration purchased, but all configurations take advantage of several new ease-of-use and reliability improvements, including:

-- A new handheld Agilent 1200 Series Instant Pilot for system control, with a color display that is highly intuitive and customizable. It allows customers to instantly monitor system status, set parameters for methods, and run basic diagnostics.

-- New Agilent ChemStation and Agilent EZChrom Elite software that provides improved instrument control and faster data analysis, review and retrieval. Customers can now quickly scan through hundreds of chromatograms.

-- New data system-independent instrument diagnostics that can reduce maintenance and troubleshooting efforts.

-- Enhanced services including a "push for help" feature. With a click of a mouse, instrument configuration details, recent logbook, and user contact information are accurately transmitted over a secure connection to an Agilent customer support center for immediate attention. This reduces user involvement in troubleshooting and maximizes instrument uptime.

Agilent offers more than 900 LC columns for the 1200 Series, ranging from 0.075 to 50 mm internal diameter, 15 to 300 mm length, and 1.8 to 10 micron particle sizes. More than 65 bonded phases are available, plus additional special-application columns.

Availability

The Agilent 1200 HPLC Series will be available for order Feb. 1, 2006, in all configurations. For sales information or a complete list of features and benefits per configuration, please contact your sales representative, the Agilent Customer Call Center (phone numbers by country available online at www.chem.agilent.com/scripts/cag_feedback.asp) or visit Agilent online at www.agilent.com/chem/1200pr About Agilent Technologies

Agilent Technologies Inc. (NYSE:A) is the world's premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company's 21,000 employees serve customers in more than 110 countries. Agilent had net revenue of $5.1 billion in fiscal 2005. Information about Agilent is available on the Web at www.agilent.com.

[actr]

Earthworks Entertainment Earns First Revenues From Suzy's Zoo Sony Plaza Stores Sales Deal

LOS ANGELES, Jan 23, 2006 (BUSINESS WIRE) -- Earthworks Entertainment's (OTCBB: EWKE.OB) President and CEO, Peter Keefe, states: "This is a major strategic accomplishment for Earthworks. We are now benefiting from our Company's first revenue generating transaction through the sale of Suzy's Zoo in the Japan market. We believe that this will be the first of many revenue generating milestones for the Company as we work to make significant further sales of the Suzy's Zoo property, and for all of our entertainment properties throughout the global marketplace."
"Suzy's Zoo generated about 1 billion dollars in sales in a recent four year period in the USA alone from merchandise licensing categories ranging from apparel to toys to greeting cards We are working to build upon that hit property history. The Sony Plaza stores operation, with 20 million customers, is our first step in expanding this world class property."


Earthworks Entertainment creates, produces, markets and distributes high quality children's and family oriented entertainment properties. The Company identifies entertainment properties that it believes have the greatest success potential in the global marketplace. It then develops and markets these properties in exchange for management, production and distribution fees and for a substantial percentage of the worldwide merchandise licensing profits.

Earthworks Entertainment properties are marketed in all areas of commercial licensing including: TV & Home Video, Toys, Video Games, Music, Books, Leisure & Play Items, Gifts & Novelties, Theme Parks, Food & Drink Promotions, and Apparel.

[actr]

23.01.2006 15:19
US Vorbörse: Aktien mit dem größten Orderflow
Anbei eine aktuelle Kursliste der US Aktien, die vorbörslich den größten Orderflow pro Zeiteinheit und damit das stärkste Momentum aufweisen.


http://img.godmode-trader.de/charts/46/2005/Orderflow36.gif

[actr]

Magma Welcomes Five New IP Partners into MagmaTies Program; Analog and Mixed-Signal IPs, I/O Libraries, Network-on-Chip Interfaces, WiMAX IPs and Magma Software Speed Development of Next-Generation SoC Designs

SANTA CLARA, Calif., Jan 23, 2006 (BUSINESS WIRE) -- Magma(R) Design Automation Inc. (Nasdaq: LAVA), a provider of semiconductor design software, today announced that five new intellectual property (IP) vendors have joined its MagmaTies program to develop "Magma-Ready" IP. Aragio Solutions, Arteris, Go2silicon, SiWave and Soft Mixed Signal have teamed with Magma to provide solutions that enable mutual customers to speed through the semiconductor design and manufacturing processes.
Through the MagmaTies program, IP vendors commit to providing synthesis and reference methodology support for soft IP products and verification of industry-standard views for hard IP products. With this level of support, Magma and its partners ensure that IP products can be quickly integrated into mutual customers' complex integrated circuit (IC) designs. In addition, these efforts provide IC designers with a comprehensive IP portfolio for design deployment.

"With over 15 IP providers already in the MagmaTies program, we have established a proven 'Magma-Ready' IP qualification process," said Michael Ma, vice president of foundry and IP relationships for Magma. "Our customers have already benefited from the time-to-market advantage of using this integrated solution. With these additional partnerships and support, Magma and its partners are creating a broad portfolio of IP products to enable our customers to tackle next-generation SoC designs quickly."

Companies Comment on Partnership with Magma

"Aragio Solutions' I/O libraries provide robust ESD protection and high latch-up immunity solutions for ASIC designs. The company specializes in custom digital and analog IC design with silicon-proven I/O library solutions for industry-standard interfaces, RF and analog circuitry," said Robert L. (Les) Veal, sales and marketing at Aragio Solutions. "Our partnership with Magma makes our solutions even more effective and responsive to customer needs."

"Arteris provides a configurable network-on-chip (NoC) subsystem for system-on-chip (SoC) communications," said K. Charles Janac, CEO of Arteris. "By working with Magma we can assure our joint customers of a rapid path to silicon, reducing SoC unit costs, project costs and time to market."

"We have collaborated to optimize and integrate our high-performance, low-cost analog and mixed-signal IP cores with Magma's tools," said Charles Yang, CEO of Go2silicon. "Through our relationship, 'Magma-Ready' Go2silicon IP is available, bringing value to our mutual customers."

"SiWave is committed to delivering a unique and wide range of PHY IP products that offer the only truly configurable and scalable solution in the 802.16/WiMAX market," said Hanni Bagnordi, CEO of SiWave. "We are very pleased to be part of the 'Magma-Ready' program. Magma's IC implementation system enables us to provide our mutual customers with highly optimized and power efficient shrink-wrap IP solutions for the next-generation portable and mobile WiMAX market.

"Soft Mixed Signal Corporation develops and offers system-level PHY and transceiver IC solutions for LAN, WAN and SAN connectivity markets utilizing proprietary mixed-signal and digital signal processing (DSP) technologies," said Muzaffer Kal, director of system architecture at Soft Mixed Signal. "By teaming with Magma, we will be able to quickly and effectively provide comprehensive IP solutions to our mutual customers."

The MagmaTies Program

The goal of the MagmaTies program is to provide Magma customers with solutions to speed through the semiconductor design and manufacturing processes. These solutions require proven tools and methodologies, along with well-trained service providers. MagmaTies works with ASIC vendors, EDA tool vendors, library vendors, IP providers, design service providers and semiconductor foundries. Through the program, Magma and MagmaTies members work together to qualify tool interfaces, and to test and qualify libraries and foundry processes for use with Magma's software. In addition, Magma works with IP providers to develop a methodology for certifying the performance of IP blocks using Blast Wrap(R). Also, Magma is working in conjunction with design service providers to build a worldwide network of design service providers certified to provide top-flight assistance for Magma customers.

About Magma

Magma's software for integrated circuit (IC) design is recognized as embodying the best in semiconductor technology. The world's top chip companies use Magma's EDA software to design and verify complex, high-performance ICs for communications, computing, consumer electronics and networking applications, while at the same time reducing design time and costs. Magma provides software for IC implementation, analysis, physical verification, characterization and programmable logic design, and the company's integrated RTL-to-GDSII design flow offers "The Fastest Path from RTL to Silicon"(TM). Magma is headquartered in Santa Clara, Calif. with offices around the world. Magma's stock trades on Nasdaq under the ticker symbol LAVA. Visit Magma Design Automation on the Web at www.magma-da.com.

Magma is a registered trademark and Blast Wrap and "The Fastest Path from RTL to Silicon" are trademarks of Magma Design Automation Inc. All other product and company names are trademarks or registered trademarks of their respective companies

[actr]

Onyx Introduces Advanced Wireless CRM For Japanese Market; Mobile CRM Benefits Available To Users Worldwide, Regardless Of Locale

BELLEVUE, Wash., Jan 23, 2006 (BUSINESS WIRE) -- Onyx(R) Software Corporation (Nasdaq: ONXS), a worldwide leader in customer management solutions for the enterprise, today announced Onyx Employee Portal Wireless (OEP Wireless) for Japan. Part of an integrated suite of mobile enterprise CRM solutions, OEP Wireless for Japan is immediately available for Foma 3G and mova 2G Series iMode devices.
Onyx's introduction of OEP Wireless for Japan offers 45 million iMode users access to Onyx's versatile CRM platform for delivering enhanced customer service and satisfaction. OEP Wireless for Japan increases business productivity by keeping mobile professionals connected and informed, while delivering advanced capabilities for quickly and easily managing customer and partner account, sales, service and support activities.

OEP Wireless features a thin client mobile interface specifically built to leverage Onyx's XML-based pure Internet platform. For the Japanese market, it has been designed to optimize the unique features and usability techniques of iMode Internet cell phones. With powerful information display and management functions, OEP Wireless for Japan enables users to efficiently perform various tasks that facilitate the delivery of rapid and superior customer service. These include initiating phone calls and emails, requesting and sending literature to customers, receiving time critical alerts directly through links on records, updating sales forecasts, and generating customer quotes.

"Mobile CRM capabilities, especially important in the Japanese market, play a vital role in cultivating customer relationships and the performance and reliability of OEP Wireless offers companies a distinct competitive advantage," said Andie Rees, Senior Vice President, International at Onyx. "There has been strong demand for an iMode-based CRM solution and we are pleased to bring this advanced level of support to Japan's mobile sales and customer service teams."

"One of the big benefits of an enterprise CRM solution is the ability to access vital customer data, regardless of device or locale," said Todd Chambers, Chief Marketing Officer at Onyx. "Onyx customers in the United States, Europe or Japan can now access and leverage customer data in real time. This is of great interest not only to our enterprise-level Japanese customers, but also to our multi-national customers with worldwide operations."

Onyx mobile solutions operate seamlessly across multiple devices, extending the power of Onyx Customer Management technology to laptops and handheld devices for real-time wireless or disconnected access with data synchronization. Onyx's ultra-light Internet architecture offers users greater convenience providing multiple access options, including Onyx Employee Portal Offline Edition as well as Onyx Employee Portal Wireless versions for Blackberry, Palm and Pocket PC devices, and now iMode.

About Onyx Software

Onyx Software Corporation (Nasdaq: ONXS) is a worldwide leader in customer management and process software for mid and large size enterprises. Onyx provides flexible solutions that enable organizations to automate, manage, and evolve their customer processes quickly and cost-effectively for strategic advantage. By providing an integrated suite of customer process automation applications encompassing customer management, process management, and analytics capabilities, Onyx enables enterprises to reduce costs, increase productivity and grow revenue. Major companies are aligning their customer-facing departments and managing their customer processes with Onyx software -- companies such as Amway Corporation, Mellon Financial Corporation, The Regence Group and State Street Corporation. More information can be found at 888-ASK-ONYX, info@onyx.com or http://www.onyx.com/.

[actr]

Chemical Financial Corporation Reports 2005 Fourth Quarter and Full Year Earnings Strategic Restructuring Initiatives on Schedule

MIDLAND, Mich., Jan 23, 2006 /PRNewswire-FirstCall via COMTEX/ -- Chemical Financial Corporation's (Nasdaq: CHFC) Board of Directors today reported earnings of $0.50 per diluted share for the fourth quarter of 2005 compared to fourth quarter 2004 earnings per diluted share of $0.57, a decrease of 12.3 percent. Net income for the fourth quarter of 2005 was $12.6 million compared to fourth quarter 2004 net income of $14.4 million. For the twelve months ended December 31, 2005, net income was $52.9 million, or $2.10 per diluted share, compared to net income of $56.7 million, or $2.25 per diluted share, for the twelve months ended December 31, 2004, a 6.7 percent decrease in diluted earnings per share between periods.
"The financial results for 2005 were less than satisfactory. Decreasing net interest income resulting from higher interest rates paid on deposits and short-term borrowings had a significant negative impact on fourth quarter and full year financial performance in 2005. The impact of rising rates was also evidenced in our mortgage banking operations, where net revenue decreased by 50 percent from 2004. While we anticipate we will continue to see unfavorable short-term financial effects from further interest rate increases, we expect that the magnitude and number of rate increases will be less severe going forward," said David B. Ramaker, President and CEO of Chemical Financial Corporation.

"We have taken significant steps during the year to stimulate future revenue growth while controlling costs, which we anticipate will over time translate into improved financial performance. While 2006 will continue to be a challenge for the Michigan economy, as well as our Company, we are optimistic that the initiatives we have employed will ultimately benefit our shareholders. Furthermore, our strong capital base positions us well for growth. We remain mindful of the potential effects of excess capital on shareholder returns, and will continue to examine our alternatives to efficiently utilize the Company's capital," Ramaker said.

During the fourth quarter of 2005, the Company announced it would undertake a strategic restructuring designed to reposition the bank holding company to better capitalize on growth opportunities in high potential markets and enhance operating efficiencies. The restructuring initiative, which resulted from an intensive examination of the Company's core retail banking franchise, encompassed consolidation of its three subsidiary state bank charters into a single state chartered institution, realigned the existing branch network, announced the closure of eight underperforming branches across the state to be completed in the first quarter of 2006, and reorganized senior management to place a greater emphasis on internal growth initiatives. Management estimated that total costs for the restructuring would not exceed $1 million, and would be incurred primarily during the first half of 2006. During the fourth quarter of 2005, restructuring costs of $0.2 million relating to employee severance were incurred. At year-end 2005, the implementation of the restructuring plan was on schedule, with the back-room

component of the consolidation of the three subsidiary banks scheduled to be completed in the second quarter of 2006.

The Company also announced during the fourth quarter of 2005 an increase in its dividend rate, from $0.265 per share paid in the fourth quarter of 2005 to $0.275 per share payable in the first quarter of 2006, an increase of 3.8 percent.

Fourth quarter 2005 net interest income was $35.1 million compared to fourth quarter 2004 net interest income of $37.3 million. The decrease was primarily due to increases in the rates paid on customer deposits and the unfavorable impact of lower average deposits outstanding. These items were partially offset by the positive impact on net interest income of higher average loans outstanding and higher yields earned on loans. Net interest margin (on a tax equivalent basis) was 3.99 percent in the fourth quarter of 2005, down from 4.18 percent in the prior year fourth quarter and up slightly from 3.96 percent in the third quarter of 2005. The Company's interest rate spread, on a fully taxable equivalent basis, decreased from 3.80 percent in the fourth quarter of 2004 to 3.39 percent in the fourth quarter of 2005, as increases in average interest yields earned on interest-earning assets failed to keep pace with increases in average interest rates paid on interest-bearing liabilities.

Total assets were $3.75 billion at December 31, 2005, down slightly from $3.76 billion at December 31, 2004, and down from $3.84 billion at September 30, 2005. At December 31, 2005, total loans were $2.71 billion, versus $2.59 billion at December 31, 2004 and $2.70 billion at September 30, 2005. Total loans increased by $125 million, or 4.8 percent, from December 31, 2004 to December 31, 2005, led by strong growth in business loans and real estate construction loans. Investment securities were $743 million at December 31, 2005, down from $893 million at December 31, 2004 and $787 million at September 30, 2005, as investment securities maturities were utilized to fund loan growth.

Total deposits were $2.82 billion at December 31, 2005, down slightly from $2.86 billion at December 31, 2004 and from $2.91 billion at September 30, 2005. In 2005, the markets in which the Company operates saw intense competition for retail deposits translate into increases in deposit pricing and a slight erosion in core deposits. Other liabilities, which include Federal Home Loan Bank advances, totaled $428 million at December 31, 2005, up from $416 million at December 31, 2004, and down from $436 million at September 30, 2005.

The provision for loan losses was $1.3 million in the fourth quarter of 2005, compared to $1.7 million in the prior year fourth quarter and $1.5 million in the third quarter of 2005. Net loan losses were $1.8 million in the fourth quarter of 2005, compared to $1.2 million in the fourth quarter of 2004. The allowance for loan losses as a percentage of total loans was 1.26 percent as of December 31, 2005, down from 1.28 percent at September 30, 2005 and 1.32 percent at December 31, 2004. At December 31, 2005, nonperforming loans as a percentage of total loans were 0.73 percent, down slightly from 0.75 percent at September 30, 2005 and up from 0.39 percent at December 31, 2004. As the Michigan economy has slowed down, the Company's credit quality ratios have moderated somewhat from the very strong levels experienced over the past few years.

Noninterest income decreased 7 percent to $9.0 million in the fourth quarter of 2005 from $9.7 million in the fourth quarter of 2004. The decline in noninterest income during the 2005 fourth quarter, as compared to the prior year quarter, was driven primarily by a loss on the sale of investment securities and declining mortgage banking revenue, offset by increases in a number of noninterest income categories, including trust and investment management services and service charges on deposit accounts. Mortgage banking revenue decreased 27 percent to $371,000 for the fourth quarter of 2005 compared to $508,000 for the fourth quarter of 2004, but up 15 percent compared to $322,000 during the third quarter of 2005. The Corporation was servicing $544 million of residential mortgage loans that were sold in the secondary market as of December 31, 2005, compared to $596 million as of December 31, 2004.

For the fourth quarter of 2005, the Company incurred losses on the sale of investment securities totaling $633,000, as compared to gains of $108,000 in the fourth quarter of 2004 and gains of $3,000 in the third quarter of 2005. The fourth quarter 2005 losses were incurred in conjunction with a realignment of the Company's investment securities portfolio. During the quarter, the Company sold $37 million in low-yielding US government agency securities scheduled to mature in 2006 and 2007 and invested the proceeds in higher yielding mortgage-backed securities with longer maturities.

Operating expenses were $23.9 million in the fourth quarter of 2005, unchanged from $23.9 million in the fourth quarter of 2004 and down from $24.8 million in the third quarter of 2005. Operating expenses remained stable as increases in occupancy, equipment and other expenses were offset by a decrease in salary and employee benefits expense. The Company's efficiency ratio rose to 54.2 percent in 2005, from 52.6 percent in 2004, as a result of the decrease in net interest income.

The Company's return on average assets during 2005 was 1.40 percent, down slightly from 1.47 percent in 2004. Shareholders' equity increased from $485 million at December 31, 2004 to $501 million at December 31, 2005. During the year, the Company repurchased 126,900 shares of its common stock at an average price of $30.32 per share. At year-end 2005, the Company's book value stood at $19.98 per share, versus $19.26 at year-end 2004. The decline in return on assets combined with the increase in shareholders' equity resulted in a decline in return on average equity to 10.7 percent in 2005 from 12.0 percent in 2004.

Chemical Financial Corporation is the fourth largest bank holding company headquartered in Michigan. Effective December 31, 2005, the Company's banking operations began operating as a single subsidiary bank, Chemical Bank, with 132 banking offices spread over 32 counties in the lower peninsula of Michigan. Chemical Financial Corporation common stock trades on The Nasdaq Stock Market under the symbol CHFC and is one of the issues comprising the Nasdaq Financial 100 index.

[actr]

und nun zum Sport

Nach der ersten Woche der Ertragssaison gehen die Meinungen an der Wall Street weit auseinander – wie immer. Einig sind sich die Experten eigentlich nur darüber, dass die enttäuschenden Zahlen vieler Blue Chips und anderer prominenter Werte die Stimmung gedrückt und unter anderem die Kursstürze vom Freitag verschuldet haben.

Von den ersten Dow-Unternehmen, die bisher gemeldet haben, kam tatsächlich kein einziges ohne schlechte Nachrichten aus. Bei GE stimmte der Gewinn, aber der Umsatz war schwach. Alcoa und Citigroup verfehlten komplett. JP Morgan leidet unter schwachem Aktienhandel. IBM kam mit starken Zahlen, aber einem schwachen Ausblick, ebenso wie Apple und Ebay außerhalb des Dow. Yahoo und Intel wiederum verfehlten die Schätzungen auf ganzer Linie.

So ein Überblick sieht nicht gut aus. Auch nicht, wenn die Statistiker darauf hinweisen, dass immerhin 60 Prozent der Unternehmen bisher die Erwartungen geschlagen haben. Wen kümmern schon ein kleiner T-Shirt-Laden oder die Lokalbank in Florida, wenn die Großen alle patzen.

Und überhaupt: Die Quote der Enttäuschungen steigt auch ein wenig. 24 Prozent der Unternehmen blieben bisher unter den Prognosen zurück. Kann es sein, dass die Prognosen zu optimistisch waren? Es sieht so aus. Die Analysten sind in das bereits vierte Jahr des Bullenmarktes mit dem gleichen Optimismus eingestiegen wie in das ertse und zweite. Und wenngleich die Unternehmen 2002 sämtliche Schätzungen bei weitem übertroffen haben, berechtigt das noch lange nicht zu grenzenloser Euphorie bis an den jüngsten Tag. Immerhin: 2002 und 2003 war das Gewinnwachstum in Corporate America nicht zuletzt deshalb so stark, weil ich die Vergleichsdaten des Vorjahres schwach waren und üppiges Wachstum erst zuließen.

Jetzt, langsam und einer nach dem anderen, senken die Analysten ihre Erwartungen für das angebrochene Jahr. Damit laufen die Experten dem Trend wieder einmal hinterher. Erneut zeigt sich, dass die meisten Analysen im Vorfeld nicht so sehr auf fundamentalen Nachfroschungen beruht haben, sondern auf Euphorie.

Und das kann langtfristig nicht hinhauen. Zwar ist optimistische Stimmung immer besser als pessimistische, und viel Optimismus kann die Wirtschaft auch antreiben und sozusagen zu einer sich selbst erfüllenden Prophezeihung werden. Aber es gibt eben doch auch eine Schattenseite: Die Gefahr von Enttäuschungen steigt.

Und nun zum Sport: Der US-Skifahrer Bode Miller wird in wenigen Wochen bei den Olympischen Spielen in Turin an den Start gehen, und könnte dort, laut dem Time-Magazin als erster „fünf Medaillen“ holen. Damit sind die Erwartungen gesetzt. Kommt Miller mit drei Mal Gold zurück, werden die Fans enttäuscht sein. Kommt er hingegen mit fünf Medaillen zurück, werden sie nicht begeistert sein. Immerhin hat Miller nur sein Soll erfüllt.

Lars Halter

[actr]

Nitches, Inc.
23.01.06 21:24 Uhr

5,95 USD

+23,79 % [+1,1433]

http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=NICH.NAS&lColors=0x000000&sSym=NICH.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=NICH.NAS&lColors=0x000000&sSym=NICH.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=NICH.NAS&lColors=0x000000&sSym=NICH.NAS&hcmask=

Börse
NASDAQ

Aktuell
5,95 USD

Zeit
23.01.06 21:24

Diff. Vortag
+23,79 %

Tages-Vol.
13,87 Mio.

Gehandelte Stück
2,6 Mio.

Nitches, Inc. (NASDAQ: NICH) announced its results for the three months ended November 30, 2005. The Company earned consolidated net income of $520,000 for the first quarter of fiscal 2006, reversing a $12,000 loss in the year ago period. First quarter earnings per share were $.42 versus a loss of $.01 for the first quarter of fiscal 2005.

[actr]

REMINGTON OIL & GAS
23.01.06 21:29 Uhr

44,83 USD

+18,10 % [+6,87]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=REM.NYS&lColors=0x000000&sSym=REM.NYS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=REM.NYS&lColors=0x000000&sSym=REM.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=REM.NYS&lColors=0x000000&sSym=REM.NYS&hcmask=

Börse
NYSE

Aktuell
44,85 USD

Zeit
23.01.06 21:30

Diff. Vortag
+18,15 %

Tages-Vol.
297,97 Mio.

Gehandelte Stück
6,9 Mio.

Remington Oil and Gas Corporation Announces Merger with Cal Dive International and Provides Operations Update

DALLAS, Jan 23, 2006 /PRNewswire-FirstCall via COMTEX/ -- Remington Oil and Gas Corporation (NYSE: REM) announced it has agreed to a merger with Cal Dive International, Inc. (Nasdaq: CDIS) Consideration for the offer from Cal Dive will be $27.00 in cash and .436 shares of Cal Dive stock for each Remington share. Completion of the merger is subject to customary conditions to closing, including, without limitation, approval by Remington's stockholders at a meeting to be called for that purpose. Remington's Board of Directors has unanimously recommended approval and adoption of the merger agreement and the merger by Remington's stockholders. Randall & Dewey, a division of Jefferies & Company, acted as financial advisor to the Company. Remington will host a conference call today at 11:30 A.M. EST (10:30 A.M. CST). The teleconference can be joined at 1-800-706-3705. International calls can join at 1-706-679-5649. A replay of the call will be available from two hours after completion of the conference by dialing 1-800-642-1687, or international calls 1-706-645-9291, conference ID #4655326.
2006 Capital Budget

Remington's Board of Directors approved a capital budget of $293 million for 2006, representing a 202% increase over its initial 2005 budget of $145 million. Management expects that this level of expenditures will be within the Company's available cash flow based on currently forecast commodity prices. Remington's approved budget includes planned exploratory wells and known developments. The budget includes the costs associated with risked completions of new exploratory successes. The 2006 program assumes drilling 26 offshore exploratory wells and 2 onshore exploratory wells for a total investment of $146 million. Two of the 26 offshore exploratory wells are located in the deepwater Gulf of Mexico. Development capital of $39 million will allow for platform and pipeline installations on recent discoveries, along with development drilling on existing fields. Additionally, the Company has budgeted $73 million for anticipated development expenditures related to the 2006 exploratory program. The remaining $35 million will be used for seismic acquisitions, workovers, and lease acquisitions. This budget assumes three to four operated rigs working continuously during the year.

Drilling Program


Listed in the table below are wells recently drilled, currently drilling

or completing, along with wells that are scheduled to be drilled in the near

term.


Prospect Category W.I. Status/Spud Date Operator

%

Offshore


Vermilion 389 #1 Exploratory 60 P&A Remington

S. Marsh Island 116 #1 Exploratory 60 Discovery-Tested 13 Remington

MMCFE/D

S. Pass 87 #6 Exploratory 50 P&A Marathon

(Aquarius)

West Cameron 383 #2 Exploratory 52 Drilling Below Remington

5,000'

Vermilion 249 #1 Exploratory 30 Discovery-T&A Tana

East Cameron 346 #6 Development 75 January Spud Remington

Vermilion 250 #1 Development 50 February Spud Remington

Eugene Island 391#1 Exploratory 50 1st Qtr. Spud Remington

Main Pass 200 #1 Exploratory 50 January Spud Cimarex

The Company's South Marsh Island 116 #1 exploratory well discovered oil and gas pay in a single sand below 8,000 feet. This well has been sub sea completed and was flow tested at 7 million cubic feet of gas and 1,000 barrels of condensate per day. Forward plans are to construct the flow line and umbilical then connect the sub sea well to a nearby platform. We expect first production from this discovery to commence in the 2nd quarter 2006. Remington operates South Marsh Island 116 and owns a 60% working interest. Cimarex (NYSE: XEC) owns the remaining 40% working interest.

Drilling operations at the Company's South Pass 87 #6 (Aquarius) well have resulted in a dry hole. This well was drilled to 22,214 feet and found no commercial quantities of hydrocarbons. The wellbore is currently being temporarily abandoned for future use for possible sidetrack opportunities on the eastern half of block 87. Information gained from this exploratory test will be beneficial to future deep potential on our adjacent blocks 86 and 89. Remington owns a 50% working interest in this Marathon Oil Company operated well (NYSE: MRO). Drilling costs incurred to date for the well are approximately $55 million. We expect take an estimated $25 million pre-tax dry hole expense for this well in the 4th quarter 2005. The remaining costs associated with the well will be incurred in the 1st quarter 2006.

Production Update

Remington's 4th quarter 2005 production is expected to range between 48 to 52 million cubic feet of gas equivalents per day compared to an average of 81 MMCFE/D for the third quarter 2005. The Company exited 2005 producing approximately 95-100 MMCFE/D. Management expected to exit 2005 at approximately 125 MMCFE/D. However, ten (10) of the Company's fields remain shut-in primarily due to third party pipeline infrastructure damage. Remington's East Cameron 346 and surrounding satellite fields remain shut-in due to problems related to the gas export line owned by a third party. Based on communications in November of 2005 from the operator and owner of this line, the line was expected to be operational in December of 2005. However this line has yet to be re-commissioned and most recent communications indicate service to be restored in the mid-first quarter 2006. Production volumes that remain shut-in from these ten fields accounted for approximately 35 to 40 MMCFE/D prior to Hurricane Rita. The Company anticipates most of the company's storm related, shut-in production to be restored by the end of the first quarter 2006.

Remington does carry business interruption insurance for most of its offshore producing assets. Because of the ongoing shut-ins the Company is experiencing, the entirety of the business interruption claim is not yet known. Rough estimates, based on the Company's interpretation of the policy, result in an expected reimbursement from the policy for the fourth quarter 2005 of approximately $8.5 million. In addition, the Company's business interruption policy covers its largest producing field, East Cameron 346, for a total of 365 days.

The Company anticipates the external audit of our year-end 2005 reserves to be completed in February 2006. Internal estimates of our year-end 2005 total proven reserves range between 270 to 285 billion cubic feet of gas equivalents. Based on this internal estimate, the Company expects 2006 annual production to range between 45 to 49 billion cubic feet of gas equivalents. A prolonged shut-in period at our East Cameron 346 complex beyond our previously stated mid-first quarter start-up could materially impact this production guidance. A more detailed guidance will be provided on 2006 production volumes, DD&A rates per Mcfe and cash costs per Mcfe upon final completion of the audited 2005 year-end reserves.

Organizational Update

Mr. Gregory B. Cox has been promoted to Senior Vice President of Exploration. Mr. Cox was previously Vice President of Exploration for the Company. He joined the Company as Exploration Manager in November of 1997.

Remington Oil and Gas Corporation is an independent oil and gas exploration and production company headquartered in Dallas, Texas, with operations concentrating in the onshore and offshore regions of the Gulf Coast.

[actr]

SPORTS AUTHORITY NEW
23.01.06 21:39 Uhr

36,83 USD

+18,62 % [+5,78]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=TSA.NYS&lColors=0x000000&sSym=TSA.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&lSyms=TSA.NYS&lColors=0x000000&sSym=TSA.NYS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=TSA.NYS&lColors=0x000000&sSym=TSA.NYS&hcmask=

Börse
NYSE

Aktuell
36,83 USD

Zeit
23.01.06 21:39

Diff. Vortag
+18,62 %

Tages-Vol.
241,38 Mio.

Gehandelte Stück
7 Mio

The Sports Authority, Inc. to Be Acquired by Leonard Green & Partners, L.P. and Management for $37.25 Per Share in Cash

ENGLEWOOD, Colo., Jan 23, 2006 (BUSINESS WIRE) -- The Sports Authority, Inc. (NYSE:TSA), announced today that it has entered into a definitive agreement to be acquired by an investor group led by Green Equity Investors IV, L.P., an affiliate of Leonard Green & Partners, L.P. and including members of Sports Authority's senior management team for $37.25 per share in cash.
The board of directors of Sports Authority, on the recommendation of a special committee of independent directors, has unanimously approved the merger agreement and recommends that Sports Authority's shareholders adopt the agreement.

The total transaction value, including assumed debt, is approximately $1.3 billion. The transaction is expected to close in the second fiscal quarter of 2006, and is subject to Sports Authority's shareholder approval, as well as other customary closing conditions, including the receipt of financing and regulatory approvals.

Gordon Barker, chair of the special committee of Sports Authority's board of directors that approved the transaction said, "The Company received an acquisition proposal from Leonard Green & Partners and after extensive negotiations and careful consideration in conjunction with our independent advisors, the independent committee of Sports Authority's board has unanimously concluded that this transaction is in the best interest of our shareholders. This transaction, which will provide Sports Authority's shareholders with an immediate and substantial cash premium for their investment in the Company, reflects the success of the merger and integration of the Company's predecessors Gart Sports and The Sports Authority. In accordance with the merger agreement, the Company will also be conducting a market test for the next 20 days to ensure that the transaction is the best available for our shareholders."

Doug Morton, Chairman and CEO, said, "Not only does this transaction provide Sports Authority's shareholders with a substantial premium for their shares, but we believe it will be good for the company's associates, customers and suppliers. As a private company, Sports Authority will have greater flexibility to accomplish its long-term goals. Leonard Green & Partners has an excellent track record of building value at its portfolio companies by providing strong financial and strategic support. Leonard Green & Partners also has significant past experience in the sporting goods industry from its prior ownership of several sporting goods retailers."

Jonathan Seiffer, Partner of Leonard Green & Partners said, "We are pleased to have the opportunity to partner with this exceptional management team and build on the company's track record of growth and success in the retail sporting goods industry."

Merrill Lynch is acting as financial advisor for Sports Authority in connection with the merger transaction and has rendered a fairness opinion to the special committee of Sports Authority's board of directors. Banc of America Securities LLC is acting as financial advisor for Leonard Green & Partners in connection with the merger transaction. Bank of America N.A. and TCW/Crescent Mezzanine have provided commitments for the debt portion of the financing for the transaction, which are subject to customary conditions.

The Sports Authority, headquartered in Englewood, CO, is one of the nation's largest full-line sporting goods retailers offering a comprehensive high-quality assortment of brand name sporting apparel and equipment at competitive prices. As of December 31, 2005, The Sports Authority operated 398 stores in 45 states under The Sports Authority(R), Gart Sports(R), and Sportmart(R) names. The Company's e-tailing website, located at www.thesportsauthority.com is operated by GSI Commerce, Inc. under a license and e-commerce agreement. In addition, a joint venture with AEON Co., Ltd. operates "The Sports Authority" stores in Japan under a licensing agreement.

Leonard Green & Partners is a Los Angeles-based private equity firm specializing in organizing, structuring and sponsoring management buy-outs, going-private transactions and recapitalizations of established public and private companies. Leonard Green & Partners is the largest private equity firm in Southern California managing approximately $3.7 billion of private equity capital.

[actr]

Google Inc.
23.01.06 21:49 Uhr

427,45 USD

+7,01 % [+27,9899]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=GOOG.NAS&lColors=0x000000&sSym=GOOG.NAS&hcmask=

Börse
NASDAQ

Aktuell
427,45 USD

Zeit
23.01.06 21:49

Diff. Vortag
+7,01 %

Tages-Vol.
8,48 Mrd.

Gehandelte Stück
22 Mio.

Google subpoena roils the Web

Jan 21, 2006 (The Boston Globe - Knight Ridder/Tribune Business News via COMTEX) -- The US government's demand for millions of Internet search records from Google Inc. and other prominent search firms has raised new questions about the vast amounts of personal information collected by companies.
While federal investigators said they weren't seeking any data that could be traced to individuals, Internet privacy activists and some lawmakers said the action underscored concerns about what the search engines know about computer users and what could become of that information.

"Internet search engines provide an extraordinary service," said Representative Edward Markey, a Malden Democrat, "but the preservation of that service [should] not rely on a bottomless, timeless database that can do great damage despite good intentions."

Markey said yesterday that he will propose legislation as early as next month that would force search companies to destroy records containing personal information after "a reasonable period of time." Markey said that he'd been working on the legislation since last year, modeling it on a law that requires cable television firms to destroy personal data about customers' viewing habits.

Google is vowing to resist efforts by the US Justice Department to obtain information about the searches run by millions of its users, even though investigators are seeking aggregate data about Internet use, not individual users' records. The Justice Department wants the information as part of its effort to defend the Child Online Protection Act, a 1998 federal law that seeks to ban Internet sites from displaying content that the government deems "harmful to minors." The Supreme Court has ruled that the law can't be enforced unless the government shows less intrusive measures such as Internet filtering are inadequate. The government hopes to use search results from Google and other companies to show that Internet pornography is so pervasive that only a federal law can protect children from it.

Yahoo Inc., Microsoft Corp.'s MSN search service, and Time Warner Inc.'s AOL service have all agreed to provide the information, according to a Justice Department spokesman. But Google has refused, saying that releasing the data would compromise its users' privacy and the company's trade secrets. "Google is not a party to this lawsuit and their demand for information overreaches," said Nicole Wong, Google's associate general counsel. "We intend to resist their motion vigorously."

Meanwhile, shares of Google had their biggest decline ever yesterday as the company continued to resist the Justice Department's demand. Google dropped nearly 8.5 percent, to close at $399.46.

During each visit to Google or any other Internet site, a visitor's computer reveals a numerical address assigned by the user's Internet provider. The site can store that information, along with the date and time of the visit. This information can be used by researchers, marketers, or investigators to trace the visitor's identity.

In papers filed yesterday at a federal court in San Jose, Calif., government attorneys said that they are not seeking information about individuals. They want the search companies to provide a sample of a million websites from the billions they currently index, as well as all the search terms typed into the services during a one-week period. All information that could identify individuals is to be removed before the data is given to the government. The government could use the data to estimate how pervasive pornography is on the Internet and how often pornographic sites come up in random Internet searches.

The federal subpoenas have dismayed Internet privacy activists. "There's something disturbing about the notion that when you search for something the government is going to be looking over your shoulder," said Kurt Opsahl, staff attorney for the Electronic Frontier Foundation, an Internet civil liberties group.

The subpoenas also drew attention to how the major search services have become repositories of their users' personal data. "They have lots of information," said Danny Sullivan, editor of Search Engine Watch, an industry trade publication. "They know what people are clicking on. They know what people are searching for." By analyzing their vast databases of past searches, the companies can improve their software to help users find data more quickly. The companies can also upgrade the lucrative software that places paid advertisements on the search results pages. Currently, Google retains information about Web users' online activity for as long as it deems the data useful, according to a company spokesman.

Some privacy activists have long feared that companies like Google could abuse the data, by providing it to government officials or by using it themselves to track individual Internet usage. One public interest group, Public Information Research Inc. of San Antonio, runs scroogle.org, an Internet service that disguises the Internet address of searchers who want to run Google and Yahoo searches anonymously.

Opsahl suggested that Internet users concerned about privacy should do their Internet searches through Scroogle or other Internet "proxies" that hide the address of the searcher. But he also urged Google and other search companies to regularly erase their database of saved searches. "Perhaps they should consider whether it's worthwhile to keep all this information indefinitely," he said.

By Hiawatha Bray

[actr]

SULPHCO INC
23.01.06 21:55 Uhr

10,10 USD

-48,21 % [-9,40]

http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=

örse
AMEX

Aktuell
10,10 USD

Zeit
23.01.06 21:55

Diff. Vortag
-48,21 %

Tages-Vol.
165,96 Mio.

Gehandelte Stück
14 Mio.


BUYINS.NET: BAS, CAPB, NSU, NVEC, PZZ, SUF have been removed from naked short lists today

Jan 19, 2006 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold lists: Basic Energy Services, Inc. (NYSE: BAS), CapitalSouth Bancorp. (NASDAQ: CAPB), Nevsun Resources, Ltd (AMEX: NSU), NVE Corporation (NASDAQ: NVEC), Prospect Medical Holdings, Inc (AMEX: PZZ), SulphCo, Inc. (AMEX: SUF)


About SulphCo, Inc.

SulphCo has developed a patented safe and economic process employing ultrasound technology to desulfurize and hydrogenate crude oil and other oil related products. The company's technology upgrades sour heavy crude oils into sweeter, lighter crudes, producing more gallons of usable oil per barrel. From time to time, the company may issue forward-looking statements, which involve risks and uncertainties. This statement may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as actual results could differ and any forward-looking statements should be considered accordingly.

[actr]

Itron, Inc.
23.01.06 22:00 Uhr

46,99 USD

+16,20 % [+6,55]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=ITRI.NAS&lColors=0x000000&sSym=ITRI.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=ITRI.NAS&lColors=0x000000&sSym=ITRI.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=ITRI.NAS&lColors=0x000000&sSym=ITRI.NAS&hcmask=

Börse
NASDAQ

Aktuell
46,99 USD

Zeit
23.01.06 22:00

Diff. Vortag
+16,20 %

Tages-Vol.
76,79 Mio.

Gehandelte Stück
1,8 Mio.


Itron Reports Q4 2005 New Order Bookings of $149 Million; Record New Order Bookings of $655 Million in 2005

SPOKANE, Wash., Jan 23, 2006 (BUSINESS WIRE) -- Itron (NASDAQ: ITRI) announced today that it set a new record for total orders received in a single year. The 2005 total of $655 million in new order bookings surpasses the previous record of $358 million set last year in 2004.
Fourth quarter new orders of $149 million include the Company's largest order ever for its distribution line design software, received from Pacific Gas & Electric, and contracts for over 2 million automatic meter reading (AMR) modules and AMR-equipped meters. For the full year 2005, new order bookings include contracts to automate over 10 million electric, gas and water meters.

"Our success rate in winning new orders in 2005 demonstrates that the business case for Itron's technology is very compelling for many utilities," said LeRoy Nosbaum, chairman and CEO. "While we continue to be very excited about the prospects for fixed network AMR and AMI in the future, Mobile AMR technology provides our customers with a valuable tool for controlling costs, increasing operating efficiency and improving customer service. And, our wide range of software solutions gives our customers leading edge tools and analytics needed to make better, more informed decisions across their operations."

Itron is scheduled to release financial results for the fourth quarter and full year 2005 on February 14, 2006 at approximately 1:00 pm PT, at which time additional details about fourth quarter results will be made available.


About Itron

Itron is a leading technology provider and critical source of knowledge to the global energy and water industries. Nearly 3,000 utilities worldwide rely on Itron's award-winning technology to provide the knowledge they require to optimize the delivery and use of energy and water. Itron creates value for its clients by providing industry-leading solutions for electricity metering; meter data collection; energy information management; demand response; load forecasting, analysis and consulting services; distribution system design and optimization; web-based workforce automation; and enterprise and residential energy management. To know more, start here: www.itron.com.

[actr]

23.01.2006
McAfee: Gewinn- und Umsatzwarnung
Der Anbieter von Antivirensoftware McAfee Inc. prognostizierte nach Börsenschluss für das vierte Fiskalquartal einen Gewinn je Aktie zwischen 16 und 20 cents und einen Umsatz von 254 Millionen Dollar. Vor Einrechnung von Sondereffekten soll der Gewinn je Aktie zwischen 25 und 27 cents liegen. Die von First Call ermittelten durchschnittlichen Analystenerwartungen lagen bei einem Gewinn je Aktie (vor Einmaleffekten) von 38 cents und einem Umsatz von 274 Millionen Dollar.

Die Aktie verliert nachbörslich um 14,4 Prozent auf 23,65 Dollar.
(boerse-go.de, wirtschaftsblatt:online Partner)

[actr]

Johnson & Johnson Reports Full-Year and Fourth-Quarter 2005 Results 2005 Full-Year EPS Rose 21.8% on Sales Increase of 6.7% 2005 Fourth-Quarter EPS Rose 78.0% on Sales Decline of 1.1%

Jan 24, 2006 /PRNewswire-FirstCall via COMTEX/ -- Johnson & Johnson today announced sales for the fourth quarter of $12.6 billion, a decline of 1.1% as compared to the fourth quarter of 2004. Operational growth was .7% with a negative currency impact of 1.8%. Domestic sales were down 4.2%, while international sales increased 3.1%, reflecting operational growth of 7.5% and a negative currency impact of 4.4%. The fourth-quarter fiscal period of 2005 included 13 weeks of sales versus 14 weeks of sales in 2004. Worldwide sales for the year 2005 were $50.5 billion, an increase of 6.7% over 2004, increasing operationally by 6.0% with currency contributing .7%.
Net earnings and diluted earnings per share for the fourth quarter of 2005 were $2.2 billion and $.73. Net Earnings for the fourth quarter of 2004 included a special charge of $789 million related to taxes associated with funds repatriated under the American Jobs Creation Act. Excluding special charges, 2005 fourth-quarter net earnings were $2.2 billion and earnings per share were $.73, representing increases of 9.1% and 9.0%, respectively, as compared with the same period in 2004.*

Net earnings and diluted earnings per share for the year, as reported, were $10.4 billion and $3.46, increases of 22.4% and 21.8%, respectively, as compared with 2004. Full year 2005 included a gain of $225 million for a tax adjustment associated with a technical correction made to the American Jobs Creation Act and after-tax in-process research and development charges of $359 million. Full year 2004 results included a tax charge of $789 million related to the American Jobs Creation Act and after-tax in-process research and development charges of $12 million. Excluding these items, net earnings for the year were $10.5 billion and earnings per share were $3.50, representing increases of 13.3% and 12.9% as compared with the same period in 2004. *

"The year 2005 was a solid one for Johnson & Johnson, despite significant challenges," said William C. Weldon, Chairman and Chief Executive Officer. "We delivered excellent full-year earnings results, while continuing to make the major investments that will fuel future growth."

Worldwide, the Medical Devices and Diagnostics segment achieved annual sales of $19.1 billion in 2005, representing an increase over the prior year of 13.1% with operational growth of 12.5% and a positive impact from currency of .6%. Domestic sales increased 10.6%, while international sales increased 15.7% (14.5% from operations and 1.2% from currency).

Cordis' circulatory disease management products were a key contributor to the segment results with the primary driver being the CYPHER Sirolimus-eluting Coronary Stent, which reduces restenosis (reblockage) of a treated coronary artery. CYPHER is the worldwide leader in drug-eluting stents having now been used to treat more than 1.7 million patients with coronary artery disease.

Also contributing to the strong performance of the segment were the results from DePuy's orthopaedic joint reconstruction and spinal products, LifeScan's blood glucose monitoring products, Vistakon's disposable contact lenses and Ortho-Clinical Diagnostics' professional diagnostic products.

During the quarter, the Company announced that it had entered into a definitive agreement to acquire Animas Corporation, a leading manufacturer of insulin infusion pumps and related products. In January 2006, the Company also announced the acquisition of Hand Innovations LLC, a privately held manufacturer of implants used for the repair of wrist fractures.

Worldwide Pharmaceutical sales of $22.3 billion for the full year 2005 represented an increase of .9% versus the prior year with operational growth of .4% and a positive impact from currency of .5%. Domestic sales decreased 3.2%, while international sales increased 9.4% (7.8% from operations and 1.6% from currency).

Sales results for DURAGESIC, a transdermal patch for chronic pain; ULTRACET, an analgesic; SPORANOX, an antifungal; and hormonal contraceptives were all negatively impacted by generic competition in the U.S. market. Offsetting the impact of generic competition was the strong performance of RISPERDAL, an antipsychotic medication; REMICADE, a biologic approved for the treatment of a number of Immune Mediated Inflammatory Diseases; TOPAMAX, an antiepileptic and a treatment for the prevention of migraine headaches; LEVAQUIN, an anti-infective; and CONCERTA, a treatment for attention deficit hyperactivity disorder.

During the quarter, the Company submitted new drug applications to the U.S. Food and Drug Administration (FDA) for Paliperidone Extended-Release Tablets, a once daily, oral medication for the treatment of schizophrenia, and TMC114, a protease inhibitor being studied as a potential treatment for people infected with HIV-1. The Company also announced that it had entered into an agreement with Bayer HealthCare to jointly develop and market BAY 59-7939 (Factor Xa inhibitor) for the prevention and treatment of thrombosis. In addition, the Company announced that it had entered into an agreement with Biovail Corporation for the marketing and distribution of two novel formulations of tramadol hydrochloride.

Worldwide Consumer segment annual sales in 2005 were $9.1 billion, an increase of 9.2% over the prior year with operational growth of 7.8% and a positive impact from currency of 1.4%. Domestic sales increased 4.3%, while international sales increased 14.2% (11.3% from operations and 2.9% from currency).

Strong growth in Consumer sales was achieved by McNeil Nutritional's SPLENDA sweetener and the skin care lines of NEUTROGENA, AVEENO and RoC.

During the quarter, the Company announced that it had completed the acquisition of the REMBRANDT Brand of oral care products from The Gillette Company.

Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 115,600 men and women in 57 countries and sell products throughout the world.

[actr]

JUPITER Global Holdings, Corp. Announces Plan to Become Target for Acquisiton or Merger

LAS VEGAS, NV, Jan 24, 2006 (MARKET WIRE via COMTEX) -- JUPITER Global Holdings, Corp. ("JUPITER" or the "Company") (OTC: JPHC) today announces that its Board of Directors has authorized its management to commence preparations to develop a plan to become a target for acquisition or merger by a suitable strategic buyer.
Specifically, management has undertaken certain preparations that include, but not be limited to: (i) the Company continuing its efforts to become current with its periodic filings with the Securities and Exchange Commission; (ii) consideration of possibly securing other strategic acquisitions; (iii) making efforts to improve the Company's balance sheet, such as the recent reduction of company debt; (iv) the successful execution of the Company's recently announced stock buyback program.

The Board of Directors and management feel that upon completion of a cohesive plan to ready the Company for a possible acquisition, JUPITER will become a more attractive target to be acquired by, or merged with other companies that see JUPITER as an ideal candidate.

The Company believes that these steps are a fundamental aspect of building shareholder value by seeking to attract one or more buyout opportunities that the Board of Directors may consider.

ABOUT JUPITER GLOBAL HOLDINGS, CORP.

JUPITER Global Holdings, Corp. is a holding company with interests and developments in a diverse number of growing industries. JUPITER plans to achieve a leadership position through the building of a synergistic network of innovative, profitable and global businesses.

[actr]

Market Pulse Breaking News Alert for Tuesday, January 24, 2006: BIEL -- BioElectronics Corporation Announces the Addition of Jeffrey Weinzweig, MD and W. Thomas McCellan, MD to the Company's Medical Advisory Committee! NOTE TO EDITORS: The Following

ATLANTA, GA, Jan 24, 2006 (MARKET WIRE via COMTEX) -- Market Pulse News Alert for this AM, Stocks to Watch are: BioElectronics Corporation (OTC: BIEL), Generex Biotechnology Corp. (NASDAQ: GNBT), Google Inc (NASDAQ: GOOG) and Apple Computer Inc. (NASDAQ: AAPL) Investors need to be watching BioElectronics Corporation (OTC: BIEL) this AM! BioElectronics is the developer and marketer of advanced, inexpensive, disposable, drug-free, medical devices cleared by the US FDA, the European Union and the Canadian regulatory authorities. The company's primary suite of products are the ActiPatch(TM) Therapy medical devices. These devices are miniaturized, battery operated and deliver pulsed electromagnetic frequencies, which are embedded in a dermal patch for continuous therapeutic treatment for a few dollars a day. The company's patented technology provides therapy designed to reduce swelling, relieve pain and enhance healing of surgical incisions, chronic wounds and orthopedic conditions. BioElectronics is emerging from a development stage company and is ready to capitalize on the potential market for effective therapies which is estimated at $6.5 billion in the U.S. and over $20 billion worldwide. BIEL is poised to become a significant player in the medical devices industry. BIEL just had excellent news out in a press release before today's opening bell announcing the addition of Jeffrey Weinzweig, MD and W. Thomas McCellan, MD, of the Lahey Clinic in Boston, Massachusetts, to the company's Medical Advisory Board! Investors should be watching this one closely!
BioElectronics Corporation (OTC: BIEL) announced today the addition of Jeffrey Weinzweig, MD and W. Thomas McClellan, MD, of the Lahey Clinic in Boston, Massachusetts, to the company's Medical Advisory Board. Drs. Weinzweig and McClellan have been elected to the company's Medical Advisory Board to facilitate the collaboration of clinical studies using the renowned Lahey Clinic (Burlington, MA) and to assist with the research and development of the company's ActiPatch(TM) Therapy products.

Dr. Jeffrey Weinzweig, Chairman of the Department of Plastic Surgery for the Lahey Clinic, joins the board with a long history of clinical research, surgical experience and medical education. Dr. Weinzweig has authored more than a hundred and fifty scientific papers and chapters on various topics within the plastic surgery, hand surgery and craniofacial surgery arena and is currently editing his fifth textbook. He also serves as Director of the Institute of Craniomaxillofacial Surgery and Director of Research of the Craniofacial Biology & Tissue Engineering Laboratory at Lahey and has lectured to medical professionals around the world.

Dr. W. Thomas McClellan, Chief Plastic Surgery Resident at the Lahey Clinic, also joins the committee with a long-standing reputation for excellence in medicine. In addition to serving as chief resident, Dr. McClellan has also authored numerous scientific papers and been awarded such prestigious honors as 2002, 2003 and 2004 Resident Physician Teacher of the Year from West Virginia School of Medicine and admission into Alpha Omega Alpha Honor Medical Society.

"We are thrilled and quite fortunate to have these two esteemed surgeons join our team. We look forward to having their insight and talents enhance our mission in the clinical study of our break through technology," said Bioelectronics' Executive Vice President and Chief Operating Officer Thomas O'Connor.

"To have such talent as Drs. Weinzweig and McClellan join our board speaks volumes about ActiPatch(TM) and the scientific advancements being generated at BioElectronics. I look forward to working with them in these important endeavors," said BioElectronics' Medical Advisory Board Chairman Lawrence L. Michaelis, MD.

The appointments are effective immediately.

ActiPatch(TM) is a drug-free, anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch(TM) delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.

[actr]

Tidewater Reports Third Quarter Results For Fiscal 2006

NEW ORLEANS, Jan 24, 2006 (BUSINESS WIRE) -- Tidewater Inc. (NYSE:TDW) announced today third quarter net earnings for the period ended December 31, 2005, of $60.0 million, or $1.04 diluted earnings per common share, on revenues of $234.6 million. For the same quarter last year, net earnings were $19.8 million, or $.34 per share, on revenues of $187.6 million. Net earnings in the immediately preceding quarter ended September 30, 2005, were $82.2 million, or $1.42 per share (inclusive of a $42.8 million, or $.74 per share, gain related to the sale of six vessels during the quarter), on revenues of $204.4 million.
As previously announced, Tidewater will hold a conference call to discuss December quarter earnings on Tuesday, January 24, 2006 at 10:00 a.m. CST promptly following the Company's release of quarterly earnings.


TIDEWATER INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and par value data)


December 31, March 31,

ASSETS 2005 2005

----------- -----------

Current assets:

Cash and cash equivalents $ 167,064 15,376

Trade and other receivables, net 232,148 169,784

Marine operating supplies 40,351 38,959

Other current assets 4,437 3,837

----------- -----------

Total current assets 444,000 227,956

----------- -----------

Investments in, at equity, and advances to

unconsolidated companies 35,240 32,074

Properties and equipment:

Vessels and related equipment 2,442,080 2,483,970

Other properties and equipment 50,047 48,512

----------- -----------

2,492,127 2,532,482

Less accumulated depreciation and

amortization 1,121,782 1,080,296

----------- -----------

Net properties and equipment 1,370,345 1,452,186

----------- -----------

Goodwill 328,754 328,754

Other assets 116,971 172,203

----------- -----------

Total assets $ 2,295,310 2,213,173

=========== ===========


LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable and accrued expenses 81,129 82,261

Accrued property and liability losses 8,368 9,286

Income taxes 10,024 695

----------- -----------

Total current liabilities 99,521 92,242

----------- -----------

Long-term debt 300,000 380,000

Deferred income taxes 179,903 184,410

Accrued property and liability losses 28,144 34,778

Other liabilities and deferred credits 95,695 79,041

Stockholders' equity:

Common stock of $.10 par value,

125,000,000 shares authorized, issued

60,488,807 shares at December and

60,718,231 shares at March 6,049 6,072

Other stockholders' equity 1,585,998 1,436,630

----------- -----------

Total stockholders' equity 1,592,047 1,442,702

----------- -----------

Total liabilities and

stockholders' equity $ 2,295,310 2,213,173

=========== ===========

[actr]

Eaton Announces Record Date for First Quarter 2006 Dividend

CLEVELAND, Jan 24, 2006 (BUSINESS WIRE) -- As announced in yesterday's fourth quarter 2005 earnings news release, the Board of Directors of diversified industrial manufacturer Eaton Corporation (NYSE:ETN) has declared a first quarter dividend of $.35 per share, representing a 13 percent increase over the previous quarterly dividend of $.31 per share.
The dividend is payable on February 24, 2006 to shareholders of record at the close of business on February 6, 2006. Eaton has paid dividends on common shares every year since 1923.

Eaton Corporation is a diversified industrial manufacturer with 2005 sales of $11.1 billion. Eaton is a global leader in electrical systems and components for power quality, distribution and control; fluid power systems and services for industrial, mobile and aircraft equipment; intelligent truck drivetrain systems for safety and fuel economy; and automotive engine air management systems, powertrain solutions and specialty controls for performance, fuel economy and safety. Eaton has 59,000 employees and sells products to customers in more than 125 countries. For more information, visit www.eaton.com.

[actr]

Compuware Corporation to Announce Third Quarter Results on January 26, 2006

Jan 24, 2006 /PRNewswire-FirstCall via COMTEX/ -- Compuware Corporation (Nasdaq: CPWR) today announced that it will report results for its third quarter -- ended December 31, 2005 -- after market-close on January 26, 2006. The company will also hold a conference call to discuss these results at 5:00 p.m. Eastern time (22:00 GMT) on January 26.

Compuware Corporation (NASDAQ: CPWR) maximizes the value IT brings to the business by helping CIOs more effectively manage the business of IT. Compuware solutions accelerate the development, improve the quality and enhance the performance of critical business systems while enabling CIOs to align and govern the entire IT portfolio, increasing efficiency, cost control and employee productivity throughout the IT organization. Founded in 1973, Compuware serves the world's leading IT organizations, including more than 90 percent of the Fortune 100 companies. Learn more about Compuware at http://www.compuware.com.

[actr]

Head-To-Head Study Shows More Elderly Patients With Community-Acquired Pneumonia Recovered at Days 3 to 5 With AVELOX(R) (Moxifloxacin HCl) Compared to LEVAQUIN (Levofloxacin) CAPRIE first clinical study to compare fluoroquinolones in elderly populat

KENILWORTH, N.J., Jan 24, 2006 /PRNewswire-FirstCall via COMTEX/ -- Significantly more elderly patients treated with AVELOX(R) (moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at days 3 to 5 of a 7 to 14 day course of treatment than those treated with LEVAQUIN (levofloxacin), according to results of a clinical study published in the current issue of Clinical Infectious Diseases.(1) The first comparative, head-to-head evaluation of two fluoroquinolone antibiotics in hospitalized elderly CAP patients showed that 97.9 percent of AVELOX patients recovered at days 3 to 5 compared to 90.0 percent of LEVAQUIN patients (P=0.01). There was no significant difference between the two treatments with regard to cardiac safety, the primary endpoint of the study, or clinical cure rates 5 to 21 days after the end of treatment, the primary efficacy endpoint.
Additional analyses examined cure rates across CAP severity and age subgroups, including mild to moderate CAP, severe CAP, CAP in patients 65-74 years of age, and CAP in patients 75 years of age or older. Patients treated with AVELOX achieved a cure rate of 90 percent or greater in all CAP severity and age subgroups. The rates of investigator-reported drug-related adverse events in the study were similar for both treatment regimens.

The clinical study, called CAPRIE (Community-Acquired Pneumonia Recovery In the Elderly), is one of only a few studies that have specifically evaluated CAP treatment among elderly (age 65 or older) and very elderly (age 75 or older) patients. These patients are 60 percent more likely to contract CAP than the general population.(2)

"The incidence of pneumonia increases with age and elderly pneumonia patients are a vulnerable patient population that faces a high mortality rate when they enter a hospital," said Dr. Antonio Anzueto, lead study author and associate professor of medicine, University of Texas Health Science Center, San Antonio. "The CAPRIE study findings not only reinforce that AVELOX is an effective and safe treatment option for elderly patients with CAP, but also show that more patients taking AVELOX recovered at days 3 to 5 compared to patients taking LEVAQUIN."

Each year, there are nearly one million cases of community-acquired pneumonia among the elderly in the United States and among those age 85 or older, at least 1 in 20 have to be hospitalized.(3,4) The disease is the fifth leading cause of death in the elderly and research has shown that the appropriate and timely administration of antibiotics to elderly CAP patients may lead to decreased mortality and faster hospital discharge.(5)

Study Design

The CAPRIE study was a prospective, randomized, controlled, double-blind, double-dummy, comparative study conducted at 47 centers across the United States. Patients were stratified by CAP severity before randomization to I.V./oral AVELOX 400 mg once daily or I.V./oral LEVAQUIN 500 mg once daily for seven to 14 days. The study enrolled 394 patients, of which 281 were valid for the primary efficacy analysis. Most patients had multiple co-morbidities, including chronic obstructive pulmonary disease (COPD), cardiac disease and diabetes, and 16 percent of patients had severe CAP.

About Community-Acquired Pneumonia (CAP)

Community-acquired pneumonia affects 5.6 million adults in the United States annually, resulting in nearly two million cases of hospitalization.(6,7) It is the fifth leading cause of death among people older than 65 years, and a larger percentage of these patients have frequent co-morbidities and require hospitalization and longer hospital and intensive care unit (ICU) stays.(8,9) The cost of treating CAP patients is estimated at $10 billion per year, with 92 percent of those costs spent on hospitalized care.(10) Community-acquired pneumonia is a particular concern for seniors and people with chronic illnesses or impaired immune systems, although it also affects young and healthy people. The elderly population is 60 percent more likely than the general population to be affected by CAP.(11)

About AVELOX

AVELOX, available in tablet and I.V. formulations, was developed by Bayer Pharmaceuticals Corporation and is marketed in the United States by Schering- Plough. AVELOX offers patients a once-daily dosing regimen that does not require dosage adjustment when switching from I.V. to oral therapy. AVELOX patients suffering from renal impairment do not need to have their dosage adjusted.

AVELOX is approved to treat: Acute Bacterial Sinusitis (ABS) caused by Streptococcus pneumoniae, Haemophilus influenzae or Moraxella catarrhalis; Acute Bacterial Exacerbations of Chronic Bronchitis (ABECB) caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, methicillin-susceptible Staphylococcus aureus or Moraxella catarrhalis; Community Acquired Pneumonia (CAP) caused by Streptococcus pneumoniae (including multi-drug resistant strains*), Haemophilus influenzae, Moraxella catarrhalis, methicillin-susceptible Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae or Chlamydia pneumoniae; Uncomplicated Skin and Skin Structure Infections (uSSSI) caused by methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes; Complicated Skin and Skin Structure Infections (cSSSI) caused by methicillin-susceptible Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae or Enterobacter cloacae; and Complicated Intra-Abdominal Infections (cIAI) including polymicrobial infections such as abscesses caused by Escherichia coli, Bacteroides fragilis, Streptococcus anginosus, Streptococcus constellatus, Enterococcus faecalis, Proteus mirabilis, Clostridium perfringens, Bacteroides thetaiotaomicron or Peptostreptococcus species.

* MDRSP, multi-drug resistant Streptococcus pneumoniae, includes isolates previously known as PRSP (penicillin-resistant Streptococcus pneumoniae), and are strains resistant to two or more of the following antibiotic classes: penicillin (MIC greater than or equal to 2 mcg/mL), second generation cephalosporins (e.g., cefuroxime), macrolides, tetracyclines and trimethoprim/sulfamethoxazole.

SAFETY INFORMATION about AVELOX

AVELOX is generally well tolerated, with adverse events being similar to standard therapy. The most common side effects caused by AVELOX, which are usually mild, include dizziness, nausea and diarrhea. Patients should be careful about driving or operating machinery until they are sure that AVELOX is not causing dizziness. Patients should inform a health care professional of other side effects.

Patients who have ever had an allergic reaction to AVELOX or any of the other group of antibiotics known as "quinolones," such as levofloxacin should avoid taking AVELOX.

Patients who have been diagnosed with an abnormal heartbeat such as an arrhythmia or are using certain medications used to treat an abnormal heartbeat should avoid taking AVELOX. These medications include quinidine, procainamide, amiodarone and sotalol.

AVELOX is not for use during pregnancy or nursing, as the effects on the unborn child or nursing infant are unknown. AVELOX is not for children under the age of 18 years.

Convulsions have been reported in patients receiving quinolone antibiotics. Patients should be sure to let their physician know if they have a history of convulsions.

Many antacids and multivitamins may interfere with the absorption of AVELOX and may prevent it from working properly. Patients should take AVELOX either 4 hours before or 8 hours after taking these products.

Please see full prescribing information for AVELOX available at www.AVELOXUSA.com.

About Schering-Plough Corporation

Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its more than 30,000 people around the world. The company's Web site is www.schering-plough.com.

[actr]

24.01.2006 14:43
US Vorbörse mit Kursgewinnen


http://img.godmode-trader.de/charts/8/2005/4018.gif

[actr]

Verint Expands ULTRA Actionable Intelligence Suite With IntelliScreen Analytics Solution New Analytics Solution Transforms Unstructured Desktop Screen Data into Actionable Intelligence to Optimize Contact Center and Enterprise Performance

MELVILLE, N.Y., Jan 24, 2006 (BUSINESS WIRE) -- Verint Systems Inc. (NASDAQ: VRNT), a leading provider of analytic software-based solutions for communications interception, networked video security and business intelligence, today announced the introduction of ULTRA(TM) IntelliScreen, a new analytical solution for generating actionable intelligence from unstructured data displayed on desktop screens.
IntelliScreen is the latest addition to the ULTRA Analytics(TM) suite consisting of IntelliFind speech analytics and IntelliMiner performance analytics solutions. This powerful trio provides a comprehensive view of business process, customer interactions and performance trends and delivers actionable intelligence about quality and performance issues across the enterprise.

"Verint's ULTRA suite transforms customer interactions and other enterprise data into actionable intelligence that can help drive business improvement," said Dan Bodner, President and CEO of Verint Systems Inc. "ULTRA IntelliScreen(TM), the latest addition to our actionable intelligence portfolio, delivers valuable insight into the ongoing effectiveness of customer operations."

ULTRA IntelliScreen monitors activity on the desktop screen of a contact center agent or back-office worker and tracks application usage, data entry, and screen content. IntelliScreen then analyzes this data, and can trigger a broad range of actions and alerts based on the resulting intelligence. These alerts can provide insight into operational performance and business process issues, automate agent assistance and trigger target coaching or other actions.

With ULTRA IntelliScreen, enterprise transaction information, such as call outcome or transaction value, is intelligently linked to customer interactions. This data can then facilitate optimization of front office and back office processes, enable targeted data mining of specific transaction types and power more effective speech analysis. ULTRA's unique root cause analytics automatically surfaces potential quality and performance issues that are not yet identified, before they impact operational efficiency or threaten customer satisfaction.

Continued Bodner, "ULTRA IntelliScreen is designed to help businesses extract actionable intelligence from the screen data captured in their contact centers and other transaction-intensive departments across the enterprise and enables a more intelligent approach to performance management and process optimization initiatives."

About ULTRA

Verint's ULTRA solution and its Analytics suite drive total quality by enabling organizations of all sizes to cost-effectively capture all customer interactions and extract actionable intelligence from telephone, Voice-over-IP, email or chat. Easy access to all customer data through ULTRA's Web-based desktop portal enables enterprises to use what they learn from customer contacts to optimize their processes, increase productivity, comply with risk management requirements and improve service to their customers.

About Verint Systems Inc.

Verint Systems Inc., headquartered in Melville, New York, is a leading provider of analytic software-based solutions for communications interception, networked video security and business intelligence. Verint software, which is used by over 1,000 organizations in over 50 countries worldwide, generates actionable intelligence through the collection, retention and analysis of voice, fax, video, email, Internet and data transmissions from multiple communications networks. Verint is a subsidiary of Comverse Technology, Inc. (NASDAQ: CMVT) Visit us at our website www.verint.com.

[actr]

ICE Announces Point-to-Point Connectivity with Addition of Chicago Hub Additional Hubs in London and Singapore Planned

ATLANTA, Jan 24, 2006 /PRNewswire-FirstCall via COMTEX/ -- As part of its global network strategy, IntercontinentalExchange (NYSE: ICE), the leading electronic energy marketplace, today announced its second telecommunications hub with the launch of its new Chicago hub located within the Equinix Chicago Internet Business Exchange(TM) (IBX(R)) center. The hub is designed to improve access and reduce connectivity costs to ICE's electronic energy trading platform for current and prospective ICE market participants in the region.
Six trading and technology firms that are co-located within Equinix's Chicago center have connected to the ICE platform via the new hub, enabling hundreds of their traders and customers to access ICE's markets.

The ICE global network strategy includes plans to open additional regional connection hubs in London in February, Singapore in April and New York in May. In 2005, ICE launched its European hub outside of London. Approximately 20 customers utilize the regional connection hub to access ICE's energy futures and over-the-counter (OTC) markets from within the United Kingdom and Western Europe.

"We are very pleased to be among the first to connect to ICE's new Chicago hub from our U.S. data center in the same facility," said Hamish Purdey, President of FFastFill Inc., the U.S. unit of London-based FFastFill plc. "ICE's energy markets have captured a great deal of attention in the Chicago market, and the continued build-out of their connectivity infrastructure demonstrates that both ICE and FFastFill share in a commitment to serving the electronic trading community with superior technology and cost-efficient solutions." FFastFill is the leading provider of application services to the global derivatives community.

"To continue to grow our electronic energy markets, we are taking an aggressive approach to technology enhancements and expanded connectivity options to meet the needs of participants around the globe," said Chuck Vice, ICE's President and Chief Operating Officer. "Chicago is an important market for us, and we are gratified by the early response to the new hub."

ICE's Chicago hub offers customers the ability to connect directly to ICE via data circuits ordered through their preferred local telecommunication vendors or via cross-connected Ethernet circuits within the state-of-the-art Equinix facility. Customers can determine the bandwidth size for their connections, as well as the number and type of circuits they require to meet their specific data needs.

Equinix, Inc. is the leading provider of network-neutral data centers and Internet exchange service. Equinix's Chicago facility, which is recognized as a leading connectivity point for the financial trading industry, features an aggregation of leading financial trading companies all operating within the same center. It also provides a redundant and secure infrastructure, with interlocking "mantrap" doors, multiple layers of biometric hand-geometry scanners controlling access, hundreds of surveillance cameras and 24-hour security officers. The power operations of the center include a high- performance back-up system that guarantees uninterrupted power even in the event of utility power disruption.

About IntercontinentalExchange

IntercontinentalExchange(R) (NYSE: ICE) operates the leading electronic global futures and OTC marketplace for trading energy commodity contracts, including crude oil and refined products, natural gas, power and emissions. ICE conducts its markets for futures trading through its regulated subsidiary, ICE Futures (formerly the International Petroleum Exchange, or IPE), Europe's leading energy futures and options exchange. ICE also offers a range of risk management and trading support services, including cleared OTC contracts, electronic trade confirmations and energy market data. ICE's common stock began trading on the New York Stock Exchange on November 16, 2005. ICE is based in Atlanta, Georgia with offices in Calgary, Chicago, Houston, London, New York and Singapore. For more information, please visit www.theice.com.

[actr]

24.01.2006 14:50
McDonald's verdient im vierten Quartal mehr - Trifft Analystenschätzungen

Die weltgrößte Fast-Food-Kette McDonald's <MCD.NYS> <MDO.FSE> (Nachrichten/Aktienkurs) hat im vierten Quartal bei einem Umsatzzuwachs mehr verdient als vor einem Jahr. Der Gewinn je Aktie sei auf 0,48 (Vorjahr: 0,31) Dollar gestiegen, teilte das Unternehmen am Dienstag in Oak Brook mit. Damit traf McDonald's exakt die Schätzungen der Analysten. Der Umsatz kletterte um vier Prozent auf 5,23 (Vorjahr: 5,01) Milliarden Dollar. Bei konstanten Wechselkursen wuchsen die Erlöse um sechs Prozent.

Im Gesamtjahr betrug der verwässerte Gewinn je Aktie 2,04 (Vorjahr: 1,79) Dollar, teilte McDonald's weiter mit. Das operative Ergebnis stieg von 3,54 Milliarden Dollar in 2004 auf 4,02 Milliarden Dollar. Die Gesellschaft setzte mit 20,46 Milliarden Dollar sieben Prozent mehr um als im Vorjahr.

Im ersten Quartal des laufenden Geschäftsjahres will McDonalds eigene Aktien im Wert von einer Milliarde Dollar zurückkaufen. Weiterhin plant die amerikanische Fast-Food-Kette 1,8 Milliarden Dollar in die Eröffnung von 800 neuen Filialen stecken.

McDonald's bekräftigte am Dienstag zudem seine langfristigen Wachstumsziele. Danach soll der Umsatz jährlich zwischen drei bis fünf Prozent wachsen. Für das operative Ergebnis peilt das Unternehmen einen jährliches Plus von sechs bis sieben Prozent an./ne/tav

ISIN US5801351017

AXC0116 2006-01-24/14:49

[actr]

BiovaxID(TM) Yields 89% Survival in Patients with Aggressive Non-Hodgkins Mantle Cell Lymphoma at Median Follow-up of 3.8 Years Personalized Anti-Cancer Vaccine, BiovaxID, Stimulates Patient's Immune System to Seek out and Destroy Cancer Cells withou

WORCESTER, Mass., Jan 24, 2006 (BUSINESS WIRE) -- Biovest International, Inc. (OTCBB: BVTI), a subsidiary of Accentia Biopharmaceuticals, Inc (NASDAQ: ABPI), reports follow-up data to a Phase 2 trial conducted by the National Cancer Institute (NCI) that shows Biovest's BiovaxID yielded an 89% survival rate in mantle cell lymphoma patients. The median follow-up was 3.8 years. Historically, patients with this type of lymphoma only have had a 50% chance of surviving 3 years and 20% chance of surviving 5 years. BiovaxID, an investigational personalized anti-cancer vaccine, stimulates the immune system to seek out and destroy tumor cells. The data were published in a recent edition of Nature Medicine (Nat Med.2005; 11(9):986-91).
In this single-arm, open-label Phase 2 clinical study, patients with untreated mantle cell non-Hodgkin's lymphoma (NHL) were administered six cycles of dose-adjusted EPOCH-R, a chemotherapy regimen that includes Rituxan(R)(1) (rituximab). Of the 26 patients in the study, 23 received vaccinations with BiovaxID commencing at least three months after completing their last chemotherapy and Rituxan treatments. Upon the 46-month (3.8-year) follow-up, the overall survival rate was 89%. This study showed that, despite an almost complete depletion of normal B-cell lymphocytes due to EPOCH-R therapy, BiovaxID did induce anti-tumor T-cell lymphocyte responses in most patients. Depletion of normal B-cell lymphocytes is a consequence of the combination of chemotherapy and Rituxan, but not of BiovaxID therapy. Thus, "it is justifiable to administer vaccines in the setting of B-cell depletion, but vaccine boosts after B-cell recovery may be necessary for optimal humoral responses," concluded the investigators.

Lymphocytes are a type of white blood cell. There are two types of lymphocytes: B-cell lymphocytes, which produce antibodies ("humoral" immunity) in response to immune stimulation; and T-cell lymphocytes, which mediate cell responses to immune stimulation ("cellular" immunity). B-cell lymphocytes can undergo malignant transformation to become non-Hogkins lymphoma, multiple myeloma or chronic lymphocytic leukemia.

"This is the first human cancer vaccine study to see T-cell responses in the absence of B-cells," said the study's first author, Sattva Neelapu, M.D., Assistant Professor in the Department of Lymphoma at the University of Texas M. D. Anderson Cancer Center. "This paves the way to use vaccines in a number of hematological cancers that are treated by eliminating diseased B-cells."

Biovest is now enrolling patients in a pivotal Phase 3 trial to test BiovaxID against follicular non-Hodgkin's lymphoma (NHL). Follicular NHL is an indolent (slow-growing) form of lymphoma not considered curable with existing therapies. The impressive findings from the Phase 2 clinical trial using BiovaxID in mantle cell lymphoma suggest the vaccine could potentially be used to treat other types of NHL, in addition to follicular NHL.

Background on immunotherapeutics for non-Hodgkin's lymphoma

Rituxan is a passive immunotherapeutic consisting of a monoclonal antibody administered intravenously. The monoclonal antibody is directed to an antigen (CD20) present on most B-lymphocytes. Accordingly, Rituxan promotes the elimination of cancerous and normal B-lymphocytes bearing this antigen. Rituxan therapy is typically repeated as necessary at intervals in order to control the lymphoma. Annual sales for Rituxan are about $1.5B.

BiovaxID is an active immunotherapeutic that stimulates the production of anti-tumor antibodies and induces a cell-mediated immune response to cancerous B-lymphocytes but not to normal B-lymphocytes. As an active immunotherapeutic, BiovaxID may also provide ongoing immunosurveillance for recurrent tumors.

BiovaxID is a personalized therapeutic comprised of tumor-derived Id protein (tumor-specific antigen) conjugated (linked) to KLH (keyhole limpet hemocyanin) as a carrier protein administered with GM-CSF (granulocyte macrophage colony stimulating factor). GM-CSF is commercially available for other indications. BiovaxID is administered on an outpatient basis in the oncologist's office by means of a subcutaneous injection similar to an insulin shot.

BiovaxID is a premiere example of a targeted therapeutic. It stimulates the immune system to seek out and destroy only cancerous B-cell lymphocytes without collateral damage to normal B-cell lymphocytes or to other cells.

BiovaxID is produced using a hybridoma cell-line developed by and licensed exclusively from Stanford University. BiovaxID contains high-fidelity copies of a tumor-specific antigen that is unique to each patient and that is found exclusively on the surface of each and every malignant B-lymphocyte but not found on the surface of normal B-lymphocytes or other cells. Competing technologies use recombinant techniques, which are copies of just a portion of the tumor-specific antigen. Biovest believes that a complete copy of the tumor specific antigen results in higher rates of immune responses in patients and more robust clinical outcomes, including molecular remissions.

Patients who believe they may be eligible to participate in a clinical trial with BiovaxID are encouraged to call 1-877 654-6052 or visit the web site at http://www.accentia.net.

About Biovest International

Biovest International, Inc. is a pioneer in the development of advanced individualized immunotherapies for life-threatening cancers of the blood system. Biovest is a majority owned subsidiary of Accentia Biopharmaceuticals, Inc. with its remaining shares publicly traded. Biovest has a foundation in the manufacture of biologics for research and for clinical trials. In addition, Biovest develops, manufactures, and markets patented cell culture systems, including the AutovaxID(TM), an instrument which is being developed for multiple commercial applications inclding automated vaccine manufacturing. Biovest's therapy for follicular non-Hodgkin's lymphoma is currently in a Phase 3 pivotal clinical trial at over 20 major centers in the U.S. being conducted under a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute. For further information, please visit Biovest's website: http://www.biovest.com.

[actr]

Syntax-Brillian Chief Financial Officer, Wayne Pratt, to Speak at Upcoming Brean Murray, Carret & Co. Institutional Investor Conference '06

TEMPE, Ariz., Jan 24, 2006 (BUSINESS WIRE) -- Syntax-Brillian Corp. (NASDAQ: BRLC) Chief Financial Officer Wayne Pratt will be a presenter at the Brean Murray, Carret Small Cap Institutional Investor Conference, Feb. 1, 2006, at the Grand Hyatt New York.
The two-day event, Jan. 31 to Feb. 1, 2006, is designed to introduce institutional clients to top small cap investment opportunities through a series of sector-specific presentations. Pratt will present an update on the Syntax-Brillian merger and highlight the company's 2006 strategic plans as part of Wednesday's Technology track presentations. The presentation will be posted on the investor relations section of the Syntax-Brillian Web site after the event.

About Syntax-Brillian

Founded in December 2005, with the merger of Syntax Groups Corp. and Brillian Corp., Syntax-Brillian is one of the world's leading manufacturers of LCD and LCoS(TM) HDTVs and digital entertainment products. With its extremely successful Olevia brand of widescreen HDTV-ready LCD TVs, one of the fastest-growing global TV brands, and its highly acclaimed Gen II LCoS(TM) 720p and 1080p rear-projection HDTVs, for the high-end video/audio market, Syntax-Brillian is uniquely positioned to deliver quality digital entertainment products that span from high-end, specialty applications to the fast-growing global mass market. Syntax-Brillian has established retail and distributor sales channels in North America, a global supply chain, and operations in Asia that allow it to leverage economies of scale to deliver both extraordinarily high-quality products and outstanding value. Company information is available at www.syntaxgroups.com as well as www.brilliancorp.com.

Brillian is a registered trademark and LCoS is a trademark of Syntax-Brillian Corp. All other trademarks are the property of their respective owners.

[actr]

FuelCell Energy Announces Sale of Its First 1 Megawatt Power Plant in Japan at Sharp Electronics Manufacturing Facility Ultra-Clean, Efficient Power Generation Takes on Central Role in Electronic Product Developer's Certification of the Site as a Low

DANBURY, Conn., Jan 24, 2006 (BUSINESS WIRE) -- FuelCell Energy, Inc. (NasdaqNM:FCEL), a leading manufacturer of ultra-clean electric power generation plants for commercial and industrial customers, today announced that its Asian distributor, Marubeni Corporation (TSE:8002), has sold a one megawatt (MW) Direct FuelCell(R) (DFC(R)) power plant to provide electric power and high-quality heat for a Sharp Corp. production facility in Japan that manufactures advanced flat-screen TVs.
The DFC power plant will provide Sharp's Kameyama manufacturing facility with a portion of its base load electricity needs and supply heat byproduct for air conditioning by means of absorption chilling. The Kameyama factory, situated in the Mie prefecture, occupies 3.5 million square feet (330,000 square meters) and hosts end-to-end production of LCD TVs -- construction of the LCD panels through final product assembly. Sharp estimates its share of the market for LCD panels is over 30 percent worldwide.

"This is our first international megawatt-class installation, showing growing acceptance in Japan of our larger ultra-clean DFC power plants," said R. Daniel Brdar, President and CEO of FuelCell Energy. "The manufacturing sector, one of the 10 vertical markets we continue to target, demands the efficient and firm, 24/7 reliable power generation that our DFC units deliver."

The 1 MW DFC power plant will be part of a green onsite generation power system in which the fuel cells will provide base load power, and a photovoltaic array will provide peaking power. The combined heat and power (CHP) application of the DFC power plant is expected to reduce the Kameyama factory's CO2 emissions by 2,300 tons. Because the plant integrates LCD manufacturing with assembly, Sharp eliminated the need to transport LCD panels between locations, reducing the need for interim packaging material and further lowering CO2 and NO2 emitted by transport vehicles.

"With eight installations in Japan since 2003, and with ratification of the Kyoto Protocol earlier this year, Marubeni has seen a greater commitment from Japanese industrial companies for fuel cell applications to reduce greenhouse gas emissions," said Mamoru Sekiyama, Corporate Senior Vice President and COO, Plant, Power & Infrastructure Projects Division of Marubeni. "FuelCell Energy's DFC products have the lowest carbon dioxide emissions of any fossil-fuel power generation technology in their size range, which makes them consistent with Sharp's goals of pursuing environmental sustainability in every part of its business."

The Kameyama plant is Sharp's first "Super Green Factory" -- so designated for establishing technologies and policies to achieve maximum environmental protection. For example, Sharp recycles 100 percent of its manufacturing process wastewater and introduced a Liquefied Natural Gas cogeneration system -- moves that earned the company the 2004 Japan Sustainable Management Award.

As fuel prices have increased around the globe, the high efficiency of DFC power plants in CHP applications versus other onsite power generating technologies of similar size gives operators an important advantage in effectively managing their fuel costs. The high electrical and thermal efficiencies of DFC units translate into lower fuel use per kilowatt hour of electricity and BTU of heat generated.

Because Japan historically has had few domestic power sources like oil or natural gas, its industries have focused on ways to save energy in their manufacturing operations. For example, the Wall Street Journal (in its Oct. 7, 2005, editions) noted that Japanese companies rely on highly efficient power-generation systems to minimize the fuel they use to manage their energy costs.

Installation of the DFC power plant is expected to be complete by second calendar quarter of 2006. The unit will operate on liquefied natural gas -- supplied via a newly installed 17-kilometer pipeline from Toho Gas. The pipeline eliminates the need for LNG tanker truck transportation of fuel, reducing emissions associated with the delivery vehicles.

C-Energy, a subsidiary company of Chubu Electric, will own the equipment and sell the power and heat output to Sharp. Japan's Ministry of Economy, Trade and Industry (METI) is providing a subsidy.

About Marubeni

The Marubeni Corporation (http://www.marubeni.co.jp/english/index.html), established in 1858, is one of Japan's leading general trading/marketing houses (sogo shosha). The company was ranked as the 25th largest in Fortune Magazine's Global Fortune 500 list for 2002. Marubeni has 12 Divisions with operations that encompass domestic, import/export, offshore trade and investment activities, which range from the development of natural resources to the retail marketing of finished products. The Company, based in Tokyo, conducts these operations through a worldwide business network that includes 52 overseas corporate offices and 28 overseas subsidiaries, for a total of 131 offices in 73 countries.

Marubeni's Utility & Infrastructure Division has been involved in the development of over 20,000 megawatts of power generation worldwide. The Division has expanded its efforts to include distributed generation technologies, power quality & reliability technologies and energy & environmental services.

About FuelCell Energy

FuelCell Energy Inc. develops and markets ultra-clean power plants that generate electricity and heat with higher efficiency than conventional fossil fuel plants and with virtually no air pollution. Fuel cells produce base load electricity giving commercial and industrial customers greater control over their power generation economics, reliability and emissions. Emerging state, federal and international regulations to reduce harmful greenhouse gas emissions consider fuel cell power plants in the same environmentally friendly category as wind and solar energy sources -- with the added advantages of running 24 hours a day and the capacity to be installed where wind turbines or solar panels often cannot. Headquartered in Danbury, Conn., FuelCell Energy services over 40 power generation sites around the globe that have produced more than 80 million kilowatt hours, and conducts R&D on next-generation fuel cell technologies to meet the world's ever-increasing demand for ultra-clean distributed energy. For more information on the company, its products and its worldwide commercial distribution alliances, please see www.fuelcellenergy.com.

Direct FuelCell, DFC and DFC/Turbine are registered trademarks of FuelCell Energy, Inc. All other trademarks are the property of their respective owners. The Company's sub-megawatt DFC fuel cell power plant is a collaborative effort combining its Direct FuelCell technology with a Hot Module(R) balance of plant design from MTU CFC Solutions, GmbH, a subsidiary of DaimlerChrysler.

[actr]

24.01.2006 15:11
Cingular Wireless dreht in die Gewinnzone
Das aus AT&T und BellSouth Corp. bestehende Mobilfunk-Joint-Venture Cingular Wireless erwirtschaftete im dritten Geschäftsquartal einen Gewinn von 204 Millionen Dollar. Im Vergleichszeitraum des Vorjahres wies Cingular einen Nettoverlust von 495 Millionen Dollar aus. Auf Pro Forma-Basis wurden 811 Millionen Dollar verdient. Die Erlöse stiegen um 9,4% auf 8,8 Milliarden Dollar. Das größte US-Mobilfunkunternehmen generierte in der abgelaufenen Periode 1,8 Millionen neue Kunden.

Wie Cingular am Dienstag weiter mitteilte, sanken die durchschnittlichen Einnahmen pro Nutzer um 2,2% auf 48,86 Dollar. Die Rückläufigkeit sei auf einen harten Wettbewerb und einen höheren Anteil von Kunden mit geringer Ausgabebereitschaft zurückzuführen.

[actr]

Market Pulse Announces its AM Stock Picks for Tuesday, January 24, 2006: AMD, BIEL, CSCO, NENG

ATLANTA, Jan 24, 2006 (PRIMEZONE via COMTEX) -- Market Pulse is pleased to announce the following stock recommendations. Bernard Schmitt of Market Pulse states, "These notable stocks should be watched because they look great from a fundamental and technical perspective." Bernard possesses many years of experience in the financial industry recommending and evaluating stocks. He rates them as follows:
Advanced Micro Devices Inc. (NYSE:AMD) : Market Outperform

BioElectronics Corporation (Pink Sheets:BIEL) : Attractive

Cisco Systems Inc. (Nasdaq: CSCO) : Bearish

Network Engines Inc. (Nasdaq: NENG) : Attractive


After The Bell Market Commentary

According to Bernard Schmitt, "On Monday, the markets posted modest gains as crude oil prices slipped 38 cents to settle at $68.10. The Conference Board said its Index of Leading Economic Indicators rose 0.1 percent last month, smaller than the 0.2 percent gain forecast by analysts. The Board's coincident index also improved, gaining 0.2 percent, following a 0.4 percent increase in November. The Dow rose 21.38, or 0.2 percent, to 10,688.77. The Nasdaq composite index gained 0.77, or 0.03 percent, to 2,248.47. The Standard & Poor's 500 index added 2.33, or 0.18 percent, to 1,263.82. The Russell 2000 index rose 3.22, or 0.46 percent, to 707.82."

[actr]

24.01.2006 15:23
AMD: Kapitalerhöhung
Der Prozessorhersteller AMD (Nachrichten) plant eine Kapitalerhöhung im Umfang von 496 Millionen Dollar. Der Intel-Rivale will die Erlöse aus der Kapitalerhöhung, die durch die Ausgabe von 14,1 Millionen Aktien zu einem Kurs von 35,20 Dollar abgewickelt werden soll, zur Tilgung von ausstehenden Anleihen mit einem Kupon von 7,75 Prozent verwenden. Die Anleihen haben eine generelle Laufzeit bis 2012. Ein Teil des Erlöses aus der Kapitalerhöhung soll zudem für allgemeine Geschäftszwecke verwendet werden.

Die Aktie steigt vorbörslich um 0,79 Prozent auf 35,75 Dollar.

[actr]

Applix Announces New Partnership with Information Technology Consulting Firm SKYTEC AG Agreement to Help Expand TM1's Reach in Germany, Austria With Solutions for Business Performance Management, Real-Time Analytics for SAP BW

MUNICH and WESTBOROUGH, Mass., Jan 24, 2006 /PRNewswire-FirstCall via COMTEX/ -- Applix, Inc. (Nasdaq: APLX), a global provider of single platform solutions for Business Performance Management (BPM) and Business Intelligence (BI), today announced a new partnership with SKYTEC AG, an IT consulting firm and service provider. With this partnership, Applix is further expanding its global partner network to meet the needs of firms using SAP.
SKYTEC, employing 150 staff in its Munich and Stuttgart, Germany, and Vienna, Austria offices, specializes in Business Intelligence -- from strategic consulting for data warehouse architectures to solution suites for business performance management, as well as implementation and customization services for SAP BW.

Applix TM1 is among the top five third-party software packages used as a front end to SAP, according to The OLAP Survey 51. Adding more complex and flexible analytics, TM1 enables SAP customers to gain more insight into their business through their SAP applications.

"The new partnership with Applix is an important addition to our solution portfolio on two levels: first, TM1 has achieved certified integration with SAP BW, and many of our customers deploy SAP BW," said Marco Kiernan, director of sales and consulting, SKYTEC. "Secondly, TM1 presents an extremely powerful, single application for all aspects of business performance management -- i.e., planning, budgeting, business modeling, analysis, and reporting -- which are becoming more important to all of our customers, and Applix is the only vendor of an OLAP-based solution offering such a complete package."

"SKYTEC is an ideal partner for Applix, with deep BI/BPM knowledge, experienced consultants, and the ability to leverage TM1's real-time, read/write environment to help extend the customer's SAP BW investment," said Hans-Georg Schieb, managing director, Applix GmbH. "Because TM1 is ranked the top solution for overall business benefits achieved in The OLAP Survey 5, it is a compelling choice for SKYTEC's prospects and customers."

Applix TM1

Applix's TM1 is a unified, multidimensional application, delivering business planning, reporting and analytics for powering strategic analysis of financial, operational, transactional and other business data. The 2005 OLAP Survey 5 (http://www.survey.com/olap) by independent analyst Nigel Pendse, gave TM1 the highest marks for speed of query, deployment, and data load and pre-calculation, as well as the highest ranking for overall business benefits achieved and the lowest number of technical problems. The annual BPM Partners "Beyond the Hype" Webcast (http://www.bpmpartners.com/events_webinars.shtml) named Applix the 2004 leader in the tools category and in 2005 recognized that Applix customers had the highest level of satisfaction of any of the leading BPM solutions, suites, tools and vendors. Customers using TM1-based applications have won industry awards from several leading publications, including Start Magazine and Business Finance Magazine.

Applix recently released TM1 Version 9.0 with its high performance Web solution for real-time business performance management and reporting across the enterprise. The company also offers TM1 Planning Manager(TM) to provide workflow and compliance capabilities for all TM1-based applications, TM1 Financial Reporting(TM) for rapid and easy reporting applications, TM1 Financial Consolidations(TM) to streamline journal entries, inter-company eliminations and other consolidation processes, and TM1 Web(TM), a Web-enabled front end for global and remote read/write capabilities of BPM and BI applications.

About Applix

Applix (Nasdaq: APLX) is a global provider of Business Performance Management and Business Intelligence solutions. These solutions, based on Applix's TM1 analytics platform, enable the continuous planning, management and monitoring of performance across the financial and operational functions within the enterprise. Applix is a founder of the BPM Standards Group (http://www.bpmstandardsgroup.org), and has been recognized by numerous industry analyst groups for its technical leadership and vision in the marketplace.

More than 2,100 customers worldwide use TM1 for business performance management because of its tight integration with Excel, real-time response, adaptability, and low total cost of ownership. Delivered by Applix and by a global network of partners, TM1-based solutions help customers manage their business performance and respond to the marketplace in real time. Headquartered in Westborough, MA, Applix maintains offices in four countries in Europe, North America and the Pacific Rim. For more information about Applix, please visit http://www.applix.com.

[actr]

24.01.2006 20:50
McDonald's will hunderte eigene Filialen an Franchisenehmer geben
DES MOINES (Dow Jones)--Die McDonald's Corp, (Nachrichten/Aktienkurs) Oak Brook, will hunderte bislang in Eigenregie betriebene Fast-Food-Restaurants außerhalb der USA an Franchisenehmer vergeben. Das teilte der US-Konzern am Dienstag nach Veröffentlichung seiner Zahlen für das vierte Quartal und Gesamtjahr 2005 mit. "Wir glauben, dass einige der rund 8.000 Restaurants, die wir besitzen, besser in den Händen von Franchisenehmern aufgehoben sind", sagte Chief Financial Officer (CFO) Matthew Paull während einer Telefonkonferenz vor Analysten.

McDonald's werde sich bei den geplanten Maßnahmen zunächst vor allem auf den britischen Markt konzentrieren. Dort sind den Angaben zufolge rund 800 McDonald's-Restaurants im Unternehmensbesitz. Spekulationen um eine Abspaltung des Franchise-Geschäfts erteilte (CFO) Paull erneut eine Absage. Demnach gehörten Franchise und der eigene Betrieb von Filialen für ein erfolgreiches Geschäft von McDonald's zusammen.

Für die geplanten rund 800 Neueröffnungen von McDonald's-Restaurants im laufenden Jahr sollen die USA, China, Frankreich und Russland die Hauptzielmärkte sein. Rund 125 Filialen sollen 2006 in China eröffnet werden.

-Von Richard Gibson, Dow Jones Newswires, +49 (0)69 - 29725 111,

unternehmen.de@dowjones.com

[actr]

InterDigital Communications Corp.
24.01.06 21:25 Uhr

24,88 USD

+33,69 % [+6,27]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=IDCC.NAS&lColors=0x000000&sSym=IDCC.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=IDCC.NAS&lColors=0x000000&sSym=IDCC.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=IDCC.NAS&lColors=0x000000&sSym=IDCC.NAS&hcmask=

Börse
NASDAQ

Aktuell
24,88 USD

Zeit
24.01.06 21:25

Diff. Vortag
+33,69 %

Tages-Vol.
134,93 Mio.

Gehandelte Stück
6,1 Mio.


BUYINS.NET: InterDigital Communications Corp. (IDCC) SqueezeTrigger Price Is $17.57. Short Sellers Are Down Approximately $15 Million After Company Signs 5 Year Deal With LG Electronics.

Jan 24, 2006 (M2 PRESSWIRE via COMTEX) -- www.buyins.net, announced today that the 2.27 million shares declared short on InterDigital Communications (NASDAQ: IDCC) have a SqueezeTrigger Price of $17.57 per share. According to TheStreet.com, the wireless technology outfit struck a five-year license agreement with LG Electronics. The license covers the sale of second-generation and third-generation wireless technology on the time division multiple access standard. LG is obligated to pay InterDigital three equal installments of $95 million, in the first quarters of 2006, 2007, and 2008. At the end of the five-year term, LG will receive a paid-up license to sell single-mode GSM/GPRS/EDGE terminal units under the patents included under the license. Short sellers are down approximately $15 million as the stock is currently trading near $24.28. To access SqueezeTrigger Prices ahead of short squeezes beginning, visit http://www.buyins.net/squeezetrigger.pdf.
From January to December of 2005, an aggregate amount of 35,007,183 shares of IDCC have been shorted for a total dollar value of $615 million. The IDCC SqueezeTrigger price of $17.57 is the volume weighted average price that all shorts are short in shares of IDCC. Since crossing above the SqueezeTrigger Price, shares of IDCC are up nearly 38%. There is still approximately $55 million worth of potential short covering in shares of IDCC.

InterDigital Communications Corporation (NASDAQ: IDCC) engages in the design, development, licensing, and sale of wireless technology solutions for voice and data communications. Its solutions primarily include time division multiple access and code division multiple access technologies, as well as technologies covering 2G, 2.5G, 3G, and 802 standards. The company's solutions are incorporated in various products, which principally comprise mobile phones and personal digital assistants; other wireless devices, such as laptops, PC cards, and USB sticks; base stations and other infrastructure equipment; and modules and components for wireless devices. InterDigital Communications offers its solutions to semiconductor companies and equipment producers primarily in Japan and Europe. The company was incorporated in 1972. It was formerly known as International Mobile Machines Corporation and changed its name to InterDigital Communications Corporation in 1992. InterDigital Communications is headquartered in King of Prussia, Pennsylvania.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 550,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

[actr]

China Natural Resources, Inc.
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=CHNR.NAS&lColors=0x000000&sSym=CHNR.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=CHNR.NAS&lColors=0x000000&sSym=CHNR.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=CHNR.NAS&lColors=0x000000&sSym=CHNR.NAS&hcmask=

Börse
NASDAQ

Aktuell
7,28 USD

Zeit
24.01.06 21:01

Diff. Vortag
+95,49 %

Tages-Vol.
13,43 Mio.

Gehandelte Stück
1,9 Mio



China Natural Resources, Inc. (NASDAQ: CHNR), through its subsidiary, iSense Limited, provides advertising, promotion, and public relations services in Hong Kong and Mainland China. It offers advertising and promotions services to local and international customers operating in various industries, including technology and new media, healthcare products, and consumer goods. The company was founded in 1986 and is headquartered in Sheung Wan, Hong Kong.

[actr]

Vitesse Semiconductor Corporation
24.01.06 22:00 Uhr

2,74 USD

+23,42 % [+0,52]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=VTSS.NAS&lColors=0x000000&sSym=VTSS.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=VTSS.NAS&lColors=0x000000&sSym=VTSS.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=VTSS.NAS&lColors=0x000000&sSym=VTSS.NAS&hcmask=

Börse
NASDAQ

Aktuell
2,74 USD

Zeit
24.01.06 22:00

Diff. Vortag
+23,42 %

Tages-Vol.
112,40 Mio.

Gehandelte Stück
44 Mio

bellwetherreport.com: The Bellwether Report continues its watch of Vitesse Semiconductor Corporation

Jan 24, 2006 (M2 PRESSWIRE via COMTEX) -- Today the Bellwether Report has identified Vitesse Semiconductor Corp. (NASDAQ: VTSS), a company that our analysts will be tracking over the ensuing weeks. They recently came out with a significant corporate development this month, causing a positive correction

Yesterday after market close the company announced their first quarter financials, sending shares up over 16% this morning. Revenues in the first quarter of fiscal 2006 were $53.0 million, compared to $44.5 million in the first quarter of fiscal 2005, and $48.2 million in the fourth quarter of fiscal 2005.
Non-GAAP net loss including the effect of share-based payment charges for the first quarter of fiscal 2006 was $7.9 million, or $(0.04) loss per share, compared to net loss of $9.5 million, or $(0.04) loss per share, in the first quarter of fiscal 2005, and net loss of $9.4 million, or $(0.04) loss per share, in the fourth quarter of fiscal 2005.

During the quarter, the Company implemented a restructuring program in order to align its costs with its projected revenues. This restructuring involved the closure of one design facility and the termination of approximately 70 employees. In connection with this restructuring, the Company recorded a charge for severance, fixed asset impairment and lease termination costs in the amount of $1.3 million.

Vitesse's President and CEO, Lou Tomasetta, said, " I am pleased to see our revenues grow 10% sequentially to $53.0 million in the first fiscal quarter in spite of the challenges we faced with longer assembly and test lead times.

[actr]

24.01.2006 22:35
Sun Microsystems muss Verlust ausweisen
Die Sun Microsystems Inc. (ISIN US8668101046 (Nachrichten/Aktienkurs)/ WKN 871111) hat am Dienstag nach US-Börsenschluss die Zahlen für das zweite Quartal vorgelegt.

Demnach belief sich der Nettoverlust auf 223 Mio. Dollar bzw. 7 Cents je Aktie, nach einem Gewinn von 4 Mio. Dollar, bzw. Break-Even je Aktie im Vorjahreszeitraum. Um außerordentliche Effekte bereinigt belief sich der Verlust auf 1 Cent je Aktie, was den Erwartungen der Analysten entspricht.

Die Umsatzerlöse beliefen sich auf 3,34 Mrd. Dollar, nach 2,84 Mrd. Dollar im Vorjahreszeitraum. Im Vorfeld hatten die Analysten Umsätze von 3,49 Mrd. Dollar erwartet.

Für das dritte Quartal erwarten die Analysten derzeit einen Verlust von 3 Cents je Aktie bei Umsätzen von 3,22 Mrd. Dollar.

Die Sun-Aktie schloss heute an der NASDAQ bei 4,37 Dollar. Nachbörslich gab die Aktie 2,29 Prozent auf 4,27 Dollar ab.

[actr]

Virulent Selling

By Lawrence Carrel
January 24, 2006


--------------------------------------------------------------------------------
McAfee, Inc. (MFE1)

--------------------------------------------------------------------------------
Share price as of Monday's close: $27.63
Share price now: $22.75
Change: -17.7%
Volume: 25.8 million shares, daily average 2.0 million shares
Last time this low: May 5, 2005
52-week high: $33.24
52-week low: $20.35
Forward P/E before announcement: 19.3 (based on $1.43 a share)
Forward P/E after announcement: 17.2 (based on $1.32 a share)

--------------------------------------------------------------------------------

A MAKER OF ANTIVIRUS software saw infectious selling in its stock Tuesday.
McAfee's (MFE2) shares tumbled 18% to $22.75 following a warning late Monday that fourth-quarter results would miss Wall Street's expectations. The Santa Clara, Calif., company did little to clarify the reasons behind the shortfall in its press release and subsequent conference call. Analysts, surprised by the 11th-hour guidance reduction, were quick to punish McAfee with stock downgrades.

"Everyone thought that McAfee was completely in the clear at this point in the quarter, so it begs the question of what is new that caused them to release these results," says Gregg Moskowitz of Susquehanna Financial Group, an investment bank based in Bala Cynwyd, Pa. "One thing we can tell is that gross margin took a very significant hit quarter-over-quarter, four percentage points or more, which for a software company is very rare. But we don't have good visibility on the nature of the declines."

McAfee said it now expects fourth-quarter adjusted earnings to total $44 million to $46 million, or 25 cents to 27 cents a share, on sales of $254 million. Those numbers are well below the Thomson First Call consensus profit estimate of 38 cents a share on $274.5 million in sales, and they're a slim improvement from the fourth quarter of 2004. A year ago McAfee posted adjusted earnings of 23 cents a share on sales of $244 million.

Chris Hovis of Memphis-based investment bank Morgan Keegan & Co. blamed the earnings shortfall on an increased contribution from lower-margin products like combination hardware-software devices, as well as pricing pressure on business products.

"We heard anecdotes throughout the quarter about the company — and some of its competitors, e.g., Trend Micro (TMIC3) — becoming more aggressive with pricing in an effort to win business," wrote Hovis in a Tuesday note in which he lowered his rating on the stock to Market Perform from Outperform. "[We] believe McAfee's results likely indicate an even tougher environment than anticipated."

McAfee makes antivirus and firewall programs that improve computer security by blocking outside intrusions and preventing system disruptions. The earnings warning comes at a particularly bad time for the company. Two weeks ago its president, Gene Hodges, stepped down to become chief executive of Websense (WBSN4), which makes software that allows bosses to monitor workers' computer usage. The resignation came soon after the departure of Vincent Gullotto, vice president of McAfee's Anti-Virus Emergency Response Team.
Late Monday, the company held a short conference call during which management declined to answer questions. "We did more large transactions in the fourth quarter than we have in recent quarters, and those deals, because of their size and nature, led to more ratable revenue recognition," said Chief Executive George Samenuk during the call. "Fourth-quarter bookings that did not go into revenue this quarter will come off the balance sheet and post as profits and revenues in future quarters. The demand for McAfee's proven security remains strong and we are excited about new 2006 products additions." Samenuk said the company was continuing to analyze the results and would provide more information on Feb. 9.

Bookings for the fourth quarter increased 14% year-over-year and 23% sequentially to $361 million world-wide — an amount the company called a record high. Of that, $152 million was from consumers, $73 million was from small and medium businesses, and $136 million was from large enterprises. Deferred revenue grew sequentially by approximately $87 million to $744 million, another new high.

But Morgan Keegan's Hovis noted that McAfee reports gross bookings, which don't back out anticipated rebates that are common to antivirus software packages. In their financial reports companies subtract the value of rebates before arriving at their "net revenues," or sales. So $361 million in gross bookings doesn't necessarily equate to $361 million in sales.

"In addition to questions arising from 'gross bookings' vs. 'net revenue' reporting, we are somewhat concerned that bookings have increased due to a longer average term of contracts, which is spreading out revenue recognition over longer subsequent periods," Hovis wrote. "McAfee noted approximately half its $87 million in deferred revenue was long term, which dropped their ratio of total current-to-long-term deferred revenue revenue [by 18%]."

McAfee recently began selling security software through PC companies under multiyear, rather than just single-year, contracts. With sales having to be recognized over two or three years vs. much shorter periods, booking numbers are showing larger gains than sales.

Katherine Egbert of Jefferies & Co. cut her rating on the stock on Tuesday to Underperform from Hold. "Our concerns regarding consumer antivirus software is predicated on: (1) the looming presence of Microsoft's (MSFT5) ongoing push into consumer security, and (2) our belief that service providers will increasingly bundle such security technology for free or at a very discounted price," she wrote.

Not everyone was down on McAfee. "In nearly six years of covering the software industry, this is the latest [earnings warning] I have witnessed, in terms of 23 days after the quarter has ended," says Daniel Ives, an analyst at Friedman Billings Ramsey & Co., an Arlington, Va., investment bank. "This implies that this is more of a revenue recognition issues in respect to a few large deals, rather than anything systemic."

Ives says investors should focus on core bookings as the key metric to determine McAfee's health, rather than revenue. He says bookings tell investors the company's core organic growth rate in both the consumer and enterprise businesses. McAfee derives about 75% of its sales from deferred revenues. Since sequential bookings showed the biggest growth in a year, Ives thinks the company remains healthy.

McAfee officials didn't return phone calls seeking comment.

Quote:
"Shares will remain under pressure until McAfee reports on Feb. 9," says Ives of Friedman Billings Ramsey. "We think investors should use this weakness as a buying opportunity."

[actr]

WellPoint Reports Results for Fourth Quarter and Full Year 2005 * Medical enrollment was 33.9 million members at December 31, 2005 * Net income was $1.04 per share in fourth quarter, exceeding previous guidance * Full year net income was $3.94 per sh

Jan 25, 2006 /PRNewswire-FirstCall via COMTEX/ -- WellPoint, Inc. (NYSE: WLP) today announced that fourth quarter 2005 net income was $652.0 million, or $1.04 per share, including net realized investment losses of $0.01 per share. Net income for the fourth quarter of 2004 was $184.5 million, or $0.46 per share, which included expenses of $0.24 per share due to the repurchase of high coupon surplus notes and $0.15 per share for undertakings related to the Anthem-WellPoint Health Networks merger.
Net income for the full year of 2005 was $2.5 billion, or $3.94 per share. These results included expenses of $0.10 per share due to the multi-district litigation settlement agreement in the second quarter and net realized investment losses of $0.01 per share, partially offset by benefits of approximately $0.04 per share for the favorable resolution of a tax matter in the first quarter.

Full year 2004 net income was $3.05 per share, which included expenses of $0.30 per share for the surplus note repurchase and $0.20 per share for the merger-related undertakings, partially offset by benefits of $0.14 per share for a first quarter tax law change and net realized investment gains of $0.09 per share.

"Looking back, 2005 was truly an exceptional year for our company as we accomplished a number of milestones including achieving organic growth of 1.2 million members, acquiring WellChoice and Lumenos, delivering strong financial results in all four quarters, and generating $3.3 billion in full year operating cash flow," said Larry C. Glasscock, chairman, president and chief executive officer of WellPoint, Inc. "Going forward, we have high expectations for 2006 and believe we are uniquely positioned in the marketplace resulting from our broad portfolio of products, extensive and cost-effective provider networks, and distinctive customer service."


COMPARABLE BASIS INFORMATION

On November 30, 2004, Anthem, Inc. acquired WellPoint Health Networks Inc. and Anthem, Inc. changed its name to WellPoint, Inc. Accordingly, fourth quarter and full year 2005 financial results include operations of the combined company for the entire periods. Fourth quarter and full year 2004 financial results, however, only include operations of the former WellPoint Health Networks Inc. for the one month ended December 31, 2004.

On December 28, 2005, WellPoint, Inc. acquired WellChoice, Inc. For accounting purposes, the transaction was assumed to have closed on December 31, 2005. Accordingly, fourth quarter and full year 2005 income statement and operating cash flow results do not include operations of the former WellChoice, Inc. However, balance sheet and membership information as of December 31, 2005, does include the former WellChoice, Inc.

Unless otherwise indicated, the analysis in this press release compares reported financial results and does not adjust results for the effects of these acquisitions. In certain areas, we have included "comparable basis" analyses that we believe provide more meaningful comparisons between periods, due to the inclusion of operations of the former WellPoint Health Networks Inc. in the comparable historical results. The "comparable basis" information is not calculated in accordance with generally accepted accounting principles ("GAAP") and is not intended to represent or be indicative of the results that WellPoint, Inc. would have reported had the acquisitions been completed as of the dates presented, and should not be taken as representative or indicative of our future results. The methodologies for calculating the comparable basis information are either described within the text of the press release, or in the tables at the end of the press release where such comparable basis information is reconciled to WellPoint, Inc.`s reported GAAP financial results.


CONSOLIDATED HIGHLIGHTS

Membership: Medical enrollment totaled approximately 33.9 million members at December 31, 2005, an increase of 6.1 million members since December 31, 2004. The increase included approximately 4.8 million members acquired on December 28, 2005, through the WellChoice transaction.

Organically, enrollment increased by almost 1.2 million members during 2005, with growth realized in every region and across all lines of business. The increase in organic enrollment was driven by the National Accounts business unit and also included strong gains in State Sponsored operations. Enrollment grew organically by 81,000 members during the fourth quarter, with most of the increase in the State Sponsored and National Accounts businesses.

Self-funded membership represented approximately 48 percent of medical enrollment at December 31, 2005, compared with approximately 50 percent at September 30, 2005, reflecting the addition of WellChoice`s enrollment base during the quarter. Self-funded membership represented approximately 47 percent of medical enrollment at December 31, 2004.

Operating Revenue: Operating revenue was $11.3 billion in the fourth quarter 2005, an increase of 67.5 percent from $6.7 billion in the prior year quarter. Full year 2005 operating revenue exceeded $44.5 billion, more than double the total of $20.5 billion in 2004.

On a comparable basis, fourth quarter 2005 operating revenue increased by $617.6 million, or 5.8 percent, compared with $10.6 billion in the prior year period. The increase was driven primarily by disciplined pricing, with membership gains in the Individual and Small Group ("ISG") and Senior businesses also contributing to the overall operating revenue increase.

Full year 2005 operating revenue increased by more than $2.9 billion, or 7.0 percent, versus the comparable prior year results. Increases were realized in every line of business, led by the ISG, Large Group and National Accounts operations. Revenue growth resulted from disciplined pricing and membership growth and reflected the shift in business mix towards more self- funded medical enrollment that occurred prior to the merger with WellChoice, Inc.

Benefit Expense Ratio: The benefit expense ratio was 80.1 percent in the fourth quarter of 2005, a decrease of 140 basis points, compared with 81.5 percent in the fourth quarter of 2004. The ratio was 80.6 percent for the full year of 2005, a decrease of 140 basis points from 82.0 percent in 2004.

On a comparable basis, the fourth quarter 2005 ratio declined by 110 basis points, compared with 81.2 percent in the prior year quarter. The full year 2005 ratio declined by 50 basis points from the comparable prior year ratio of 81.1 percent. The decrease in both the fourth quarter and full year 2005 reflected lower than anticipated medical costs and successful results from the Company`s medical management and health improvement initiatives.

Premium and Cost Trends: Trends include Large Group and ISG fully-insured businesses.

Medical trend for the rolling 12-month period ended December 31, 2005, continued to decline and was less than 8.5 percent. The primary drivers of medical trend were outpatient and inpatient costs. The Company`s contracting and medical cost management programs continue to be successful, and certain of the synergies related to the Anthem-WellPoint Health Networks merger have reduced medical costs.

Commercial premium yield for the rolling 12-month period ended December 31, 2005, exceeded total cost trend, where total cost trend included medical costs and selling, general and administrative ("SG&A") expense, resulting in an improvement in underwriting margin.

SG&A Expense Ratio: The SG&A expense ratio decreased by 50 basis points, to 16.5 percent in the fourth quarter 2005, compared with 17.0 percent in the fourth quarter 2004. The full year 2005 ratio declined by 70 basis points to 16.3 percent, versus 17.0 percent in the prior year.

On a comparable basis, the SG&A expense ratio increased by 20 basis points in the fourth quarter 2005, compared with 16.3 percent in the prior year period. The increase reflected advertising and implementation spending for Medicare Part D, higher incentive compensation accruals due to strong financial results, and the more rapid growth in self-funded membership. Collectively, these items offset increased efficiencies in the Company`s administrative cost structure, including the realization of synergies from the Anthem-WellPoint Health Networks merger.

The full year SG&A ratio improved by 10 basis points from the comparable 2004 ratio of 16.4 percent. The effective management of administrative costs across a growing membership base, including the achievement of Anthem- WellPoint Health Networks merger synergies, resulted in a lower ratio for 2005, despite the trend towards self-funded enrollment and additional expenses incurred during the year for Medicare Part D, the multi-district litigation settlement agreement, information technology outsourcing costs, and higher incentive compensation accruals.

Operating Cash Flow: Full year 2005 operating cash flow reached $3.3 billion, or 1.3 times net income. In the fourth quarter of 2005, operating cash flow was $964 million, or 1.5 times net income.


About WellPoint, Inc.

WellPoint, Inc. is the largest publicly traded commercial health benefits company in terms of membership in the United States. WellPoint, Inc. is an independent licensee of the Blue Cross Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield in 10 New York City metropolitan counties and as Blue Cross or Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at http://www.wellpoint.com

[actr]

Ameritrade December Quarter Produces Record Net Revenues; Eighth Consecutive Quarter of Pre-Tax Margin Above 50 Percent

OMAHA, Neb., Jan 25, 2006 (BUSINESS WIRE) -- Ameritrade Holding Corporation (NASDAQ: AMTD) today announced results for the quarter ended Dec 31, 2005, that highlight the Company's ability to produce sound financial results while also executing on its long-term strategy.
Quarterly results included the following:

-- Record net revenues of $277 million

-- Net income of $86 million, or $0.21 per diluted share, $0.22 per diluted share excluding unrealized losses on the Company's prepaid variable forward contracts on its investment in Knight Capital Group, Inc.(1)

-- Pre-tax income of $140 million, or 51 percent of net revenues

-- Operating margin(1) of $178 million, or 64 percent

-- EBITDA(1) of $148 million, or 53 percent

-- Average client trades per day of approximately 156,000

-- Annualized return on equity (ROE) of 22 percent for the quarter

-- Client assets of approximately $85.5 billion, including $13.6 billion of client cash and money market funds

-- Liquid assets(1) of $490 million; cash and cash equivalents of $188 million

-- 61,000 new accounts at an average cost per account of $435; 39,000 closed accounts; 3,739,000 Total Accounts; 1,722,000 Qualified Accounts(2)

-- Average client margin balances of approximately $3.7 billion. On Dec. 31, 2005, client margin balances were approximately $3.9 billion.

"Ameritrade has again delivered strong results, illustrated by record net revenues and excellent pre-tax margins," said Joe Moglia, chief executive officer. "We would have had a record quarter if you adjusted the days to our last quarter and excluded the impact of Knight. Moving forward, we expect to continue leveraging our low-cost platform and producing superior financial returns for TD Ameritrade shareholders."

Knight Investment Liquidated

Unrealized losses on the Company's previously disclosed Knight Capital Group, Inc. prepaid variable forward contracts decreased earnings by approximately $12 million, or $0.01 per share, for the quarter ended Dec. 31, 2005. The Company liquidated its position in Knight and the prepaid variable forward contracts on Jan. 17-20, 2006, resulting in a one-time net gain of approximately $79 million that will be recorded in the quarter ending March 31, 2006. This is reflected in the Outlook Statement available at the Company's corporate Web site located at www.amtd.com


About Ameritrade Holding Corporation

For 30 years, Ameritrade Holding Corporation has provided investment services to self-directed individuals through its brokerage subsidiaries. Ameritrade develops and provides innovative products and services tailored to meet the varying investing and portfolio management needs of individual investors and institutional distribution partners. A brokerage industry leader, Ameritrade, Inc.,(3) a subsidiary of Ameritrade Holding Corporation, recently received a four-star rating in the Barron's 2005 Review of Online Brokers for its Apex active trader program. For more information, please visit www.amtd.com.

[actr]

Sino Express Reports Fourth Quarter 2005 Unaudited Financial Results

HONG KONG, Jan 25, 2006 (BUSINESS WIRE) -- Sino Express Travel Limited (OTC:SXPT), a leading travel service provider in the greater China, today announced its unaudited financial results for the quarter ended December 30, 2005.


China. Acquired on 1st January 2006.


A -- The pro forma Net revenues were US$2.18 million in the fourth

quarter of 2005.


A -- The pro forma Gross profit was US$241,177


A -- The pro forma Net income was US$83,499

"We are pleased to announce a solid fourth quarter performance. The Sino team will continue focusing on its long-term development plan in the New Year. As we execute our expansion strategies in the greater China, we expect 2006 will be a year of high growth in profits and sales in this fragmented industry," commented Xia Chen, Chief Executive Officer of Sino Express.

Sino Express Travel Limited (www.sinoexpresstravel.com), together with its 100% owned subsidiaries, GS Travel (Hong Kong) Ltd., NSIBC Ltd., YTD Ltd. and www.v222.com, is an international travel company with operating offices in Hong Kong, Beijing, Guangzhou, Vancouver, Toronto and Seattle. Sino intends to grow its business by acquiring and operating a diversified travel business portfolio, seeking to invest in profitable travel related companies with reputable management and high growth potential.

[actr]

25.01.2006 15:08
Aktien NYSE/NASDAQ Ausblick: Freundlich - Quartalsberichte stützen

Gestützt von ermutigenden Quartalsberichten einiger Unternehmen dürften die US-Börsen am Mittwoch freundlich in den Handel starten. Der fallende Ölpreis sorge für zusätzliche Unterstützung, sagten Händler.

Der Future auf den S&P-500-Index <INX.IND> legte bis 14.15 Uhr 3,00 Punkte auf 1.273,40 Zähler zu, der NASDAQ-100-Future <NDX.X.IND> stieg um 8,50 Punkte auf 1.701,50 Zähler.

Aktien von Bristol-Myers Squibb <BMY.NYS> <BRM.ETR> (Nachrichten/Aktienkurs) kletterten im vorbörslichen Handel um 3,05 Prozent auf 21,98 US-Dollar. Der Pharmakonzern hatte im vierten Quartal des abgelaufenen Geschäftsjahres trotz eines Umsatz- und Gewinnrückgangs beim Ergebnis vor Sonderposten die Erwartungen des Marktes leicht übertroffen.

Xerox <XRX.NYS> <XER.ETR> (Nachrichten/Aktienkurs) legten 1,66 Prozent auf 14,70 Dollar zu. Der Kopiergerätehersteller hatte im vierten Quartal 2005 seinen Überschuss je Aktie (EPS) von 24 Cent im Vorjahreszeitraum auf 27 Cent gesteigert. Das EPS vor Sonderposten belief sich nach Unternehmensangaben auf 32 Cent und lag damit punktgenau auf der Prognose der acht von Thomson First Call befragten Analysten.

Colgate-Palmolive <CL.NYS> <CPA.FSE> (Nachrichten/Aktienkurs) könnten von einem überraschend deutlichen Anstieg des Gewinns im vierten Quartal profitieren. Vor Sonderposten stieg der Gewinn je Aktie (EPS) von 59 auf 69 Cent. Experten hatten im Schnitt 68 Cent erwartet. Der Umsatz erhöhte sich von 2,8 auf 2,9 Milliarden Dollar. Hier hatten die Analysten-Schätzungen allerdings einen Wert von 2,96 Milliarden Dollar vorgesehen.

Pixar <PIXR.NYS> <PIX.FSE> (Nachrichten/Aktienkurs) legten 2,92 Prozent auf 59,25 US-Dollar gewonnen. Am Dienstag hatte Walt Disney <DIS.NYS> <WDP.ETR> (Nachrichten/Aktienkurs) nach Börsenschluss bekannt gegeben, das Trickfilmstudio für 7,4 Milliarden Dollar in Aktien übernehmen zu wollen. Die Akquisition werde voraussichtlich im Sommer 2006 abgeschlossen. Disney-Papiere kletterten um 0,23 Prozent auf 26,05 Dollar.

Guidant <GDT.NYS> <GDT.FSE> (Nachrichten) gaben 1,67 Prozent auf 75,50 Dollar ab. Nach dem Rückzug von Johnson & Johnson <JNJ.NYS> <JNJ.FSE> (Nachrichten/Aktienkurs) ist der Bieterkampf um den Medizintechnik-Hersteller zunächst beendet. Johnson & Johnson gewannen 1,33 Prozent auf 60,15 Dollar. Nach dem Rückzug wird nun Boston Scientific <BSX.NYS> <BSX.FSE> (Nachrichten) Guidant übernehmen. Boston Scientific gaben 1,25 Prozent auf 23,70 Dollar ab./he/hi

AXC0133 2006-01-25/15:04

[actr]

Praxair Increases Quarterly Dividend 39%

DANBURY, Conn., Jan 25, 2006 (BUSINESS WIRE) -- The board of directors of Praxair, Inc. (NYSE: PX) has declared a quarterly dividend of 25 cents per share, an increase of 39% over the previous quarter. The dividend is payable on March 15, 2006 to shareholders of record on March 7, 2006.
"Praxair's track record of consistently strong performance in varied economic environments gives us the confidence to make this substantial increase in the dividend as well as demonstrates our continued commitment to deliver increased shareholder value," said Dennis H. Reilley, chairman and chief executive officer.

Praxair is the largest industrial gases company in North and South America, and one of the largest worldwide, with 2005 sales of $7.7 billion. The company produces, sells and distributes atmospheric and process gases, and high-performance surface coatings. More information on Praxair is available on the Internet at www.praxair.com.

SOURCE: Praxair, Inc.

[actr]

Katanga Reports 2005 Financial Results

TORONTO, ONTARIO, Jan 25, 2006 (CCNMatthews via COMTEX) -- Katanga Mining Limited, (TSX VENTURE:KAT) ("Katanga") announces its results of operations for the year ended September 30, 2005.
During the year ended September 30, 2005 Katanga entered into an option agreement ("Option Agreement") whereby Katanga can acquire 100% of the outstanding shares of Kinross Forrest Ltd. ("KFL"). KFL owns 75% of Kamoto Copper Company SARL ("KCC"). KCC is a Congolese joint venture company that was formed to hold 100% of the Kamoto Project's mineral reserves, mining, milling, hydrometallurgical facilities and other assets that are subject to a joint venture between KFL and Gecamines, a Democratic Republic of Congo ("DRC"). The joint venture and KCC have been formed and approved under DRC Presidential Decree. As well, Katanga completed a private placement financing in October 2004 under which it raised gross proceeds of US$898,320 (C$1,125,000) by issuing 4.5 million units at a price of US$0.20 (C$0.25) per unit. Each unit consisted of one common share and one-half of one share purchase warrant. Katanga's loss for the year, consisting primarily of general and administrative expenses, was US$49,752 (2004 - US$59,121) or US$0.01 per share (2004 - US$0.06).

Subsequent to year end Katanga completed a C$17.5 million private placement financing of 14 million common shares at a price of C$1.25 per share. GMP L.P. (formerly GMP Securities Ltd.) and Quest Securities Corporation, as co-lead agents, together with a syndicate that included Haywood Securities Inc., acted as agents in connection with the private placement. The net proceeds of the offering:

- will be used to fund the completion of the feasibility study of the Kamoto Joint Venture under the Option Agreement;

- were used to repay a C$1.0 million promissory note issued on November 2, 2005 to provide interim financing for the feasibility study; and

- were used to fund the purchase of a 23.33% ownership interest in KFL from Kinross Gold Corporation for C$5.45 million.

The Option Agreement and the Kamoto Joint Venture relate to the rehabilitation of the mines and plants located in Kolwezi in the DRC. At its peak production in 1986, Gecamines produced 476,000 tonnes of copper and 14,500 tonnes of cobalt, the majority of which came from the Kolwezi operations.

The Option Agreement requires Katanga to fund all costs associated with preparation of the Kamoto Project feasibility study. In order to exercise the option, Katanga must also arrange financing for capital needed to complete the first phase of redevelopment. It is estimated that the costs associated with the completion of the feasibility study will be approximately US$7.0 million. The consideration that must be paid by Katanga on the exercise of the option is set forth in Katanga's press release issued on August 2, 2005. The exercise of the option by the Company is subject to the further filing, review and acceptance by the TSX Venture Exchange.

Arthur Ditto, President and CEO of Katanga noted that "Katanga has made substantial progress in the past year in securing the option on the Kamoto Project. The funds from the private placement allowed Katanga to purchase its initial stake in KFL and will fund the completion of the Kamoto Joint Venture feasibility study. The feasibility study is proceeding well and the results of this study are expected by April 2006".

[actr]

Rediff.com India Limited - American Depositary Shares
25.01.06 19:37 Uhr

20,61 USD

+36,58 % [+5,52]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=REDF.NAS&lColors=0x000000&sSym=REDF.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=candle&ind0=VOLUME&&currency=&&lSyms=REDF.NAS&lColors=0x000000&sSym=REDF.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=REDF.NAS&lColors=0x000000&sSym=REDF.NAS&hcmask=

KursdatenBörse
NASDAQ

Aktuell
20,61 USD

Zeit
25.01.06 19:37

Diff. Vortag
+36,58 %

Tages-Vol.
186,75 Mio.

Gehandelte Stück
10 Mio


Jan 25, 2006 (M2 PRESSWIRE via COMTEX) -- StockHeadquarters.com, the newsletter, known for making stock alerts to its subscribers just days or weeks prior to big surges in the stock price does it again with an early alert in Rediff.com India Limited (Nasdaq: REDF) The newsletter has alerted the stock two times starting at $8.75 a share. The last alert was placed at $12.91 a share. Last check the stock has reached $22.12 a share for a whopping 153% gain.

[actr]

Ivanhoe Energy, Inc. - Common Shares
25.01.06 21:00 Uhr

2,251 USD

-16,32 % [-0,439]

http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=IVAN.NAS&lColors=0x000000&sSym=IVAN.NAS&hcmask=

Börse
NASDAQ

Aktuell
2,2508 USD

Zeit
25.01.06 21:00

Diff. Vortag
-16,33 %

Tages-Vol.
40,09 Mio.

Gehandelte Stück
19 Mio.

Ivanhoe Energy's California deep gas well test disappointing

BAKERSFIELD, CA, Jan. 25, 2006 (Canada NewsWire via COMTEX) -- Ivanhoe Energy Inc. (NASDAQ: IVAN and TSX: IE, IE.U) announced today that the test phase of the Aera Energy LLC Northwest Lost Hills 1-22 deep well has begun. Ivanhoe Energy has a 28% working interest in the project, but is not funding any of the cost of the test phase.
The NWLH 1-22 well was flow tested for two days, beginning January 21, which was followed by a pressure build-up. Natural gas rates from the production test were less than expected and water rates were high. A second 24-hour flow test is scheduled for January 25, followed by a 24-hour pressure build up, which will be used to verify the initial test data.

"The test data is still being evaluated, however the initial results are not promising," said Leon Daniel, Ivanhoe Energy's President and CEO. "A final determination by the operator of the future of the project is expected to be made before the end of the first quarter of 2006."

The well is in Kern County, California, and is operated by Aera Energy LLC. Designed to evaluate the natural gas and condensate reserve potential of the deep Temblor formation, drilling of the well began in August 2001 and reached a depth of 21,000 feet in August 2002. Several high-pressure sandstone formations were penetrated during the drilling, indicating the presence of natural gas. Operations were suspended by the operator in 2002 while a partner was sought to share the costs of the testing program. Completion activities were resumed in September 2005. During clean out of the well, natural gas was encountered and flared and the pressure, both downhole and at the surface, was extremely high.

Ivanhoe Energy currently holds a 28% working interest. Ivanhoe Energy originally had a 42% interest in the 9,600-acre block, but farmed out a portion of its ownership in exchange for the cost of testing of the well. Ivanhoe Energy is being carried through the initial completion and testing phase by other partners in the venture.

Ivanhoe Energy is an independent international oil and gas exploration and development company building long-term growth in its reserve base and production. Ivanhoe Energy is a leader in technologically innovative methods designed to significantly improve reserves of oil and gas through the upgrading of heavy oil to light oil, state-of-the-art drilling techniques, enhanced oil recovery (EOR) and the conversion of natural gas to liquids (GTL). Core operations are in the United States and China, with business development opportunities worldwide.

Ivanhoe Energy trades on the NASDAQ Capital Market with the ticker symbol IVAN and on the Toronto Stock Exchange (TSX) with the symbol IE. On the TSX, Ivanhoe Energy is listed and traded in both Canadian and U.S. dollars. The U.S. dollar trading symbol on the TSX is IE.U.

[actr]

RF Micro Devices, Inc.
25.01.06 21:14 Uhr

7,34 USD

+15,23 % [+0,97]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=RFMD.NAS&lColors=0x000000&sSym=RFMD.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=RFMD.NAS&lColors=0x000000&sSym=RFMD.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=RFMD.NAS&lColors=0x000000&sSym=RFMD.NAS&hcmask=

Börse
NASDAQ

Aktuell
7,34 USD

Zeit
25.01.06 21:14

Diff. Vortag
+15,23 %

Tages-Vol.
179,74 Mio.

Gehandelte Stück
27 Mio.

BUYINS.NET: RF Micro Devices (RFMD) SqueezeTrigger Price Is $5.56. Short Sellers Are Down Approximately $23.6 Million After Q3 Earnings Come In Strong.

Jan 25, 2006 (M2 PRESSWIRE via COMTEX) -- www.buyins.net, announced today that the 13.91 million shares declared short on RF Micro Devices (NASDAQ: RFMD) have a SqueezeTrigger Price of $5.56 per share. According to AP, RF Micro Devices Inc., a maker of radio frequency chips, on posted a steep jump in third-quarter profit from higher sales during the period. The company also pegged its fourth-quarter results above Wall Street estimates. Quarterly income surged to $14.7 million, or 7 cents per share, from $582,000, or nil per share, the year before. Setting aside one-time items and stock-option costs, earnings were $16.4 million or 8 cents per share. Its adjusted earnings compared with the average estimate for income of 7 cents per share from analysts polled by Thomson Financial. Revenue for the quarter ended Dec. 31, totaled $208 million, a 23 percent increase from $168.9 million a year earlier but missing analysts' consensus target of $209.7 million. RF said its revenue growth was driven by sales of power amplifier modules, transmit modules and Polaris radio transceivers. Looking forward, the company forecast fourth-quarter earnings of 5 cents to 6 cents per share, or 6 cents to 7 cents before items and stock options, on revenue of $200 million to $215 million. Analysts are currently looking for a profit of 4 cents per share and $192.9 million in revenue. Short sellers are down approximately $23.6 million as the stock is currently trading near $7.29. To access SqueezeTrigger Prices ahead of short squeezes beginning, visit http://www.buyins.net/squeezetrigger.pdf.
From January to December of 2005, an aggregate amount of 345,665,513 shares of RFMD have been shorted for a total dollar value of $1.92 billion. The RFMD SqueezeTrigger price of $5.56 is the volume weighted average price that all shorts are short in shares of RFMD. Since crossing above the SqueezeTrigger Price, shares of RFMD are up nearly 31%. There is still approximately $101 million worth of potential short covering in shares of RFMD.

RF Micro Devices, Inc. (NASDAQ: RFMD) engages in the design, development, manufacture, and marketing of proprietary radio frequency components and system level solutions for wireless communications products and applications. The company offers various products, including power amplifiers; mixers; modulators/demodulators and single chip transmitters; Bluetooth products; and receivers and transceivers. It develops components for satellite radio and global positioning systems (GPS); and solutions for handsets, personal digital assistants, handheld navigation applications, and telematics systems. The company's infrastructure products consist of components for wireless base stations, quadrature modulators, and driver amplifiers. Its products are used primarily in cellular phones, base stations, wireless local area networks, cable television modems, and GPS. RF Micro Devices sells its products to both domestic and international original equipment manufacturers and original design manufacturers through directly sales force, as well as through sales representative firms and distributors. The company has a strategic relationship with Jazz Semiconductor, Inc. RF Micro Devices was founded in 1991 by William J. Pratt, Powell T. Seymour, and Jerry D. Neal. The company is headquartered in Greensboro, North Carolina

[actr]

SULPHCO INC
25.01.06 21:20 Uhr

7,83 USD

+13,81 % [+0,95]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=SUF.ASE&lColors=0x000000&sSym=SUF.ASE&hcmask=

Börse
AMEX

Aktuell
7,83 USD

Zeit
25.01.06 21:20

Diff. Vortag
+13,81 %

Tages-Vol.
43,59 Mio.

Gehandelte Stück
5,6 Mio.

SulphCo Sonocracking(TM) Technology - the Facts

Jan 24, 2006 /PRNewswire-FirstCall via COMTEX/ -- After close consultation with other members of the Board of Directors of SulphCo, Inc., (Amex: SUF) Robert H.C. van Maasdijk feels compelled to respond to the article in Barron's Magazine over the weekend as, in his opinion, the article is materially misleading regarding the company, its management and its technology. In response, Mr. van Maasdijk has decided to focus exclusively on his assessment of the Sonocracking(TM) technology, and in particular, test results furnished not only by SulphCo, but also those produced by one of the leading oil companies in the Middle East, a company which has tested the Sonocracking technology at the facilities during the entire month of December 2005. In the opinion of Mr. van Maasdijk, these results indicate that the Sonocracking technology developed by SulphCo will not only reduce sulphur and nitrogen content in processed crude, but more importantly, will substantially increase the yield of light distillates.
SulphCo has previously stated that its technology will increase the API gravity by 6 to 11 points, depending on the quality of the crude processed (light, medium or heavy). These test results confirm that, in volume terms, Sonocracking can yield between 20% to 50% more light oil per barrel, depending on the grade of crude processed. In dollar terms, this can mean an uplift of between $5 and $10 per barrel.

Sonocracking technology has minimal operating costs and is adaptable to both upstream and downstream applications.

SulphCo will install, by the beginning of June 2006, its first 210,000 barrels of Sonocracking capacity (seven 30,000 barrels per units) in Fujairah. The equipment will be manufactured by NTG Technology in Germany, following which 300,000 barrels of additional capacity will be installed in the following months. It is the opinion of NTG that once the seven units of 30,000 barrels each have been installed, an accelerated rollout is anticipated.

Last but not least, SulphCo is in the final stages of negotiations with several oil producing nations and companies, as has been stated before. As a consequence, the Board of SulphCo is fully focused on the rollout of the Sonocracking equipment.

About SulphCo, Inc.

SulphCo has developed a patented safe and economic process employing ultrasound technology to desulfurize and hydrogenate crude oil and other oil related products. The company's technology upgrades sour heavy crude oils into sweeter, lighter crudes, producing more gallons of usable oil per barrel.

[actr]

Entrust, Inc.
25.01.06 21:32 Uhr

4,06 USD

-17,48 % [-0,86]

http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=ENTU.NAS&lColors=0x000000&sSym=ENTU.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=ENTU.NAS&lColors=0x000000&sSym=ENTU.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=ENTU.NAS&lColors=0x000000&sSym=ENTU.NAS&hcmask=

Börse
NASDAQ

Aktuell
4,06 USD

Zeit
25.01.06 21:33

Diff. Vortag
-17,48 %

Tages-Vol.
20,83 Mio.

Gehandelte Stück
5,2 Mio

Entrust Announces Financial Results for 4th Quarter and Fiscal 2005 Highest Quarter and Annual Earnings in Company History

DALLAS, Jan. 24, 2006 (Canada NewsWire via COMTEX) -- Entrust, Inc. (Nasdaq: ENTU), a world leader in securing digital identities and information, today announced financial results for its fiscal quarter and year ended December 31, 2005.
Revenue for the fourth quarter was $24.8 million, an increase of 5% from $23.7 million in Q3, 2005, and a decrease from $27.1 million in Q4, 2004. Revenue for 2005 was $98.1 million, an 8% increase from $91 million in 2004. Product revenue for 2005 reached $34.2 million, which is up 17% from $29.3 million in 2004.

Entrust recorded Q4, 2005, net income in accordance with GAAP of $3.4 million, or $0.05 per share compared to Q3, 2005, net income of $956 thousand or $0.02 per share and Q4, 2004, net income of $2.6 million, or $0.04 per share. Entrust recorded full year 2005 net income of $6.4 million, or $0.10 per share, compared to 2004 net income of $1.1 million, or $0.02 per share. Net Income for Q4, 2005, and for the full year was the highest in company history.

Entrust recorded Q4, 2005, pro forma (non-GAAP) net income of $3.5 million, or $0.06 per share, compared to Q3, 2005, pro forma net income of $1.1 million, or $0.02 per share and Q4, 2004, pro forma net income of $2.8 million, or $0.04 per share. For the full year, Entrust recorded record pro forma (non-GAAP) net income of $7.0 million, or $0.11 per share, compared to $1.3 million or $0.02 per share for 2004, an increase of 450%. The Q4, 2005, and full year 2005 pro forma (non-GAAP) net income figures exclude approximately $202 thousand and $802 thousand respectively of purchased intangibles amortization in cost of goods sold and approximately $19 thousand and $75 thousand respectively of amortization of purchased intangible assets in operating expenses.

"While fourth quarter revenue was below our expectations, we are very pleased with the customer, product, and earnings momentum in our business," said Bill Conner, Entrust chairman, president and chief executive officer. "We continued to gain traction with IdentityGuard, which increased pilots from 55 to 88. We increased our total transaction count to 84, our highest level in 5 years, and added 35 new customers. We also increased our earnings to 5 cents per share, our highest quarter of profitability in company history."



2005 Highlights:

-- Product revenue of $34.2 million increased 17% from $29.3 million in

2004.

-- Pro forma Earnings per share of $0.11, up 450% from $0.02 in 2004.

-- Entrust added 80 new customers in 2005, which represented a 150%

increase from 2004.

-- New Products: IdentityGuard and Boundary Messaging represented 11% of

total product revenue or $3.5 million for 2005, compared to $883

thousand in 2004.

-- Entrust IdentityGuard finished its first year of commercial

availability with 29 customers and 88 pilots, reaching sales of

$2.0 million. Sales for the year represented 2.4 million

IdentityGuard licenses shipped to customers such as SHUFA, the

Government of Sweden, Commercebank, and a number of leading

Government and Financial Institutions worldwide.

-- Entrust Public Key Infrastructure (PKI) products revenue increased

15% over 2004.

-- Entrust gained additional traction within its extended government

vertical. Government product revenue was 159% higher than it was for

2004.

-- Entrust signed eight value added resellers under its U.S.

distribution network.

-- As part of its share purchase program, Entrust purchased 3.94 million

shares in 2005 for $17.9 million at an average share price of $4.54.

The company ended 2005 with $82.5 million in cash and marketable

securities and no debt.


"2005 was a terrific year for Entrust," continued Bill Conner. "We brought new products to market that delivered 11% of total product revenue, which underpinned our total product revenue growth of 17%. We also grew our revenue transactions by 26% and our new customer base by 150% in the year. All of this led to our highest earnings in the company's history at $0.11 per share, or a 450% increase. These results, coupled with the strength of our product portfolio, the overall IT market, and our funnel, give us confidence to execute on our 2006 guidance."



Q4, 2005 Business and Financial Metrics:


-- Revenues of $24.8 million consisted of 37% product ($9.1 million) and

63% services and maintenance ($15.7 million). The top five product

transactions accounted for 16% of Q4, 2005, revenues. There was one

product transaction over $1 million in the quarter.

-- Product revenue for the quarter was 57% Extended Government and 43%

Extended Enterprise.

-- The average purchase size in the fourth quarter was $91 thousand.

Total transactions in Q4, 2005 reached 84, which is up from 67 in Q3,

2005, and 75 in Q4, 2004. Thirty five of the transactions in Q4,

2005, were from new customers, up from 15 in Q3, 2005. Over 11% of

total transactions in Q4, 2005, were from Entrust's target product

areas of Entrust IdentityGuard and Boundary Messaging.

-- Entrust services revenue was $15.7 million. Entrust's support and

maintenance delivered its highest fourth quarter revenue in the

company's history.


Solutions Revenue Breakout


-- Entrust Secure Identity Management Solutions accounted for 66%

($6.0 million) of product revenue for Q4, 2005, representing a 2%

decrease ($144 thousand) from Q3, 2005, and a 22% decrease

($1.65 million) from Q4, 2004. Entrust IdentityGuard represented 7%

($0.6 million) of product revenue for Q4, 2005. Entrust Certificate

Services continued its 13th consecutive increase in quarter over

quarter revenue.

-- Entrust Secure Messaging Solutions accounted for 24% ($2.2 million)

of product revenue, a 97% increase ($1.1 million) from Q3, 2005, and

a 9% decrease ($217 thousand) from Q4, 2004.

-- Entrust Secure Data Solutions accounted for 10% ($0.9 million) of

product revenue, an increase of 112% ($469 thousand) from Q3, 2005,

and an increase 4% ($26 thousand) from Q3, 2004.


In order to better reflect the dynamics of its business, Entrust will be transitioning from solutions revenue to product categories for 2006. The new categories will be: Emerging Growth Products including Entrust IdentityGuard and Boundary messaging, Public Key Infrastructure (PKI) including all certificate based products and Single Sign-On Products. A table is available at http://www.entrust.com/investor bridging the old and new reporting methods

[actr]

Silicon Laboratories, Inc.
25.01.06 21:48 Uhr

49,03 USD

+18,03 % [+7,49]
http://isht.comdirect.de/charts/big.chart?hist=1d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=SLAB.NAS&lColors=0x000000&sSym=SLAB.NAS&hcmask=
http://isht.comdirect.de/charts/big.chart?hist=10d&type=CONNECTLINE&ind0=VOLUME&&currency=&&lSyms=SLAB.NAS&lColors=0x000000&sSym=SLAB.NAS&hcmask=
http://isht.comdirect.de/charts/large.chart?hist=6m&type=candle&asc=lin&dsc=abs&avgtype=simple&ind=BB&ind0=VOLUME&ind1=RSI&&currency=&lSyms=SLAB.NAS&lColors=0x000000&sSym=SLAB.NAS&hcmask=

Börse
NASDAQ

Aktuell
49,03 USD

Zeit
25.01.06 21:48

Diff. Vortag
+18,03 %

Tages-Vol.
416,98 Mio.

Gehandelte Stück
9,6 Mio.

[actr]

25.01.2006 23:11
Silicon Storage mit starkem Turn-around
Silicon Storage Technology hat am Mittwoch nachbörslich einen Quartalsgewinn von 8,44 Millionen Dollar oder 8 Cent je Aktie berichtet. Im Vorjahresquartal war noch ein Verlust von 26,9 Millionen Dollar oder 28 Cent je Aktie angefallen. Analysten hatten im Schnitt mit einem Gewinn von 2 Cent je Aktie gerechnet. Der Umsatz legte von 104,1 Millionen auf 133,2 Millionen Dollar zu. Analysten hatten hier mit 135 Millionen Dollar gerechnet.

Silicon notiert nachbörslich bei 5,86$.

[actr]

Oncolytics Biotech Inc. Announces Issuance of Fourth Canadian Patent - Method of Extracting Virus from Cell Culture -

CALGARY, Jan. 26, 2006 (Canada NewsWire via COMTEX) -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") has been granted Canadian Patent 2,437,962 entitled "Method of Extracting Virus from Cell Culture." The claims describe methods of producing and extracting infectious reovirus from a culture of cells.
"The claims in this Canadian patent broaden the intellectual property coverage for our manufacturing process," said Dr. Matt Coffey, Chief Scientific Officer for Oncolytics. "The Company's patent portfolio now includes 13 U.S. patents, four Canadian patents and two European patents."

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I and Phase I/II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation. For further information about Oncolytics please visit www.oncolyticsbiotech.com

[actr]

Peabody Energy (NYSE: BTU) Announces Results for the Year Ended December 31, 2005 -- Peabody posts record 2005 results -- Net income increases 141% to $422.7 million -- Earnings per share rises 128% to $3.15 -- Operating cash flow increases 148% to $

Jan 26, 2006 /PRNewswire-FirstCall via COMTEX/ -- Peabody Energy (NYSE: BTU) today reported that 2005 net income rose 141 percent to $422.7 million, or $3.15 per share, compared with $175.4 million, or $1.38 per share, in the prior year. EBITDA rose 56 percent for the year to $870.4 million.
"The Peabody team delivered record 2005 results for safety, volume, revenue, EBITDA, income and total shareholder return," said Peabody President and Chief Executive Officer Gregory H. Boyce. "We believe that Peabody's successes in 2005 and plans for 2006 mark the early stages of a long period of sustainable growth and ever-improving financial results. We are adding low- cost capacity to meet market demand and repricing contracts at much higher levels. All of our markets are experiencing very strong demand and prices - particularly our largest operating region, the Powder River Basin."

Published pricing for benchmark Powder River Basin (PRB) coal has tripled in the past year, with recent over-the-counter prices exceeding $20 per ton. The Powder River Basin, where Peabody is the number-one producer, represents nearly two-thirds of Peabody's U.S. production. The company is reaching multiple-year agreements that capture the value of these strong markets along with premiums for ultra-low sulfur coal driven by record prices for SO2 emission allowance credits. In addition, Peabody is currently securing new business at significantly higher levels in the Colorado and Illinois Basin markets, where Peabody is also the number-one producer.

FINANCIAL AND OPERATING HIGHLIGHTS

Peabody's full-year 2005 revenues of $4.6 billion were $1 billion higher than in 2004. Fourth quarter revenues of $1.2 billion grew 21 percent compared with the prior year. 2005 sales volumes increased 5.6 percent to a record 240 million tons, driven by growing customer demand in all regions where Peabody operates. EBITDA totaled $870.4 million for the year compared with $559.2 million in 2004. Operating profit of $518.4 million more than doubled prior-year results.

2005 EBITDA from Mining Operations increased 41 percent to $1,036.3 million. Margins expanded significantly in 2005, overcoming geology constraints and transportation disruptions in the United States and Australia. Peabody's solid results from operations generated 148 percent greater operating cash flow compared with the prior year.

Net income totaled $422.7 million for 2005, or $3.15 per share, and $162.2 million for the fourth quarter, or $1.21 per share. Net income more than doubled from the $175.4 million, or $1.38 per share, and $67.9 million, or $0.51 per share in the respective prior-year periods. Peabody provided a record 105 percent total return to shareholders in 2005.

Peabody operations set new production records in 2005 at eight mines representing more than 60 percent of the company's production. Peabody's Powder River Basin operations were also the three most productive mines in America, based on latest available industry data. Also during 2005, the company was honored with five environmental and community excellence awards given by the Department of the Interior, including the Gold, Silver and Bronze "Good Neighbor" Awards. Peabody operations in Colorado, Midwest and Appalachia earned an additional six reclamation awards in 2005.

Peabody's safety ratings improved another 33 percent in 2005, marking a 48 percent improvement over the last three years. Four operations achieved the company's goal of zero accidents. Peabody's record 2005 safety performance is 45 percent better than the U.S. average, based on available industry data, and received recognition at operations in both the western and eastern United States. The North Antelope Rochelle Mine received the "Safe Sam" award for the second consecutive year, recognized as the safest mine in Wyoming. The Harris Mine earned the Mountaineer Guardian Award for outstanding safety achievement from the West Virginia Office of Miners' Health, Safety and Training and the West Virginia Coal Association.

MARKET OVERVIEW

"U.S. and global market fundamentals are exceptional," said Boyce. "Amid expensive oil and natural gas, we are experiencing record coal demand to satisfy electricity plants that are operating at higher rates. New generating plants are being developed at a record pace, global steel demand continues to grow, and interest in projects to turn coal into natural gas, transportation fuels and hydrogen is rapidly increasing."

The global supply-demand balance for coal remains extremely tight, driven by the growing U.S. and China economies and increasing demand for electricity generation and steel production in the Pacific Rim. Global and U.S. coal- fueled generation is expected to reach record levels in 2006. U.S. generator stockpiles of approximately 100 million to 105 million tons are at historic low levels, and replenishing these inventories will take considerable time due to strong underlying demand growth and limited rail improvements.

Demand for metallurgical coal remains very strong around the world. In the fourth quarter, for instance, Peabody reached agreements for significant 2006 metallurgical coal deliveries in the United States at prices above the strong prior-year levels. Metallurgical coal supply agreements from Australia for the fiscal year beginning April 1 are still being negotiated.

The current record high prices of SO2 allowances are resulting in premiums of $3 to $4 per ton above the benchmark 8,800 Btu per pound Powder River Basin coal for ultra-low sulfur products from Peabody's North Antelope Rochelle Mine and the planned School Creek Mine. Sulfur emissions allowances, which have increased nearly 11-fold since 2003, are expected to remain high due to delayed scrubber installations and tightening emissions regulations.

Competing fuels remain very limited. Nuclear units continue to operate near capacity and the cost of oil and natural gas remains high due to limited supplies and very strong global demand. Recent forecasts by the U.S. Energy Information Administration (EIA) further reinforce the favorable long-term markets for coal. EIA's Annual Energy Outlook increased the long-term price estimate of crude oil by two-thirds to $54 per barrel by 2025. Long-range estimates of liquid natural gas (LNG) supplies to the United States were reduced approximately one-third due to increased global demand that makes LNG less available and more expensive in U.S. markets. The estimate of coal's share of U.S. electricity generation has been raised to 57 percent by 2030. Total U.S. coal demand is now estimated to grow from 1.1 billion tons per year in 2005 to nearly 1.8 billion tons per year by 2030.

Interest in new coal-fueled generation remains strong. Globally, approximately 435 gigawatts of new coal-based electricity generation are under various stages of planning and development. In the United States, the Department of Energy has identified 129 power plants that have been announced or are under development in 40 states, representing 77 gigawatts of electricity and more than $100 billion of investment.

During the fourth quarter, Peabody reached agreements with customers for 2006, 2007 and 2008 delivery of premium PRB coal for prices that are more than 130 percent higher than Peabody's average 2005 realized prices. As previously mentioned, prices for benchmark premium PRB coal have more than tripled over the past year. Much of the rise occurred in the second half of 2005, therefore benefiting contracted volumes for 2007 and beyond.

Peabody has substantial volumes of PRB coal that will be priced in the current favorable market conditions. Peabody's total unpriced volumes at year-end include 15 million to 25 million tons for 2006, 90 to 100 million tons for 2007, and 155 to 165 million tons for 2008.

New markets for coal are rapidly emerging via Btu Conversion initiatives. Coal to natural gas and coal to liquids greatly expand the product line for coal and Peabody long-term. For instance, the U.S. EIA for the first time estimates coal-to-liquids applications will add another 190 million tons per year of additional demand over the next 25 years. Peabody is uniquely positioned to participate in these emerging markets, with more than 9 billion tons of proven and probable coal reserves.

GROWTH INITIATIVES

Capital expenditures for 2005 totaled $503 million (excluding acquisitions) and included a number of productivity and growth investments, including $118 million related to the acquisition of high-Btu, ultra-low sulfur Powder River Basin reserves.

"In anticipation of strong Powder River Basin demand, we made the largest investment in reserves and capacity additions in the Powder River Basin in recent years," said Executive Vice President and Chief Financial Officer Richard A. Navarre. "This positions Peabody to capture both surging demand and pricing in the PRB over the next several years."

Peabody is targeting 2006 capital expenditures of $450 million to $525 million, excluding previously committed PRB lease payments, as the company implements a number of growth initiatives by focusing investments on high-growth, high-return projects. Approximately $250 million is allocated toward maintenance and replacement capital, including construction of the Black Stallion metallurgical coal mine in West Virginia. Replacement and maintenance capital represents about $1 per ton of production capacity.

The remainder of the capital is associated with growth projects and corporate initiatives. Peabody will invest more than $90 million to increase production by 15 million to 20 million tons at its PRB mines in 2006 to accommodate customer demand. Another $65 million is being invested for mine expansion projects in the Midwest to serve growing markets with an additional 4 million tons of production coming online by 2007.

"Peabody's unique combination of high-quality reserves in growth markets, expected strong cash flows and sales backlog allows us to target organic capacity growth of more than 75 million tons by 2010," said Navarre. "We expect these capital investments to average $15 to $20 per ton of new capacity, which is substantially more efficient than the industry average."


OUTLOOK

Peabody is targeting full-year 2006 EBITDA of $1 billion to $1.15 billion and earnings of $3.75 to $4.85 per share. Performance will be largely impacted by metallurgical coal production and pricing, as well as PRB rail performance. While customer indications suggest that 2006 Powder River Basin demand could increase by 15 percent or more, the railroads expect that they will only be able to accommodate half of this pent-up demand. Peabody is targeting 2006 production of 230 to 240 million tons and total sales of 255 to 265 million tons.

For the first quarter, Peabody is targeting EBITDA of $200 to $250 million and earnings per share of $0.60 to $0.90. Results will reflect lower production and higher costs related to significant longwall system installations at several of the company's longwall operations, as well as an increase in fuel, explosives and health care costs.

"We are targeting significant earnings growth in 2006, and an even brighter outlook beyond," said Boyce. "The full impact of improved prices in our key coal markets will be realized as long-term contracts are repriced. We also look forward to benefiting from planned capacity additions, new higher- priced contracts, and the expanded markets created by Btu Conversion projects."

Peabody Energy (NYSE: BTU) is the world's largest private-sector coal company. Its coal products fuel more than 10 percent of all U.S. electricity and 3 percent of worldwide electricity.

[actr]

Midwest Air Group Reports Fourth Quarter Results Summary: Fourth Quarter 2005 vs. Fourth Quarter 2004 - Operating revenue increased 37.8% to $142.8 million - Scheduled service revenue passenger miles increased 40.2% to 863.4 million on a 36.6% increa

MILWAUKEE, Jan 26, 2006 /PRNewswire-FirstCall via COMTEX/ -- Midwest Air Group, Inc. (Amex: MEH) today reported fourth quarter results for its Midwest Airlines and Skyway Airlines (dba Midwest Connect) operations.
"The competitive environment and high fuel prices continued to challenge us in the fourth quarter, as they have throughout a difficult year," said Timothy E. Hoeksema, chairman and chief executive officer. "Although disappointing from an earnings perspective, the quarter included numerous bright spots. We significantly increased revenue while lowering non-fuel costs, posted impressive gains in market share, and ended the year in a strong cash position."

Comparing fourth quarter 2005 to fourth quarter 2004, operating revenue increased 37.8% to $142.8 million. Operating results improved to a $14.0 million loss from a $19.2 million loss in the fourth quarter of 2004, while net results improved to a $13.8 million loss from a $19.4 million loss. (Due to accumulated losses, Midwest Air Group discontinued recording federal income tax benefit on losses beginning with second quarter 2004 and state income tax benefit on losses beginning with second quarter 2005.) Per share results were a loss of $0.79, compared with a $1.11 loss in the same quarter a year earlier.

The revenue increase reflects a 40.2% increase in passenger traffic, due to strong customer demand in response to strategic pricing actions and schedule and service enhancements. A 1.2% increase in revenue yield was driven primarily by the improving industry pricing environment. Total operating expenses increased 27.6%, due to increases in fuel expense, station costs and aircraft rental expenses. Fuel expense increased $23.4 million, or 75.7% -- of which $12.9 million ($0.74 per share) was related to price increases (calculated by applying 2004 prices to actual gallons consumed in 2005 and comparing the result to actual 2005 expense). The company also recorded $1.0 million ($0.06 per share) for the write-off of aircraft purchase deposits. Fuel expense includes the effect of hedging, which favorably impacted fuel costs by $2.1 million ($0.08 per gallon) in the quarter.

Midwest posted sizeable gains in market share in its Milwaukee and Kansas City hubs in November, the most recent month for which market share results are available:


-- Midwest Airlines and Midwest Connect carried 50.9% of all passengers

departing from Milwaukee during November, up from 41.2% in the same

month a year earlier. In November 2005, the airlines transported

145,376 Milwaukee passengers, up 34% from 108,588 passengers in

November 2004.

-- In Kansas City, Midwest market share rose to 8.9% for November from

5.2% in the same month a year earlier. In November 2005, Midwest

Airlines carried a total of 36,068 Kansas City passengers, up 71% from

21,123 passengers in November 2004.

For the year ended 2005, operating revenue increased 25.9% to $523.0 million. Operating results fell to a $65.2 million loss from a $45.3 million loss in 2004, while net results fell to a $64.9 million loss from a $43.1 million loss last year. Included in the 2004 loss was a tax benefit of $4.0 million. Results per share fell to a $3.71 loss from a $2.47 loss in 2004. Fuel expense increased $69.7 million, or 64.3% -- of which $48.9 million ($2.79 per share) was related to price increases.

Year-end 2005 results include a $15.6 million ($0.89 per share) impairment charge for the disposal of aircraft, $1.0 million ($0.06 per share) for the write-off of aircraft purchase deposits and $0.8 million ($0.05 per share) for the write-off of capitalized lease arranger and legal expenses, a $0.9 million ($0.05 per share) litigation settlement, and $0.7 million ($0.04 per share) in severance costs. A change in the employee vacation policy reduced expense by $1.9 million ($0.11 per share). Year-to-date 2004 results include $1.2 million ($0.07 per share) of costs related to the disposition of aircraft.

At Midwest Airlines, revenue per scheduled service available seat mile increased 6.4% in the quarter. Load factor increased 1.3 percentage points due to a 43.0% increase in passenger traffic on a 40.4% increase in capacity. Revenue yield increased 4.1%. For the year, revenue per scheduled service available seat mile increased 9.6%. Load factor increased 7.0 percentage points due to a 36.0% increase in passenger traffic on a 22.6% increase in capacity. Revenue yield decreased 1.9%.

Into-plane fuel prices increased 32.0% in fourth quarter 2005, averaging $2.10 per gallon versus $1.59 per gallon in fourth quarter 2004, and resulted in an $11.3 million (pre-tax) unfavorable price impact. Fuel consumption increases resulted in a $9.9 million (pre-tax) unfavorable impact in the quarter, primarily as a result of an increase in the number of operating hours.

In the quarter, cost per available seat mile (unit costs) at Midwest Airlines decreased $0.0079 to $0.1089, or 6.7% (excluding fuel, decreased $0.0178 to $0.0696, or 20.4%) compared with fourth quarter 2004. Contributing to the improvement in unit costs was a $1.4 million ($0.0012 per ASM) reduction in expenses due to a change in the company vacation policy.

At Midwest Connect, revenue per scheduled service available seat mile increased 14.1% in the quarter. Traffic increased 12.0% on a 2.8% increase in capacity, resulting in a 5.3 percentage point improvement in load factor, while revenue yield increased 4.8%. Cost per available seat mile increased $0.0664 to $0.3060, or 27.7% (excluding fuel, increased $0.0504 to $0.2339, or 27.5%) compared with fourth quarter 2004, due primarily to labor costs associated with new ramp and dining services functions performed for Midwest Airlines; the transfer of ramp and dining services functions to Midwest Connect has lowered the total cost to Midwest Air Group. The company recorded $1.0 million ($0.0104 per ASM) for the write-off of aircraft purchase deposits. A change in the company vacation policy reduced expenses by $0.5 million ($0.0051 per ASM). Into-plane fuel prices increased 31.2% in fourth quarter 2005, averaging $2.19 per gallon versus $1.67 per gallon in fourth quarter 2004, resulting in a $1.7 million (pre-tax) unfavorable price impact. Fuel consumption was virtually unchanged quarter over quarter.

Note: Cost per available seat mile excluding fuel expense is an industry measurement that provides management and investors the ability to track changes in cost absent fuel-related expenses.

The company ended the quarter with $99.0 million in unrestricted cash, up from $76.2 million on September 30, 2005 and $81.5 million at December 31, 2004. The improvement in the company's cash position was primarily due to the signing of a multi-year contract amendment and extension with Juniper Bank, the vendor of its Midwest Airlines MasterCard, which included a change in payments from quarterly in arrears to annually in advance starting in December 2005. The company's cash position also benefited from the overall improvement in the airline industry environment in recent months, as well as its own pricing and marketing initiatives. Capital spending -- net of credits used to fund such spending -- resulted in a cash outlay of $9.2 million for the year and consisted primarily of costs associated with the acquisition of additional spare parts for the Boeing 717 fleet, purchase of an MD-80 engine, and equipment and leasehold improvements for the in-house dining services program.

[actr]

Platinum Energy Resources Announces Merger Agreement with Tandem Energy Holdings

NEW YORK, Jan 26, 2006 /PRNewswire-FirstCall via COMTEX/ -- Platinum Energy Resources, Inc. (OTC Bulletin Board: PGRI), (OTC Bulletin Board: PGRIU), (OTC Bulletin Board: PGRIW) ("Platinum Energy"), a special purpose acquisition corporation focused on the energy industry, today announced that it has entered into a definitive merger agreement with Tandem Energy Holdings, Inc. (OTC Bulletin Board: TDYH) ("Tandem"). Tandem is an independent oil and gas company engaged in the acquisition, exploration, exploitation and development of oil and gas properties and the production of oil and gas. Under the terms of the agreement, Tandem Energy Corporation, a wholly-owned subsidiary of Tandem Energy Holdings, owning substantially all of its assets, will become a wholly-owned subsidiary of Platinum Energy. Platinum Energy will pay $105 million in cash and fees and will be guaranteed $5 million in working capital. Platinum Energy will be responsible for capital expenditures as of January 1, 2006.
Tandem's producing properties are located primarily in Texas and New Mexico. On September 30, 2005, Tandem's estimated net proved reserves were 8.849 million barrels of oil equivalent (BOE), of which approximately 64% were crude oil and 36% were natural gas. 34.4% of its total reserves were Proven Developed Producing (PDP's). Preliminary due diligence has revealed expected low-risk probable reserves and "behind pipe" opportunities of an additional 16 million BOE.

Barry Kostiner, chief executive officer of Platinum Energy, stated, "Tandem's strong producing properties combined with its development opportunity are a perfect foundation on which to execute our business plan of optimizing profit irrespective of the global energy market's performance. We look forward to building on the attractive value created by Tandem's management."

"We are looking forward to working with Platinum Energy throughout the merger process," said Tim Culp, president and CEO of Tandem Energy Holdings. "Our low-risk oil and gas resources fit very well into Platinum's stated business strategy."

James Dorman, executive vice president, geology of Platinum Energy said, "As the head of the geology team, I am extremely excited about the potential of Tandem's diverse properties. We will have the unique opportunity to build on Tandem's current proven reserves substantially by utilizing a low-cost drilling program."

Platinum Energy, based in Montvale, New Jersey, was incorporated in April 2005 to acquire an operating business in the energy industry. Platinum Energy completed its initial public offering on October 24, 2005, receiving net proceeds of approximately $106 million through the sale of 14.4 million units of its securities at $8.00 per unit. Each unit was comprised of one share of Platinum Energy common stock and one redeemable and convertible common stock purchase warrant having an exercise price of $6.00. Platinum Energy holds over $105 million in a trust account maintained by an independent trustee, which will be released to the company upon the closing of the merger with Tandem (less any amounts returned to Platinum Energy stockholders who elect to convert their shares to cash in accordance with Platinum Energy's charter).

Merger Conditions

The closing of the merger is subject to customary closing conditions, including Platinum Energy stockholder approval of the merger. In addition, the closing is conditioned on holders of fewer than 20 percent of the shares of Platinum Energy issued in the IPO voting against the business combination and electing to convert their Platinum Energy shares into cash, as permitted by the Platinum Energy certificate of incorporation. The Platinum Energy initial stockholders, officers and directors, who hold approximately 20% of Platinum Energy's voting stock, have agreed to vote their shares on the merger in accordance with the vote of the majority of the non-affiliated Platinum Energy stockholders. If approved by Platinum Energy stockholders, the transaction is expected to close in the second quarter of 2006.

About Platinum Energy Resources, Inc.

Platinum Energy Resources is a special purpose acquisition corporation seeking to acquire assets or operating businesses in the global oil and gas exploration and production industry. Platinum Energy anticipates aggressively building a portfolio of assets using multiple acquisitions subsequent to its first acquisition which will require approval of shareholders in the amount of 80% of those voting. Platinum Energy's strategy calls for the aggressive use of hedging strategies to optimize profit irrespective of the performance of the global energy market's performance.

About Tandem Energy Holdings Inc.

Tandem Energy Holdings Inc. is an oil and gas exploration and development company based in Midland, Texas. The Company's activities are focused on low- risk properties in Texas and New Mexico.


Investor and Media Contact

Alan Katz

Cubit Jacobs & Prosek Communications for Platinum Energy Resources

212-279-3115 ext. 211

alan@cjpcom.com


Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, about Platinum Energy, Tandem and their combined business after completion of the proposed merger. Forward-looking statements are statements that are not historical facts. Such forward-looking statements, based upon the current beliefs and expectations of Platinum Energy' and Tandem's management, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: Business conditions in the U.S. and abroad; changing interpretations of generally accepted accounting principles; outcomes of government reviews; inquiries and investigations and related litigation; continued compliance with government regulations; legislation or regulatory environments, requirements or changes adversely affecting the businesses in which Tandem is engaged; fluctuations in oil and gas prices and in customer demand; management of rapid growth; intensity of competition; general economic conditions; as well as other relevant risks detailed in Platinum Energy' filings with the Securities and Exchange Commission, including its report on Form 10-QSB for the period ended September 30, 2005. The information set forth herein should be read in light of such risks. Neither Platinum Energy nor Tandem assumes any obligation to update the information contained in this press release.

Additional Information

Platinum Energy stockholders are urged to read the proxy statement regarding the proposed transaction when it becomes available because it will contain important information. Copies of filings by Platinum Energy, which will contain information about Platinum Energy and Tandem, will be available without charge, when filed, at the Securities and Exchange Commission's internet site (http://www.sec.gov), and, when filed, will be available from Platinum Energy, without charge, by directing a request to Platinum Energy Resources, 3 Paragon Drive, Montvale, NJ 07654.

The respective directors and executive officers of Platinum Energy and other persons may be deemed to be participants in the solicitation of proxies in respect of the proposed merger. Information regarding Platinum Energy's directors and executive officers is available in its Prospectus dated October 24, 2005 filed with the Securities and Exchange Commission on October 26, 2005. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the Securities and Exchange Commission when they become available.

SOURCE Platinum Energy Resources, Inc.


CONTACT: Investor and Media, Alan Katz of Cubit Jacobs & Prosek Communications for

Platinum Energy Resources, +1-212-279-3115, ext. 211, alan@cjpcom.com


URL: http://www.prnewswire.com

www.prnewswire.com

Copyright (C) 2006 PR Newswire. All rights reserved.



KEYWORD: New York

Texas

INDUSTRY KEYWORD: OIL

OTC

SUBJECT CODE: TNM

[actr]

26.01.2006 14:43
US Vorbörse mit anhaltend fester Tendenz



http://img.godmode-trader.de/charts/8/2005/4044.gif

[actr]

Sybase Reports 2005 Fourth Quarter and Year-End Results, Exceeding First Call EPS Consensus Estimates - Annual License Revenues Increase 6% Year-Over Year - Annual Mobile & Wireless Business Grows 23% Year-Over-Year

Jan 26, 2006 /PRNewswire-FirstCall via COMTEX/ -- Sybase, Inc. (NYSE: SY), a leading provider of enterprise infrastructure and wireless software, today reported financial results for the 2005 fourth quarter and year ended December 31, 2005.
For the year, total revenues increased 4% to $818.7 million from $788.5 million for 2004. Total license revenue for the year increased 6% to $291.7 million from $275.9 million in 2004. Pro forma operating income increased 11% to $148.9 million, representing 18% margin. Operating income calculated in accordance with generally accepted accounting principles (GAAP) for 2005 increased 36% to $121.9 million, representing 15% margin. Pro forma net income for the year increased to $117.8 million, or earnings per diluted share of $1.26. This compares with pro forma net income of $101.6 million, or earnings per diluted share of $1.04, for 2004. GAAP net income for 2005 increased to $85.6 million, or GAAP EPS of $0.92, compared with GAAP net income of $68.0 million, or GAAP EPS of $0.69 for 2004.

Total revenues for the fourth quarter increased to $223.0 million compared with $218.6 million for the fourth quarter of 2004. License revenues grew 5% to $91.3 million for the 2005 fourth quarter compared with $87.2 million for the same quarter a year ago.

Pro forma operating income for the 2005 fourth quarter was $50.2 million, representing 23% operating margin, compared with pro forma operating income of $51.6 million, or 24% operating margin, for the fourth quarter of 2004.

GAAP operating income for the 2005 fourth quarter was $43.4 million, representing 19% operating margin, compared with operating income of $34.4 million, or 16% operating margin for the fourth quarter of 2004.

Pro forma net income for the fourth quarter reached $42.0 million, or earnings of $0.45 per share on a diluted basis (EPS). This compares with pro forma net income of $38.5 million, or EPS of $0.40 for the 2004 fourth quarter.

GAAP net income for the 2005 fourth quarter was $28.4 million, or EPS of $0.31. This compares with GAAP net income of $24.1 million, or EPS of $0.25 for the fourth quarter of 2004.

Pro forma amounts exclude amortization of certain expenses including certain purchased intangibles, unearned stock-based compensation, and restructuring costs. Accompanying this release is a reconciliation of pro forma and GAAP amounts for the 2005 fourth quarter and year-end.

"We're very pleased with our performance for the year, which marks another solid year for Sybase. We achieved our financial objectives on revenue and EPS growth, margin improvement, and cash flow from operations, as promised at the beginning of the year," said John Chen, chairman, CEO and president of Sybase.

"Sybase benefited from strong growth in our mobile/wireless business and renewed growth in our database business," added Mr. Chen. "The mobile/wireless revenues increased 23% year-over-year, while the combined license revenue from our analytics engine, Sybase IQ, and our flagship database, Adaptive Server Enterprise, grew 9% in 2005.

"We're looking forward to continuing our strong performance in 2006," concluded Mr. Chen.

Balance Sheet and Other Data

At December 31, 2005, Sybase reported $865.3 million in cash and cash investments, including restricted cash of $5.4 million. The company generated $38.5 million in cash flow from operations in the fourth quarter and $170 million for the full year.

Sybase repurchased approximately $24.5 million worth of its stock during the 2005 fourth quarter. The company repurchased a total of $169.1 million worth of its stock in 2005. Approximately $59.6 million remains authorized in the company's current share repurchase program.

Days sales outstanding for the fourth quarter was 68 days.


About Sybase, Inc.

Sybase is the largest global enterprise software company exclusively focused on managing and mobilizing information from the data center to the point of action. Sybase provides open, cross-platform solutions that securely deliver information anytime, anywhere, enabling customers to create an information edge. The world's most critical data in commerce, finance, government, healthcare, and defense runs on Sybase. For more information, visit the Sybase Website: http://www.sybase.com.

[actr]

Phase III Medical Completes Acquisition of NeoStem, Inc., an Adult Stem Cell Company

MELVILLE, N.Y., Jan 26, 2006 (BUSINESS WIRE) -- Phase III Medical, Inc. (Phase III) (OTCBB: PHSM), has completed the acquisition of NeoStem, Inc., a company that specializes in the collection and storage of adult stem cells.
Pursuant to the terms of the acquisition, Phase III, through its wholly owned subsidiary, has purchased certain assets, properties and rights of NeoStem that relate to its adult stem cell collection and storage business in exchange for the issuance of 5,000,000 shares of the Company's common stock and the assumption of certain of NeoStem's liabilities.

Executives from NeoStem have joined with Phase III executives to form the management of the new enterprise, which will focus on the business of NeoStem, a commercial autologous (donor and recipient are the same) adult stem cell bank pioneering the pre-disease collection, processing and storage of stem cells that donors can access for their own present and future medical treatment. The new Company's objective is to be the leading provider of adult stem cells for therapeutic use in the burgeoning field of regenerative medicine, including treatment for heart disease, certain types of cancer and other critical health problems.

Mark Weinreb, President and CEO, Phase III, said, "We are extremely pleased to complete this acquisition and look forward to working hard in the coming year to drive growth and position our new Company for leadership in this critical new medical arena."

Larry May, previously CEO of NeoStem, Inc. and now a member of the Phase III management team, noted, "The merger of these two companies creates a company with great potential. The business knowledge and experience of Phase III management in the life science industry, combined with NeoStem's unique capabilities to collect and store adult stem cells, present an extraordinary opportunity to provide an important service in the emerging stem cell industry."

About Phase III Medical. Inc.

Phase III Medical, Inc. (OTCBB: PHSM), a Delaware corporation, is an innovative, publicly traded company that, through the acquisition of NeoStem, is positioned to become a leader in the adult stem cell field and to capitalize on the increasing importance the Company believes adult stem cells will play in the future of regenerative medicine. The management and board of directors and advisors of Phase III have collective experience in life science marketing, business management, and financial expertise, as well as significant technical, medical and scientific experience.

[actr]

Norfolk Southern Corp. reports 37 percent increase in profits

NEW YORK, Jan 26, 2006 (The Virginian-Pilot - Knight Ridder/Tribune Business News via COMTEX) -- Norfolk Southern Corp.'s outgoing chairman David Goode was anything but retiring Wednesday as he capped his nearly 14-year run as the railroad's top executive with record results, smashing the expectations of Wall Street. A beaming Goode eagerly jumped right into the Norfolk-based company's quarterly and annual financials, skipping his usual discussion of its safety record at what was his last quarterly meeting with rail stock analysts in midtown Manhattan. "By any standard, Norfolk Southern reported a remarkably strong performance in 2005," said Goode, who will be succeeded as the railroad's chairman by Wick Moorman on Wednesday. Norfolk Southern earned $362 million, or 87 cents per share, in the October-to-December quarter. That's up 37 percent from the same period last year when it made $264 million, or 65 cents per share. For all of 2005, Norfolk Southern earned $1.28 billion, or $3.11 a share, up nearly 39 percent from 2004's $923 million, or $2.31 a share. Results for both years include some one-time gains and charges but largely reflect the railroad's revenue growth and operating performance. The results easily exceeded the average expectations of analysts who had projected Norfolk Southern would earn 75 cents per share in the fourth quarter and $2.70 a share for the year, according to Nelson Information. The railroad's stock surged $1.84 to an all-time high of $47.64 a share in trading Wednesday on the New York Stock Exchange. "Great job on the quarter," Merrill Lynch analyst Ken Hoexter told the railroad's executives during a question-and-answer session after the presentation. Hoexter issued a report titled "Norfolk Southern Blows Past Targets" later Wednesday, reiterating his "buy" recommendation for the railroad's stock and crediting the railroad's strong revenue growth for the gains. Norfolk Southern railroad generated $2.26 billion in revenue for the quarter and $8.53 billion for all of 2005, increases of 16 percent and 17 percent , respectively. Much of the revenue growth came from increased rates the railroad is able to charge its customers, but volumes also grew. While revenue per unit jumped 13 percent for the year, volume was up 4 percent. The railroad experienced revenue growth across all its lines of business, led by a 22 percent gain in its coal-hauling franchise. Its so-called intermodal business -- the shipment of truck trailers and international shipping containers -- saw 19 percent revenue growth. The intermodal growth was driven in large part by shipments of containers inland from ports in Hampton Roads; Savannah, Ga.; New York and New Jersey, said Ike Prillaman, Norfolk Southern's vice chairman and chief marketing officer. International shipping lines are increasingly using East Coast ports for imports from Asia, Prillaman said. In its merchandise sector, Norfolk Southern's 13 percent revenue growth was driven by volume gains in its agricultural, paper, and metals and construction materials businesses, Prillaman said. However, volumes slipped in both its chemicals and automotive sectors. The chemical business was down because of disruptions caused by last year's hurricanes along the Gulf Coast, while the automotive decline reflects the domestic auto industry's troubles, Prillaman said. And, while its overall coal franchise is strong, driven by demand from electric utilities, its export coal business faltered in 2005 with shipments slipping 11 percent. Norfolk Southern serves coal export terminals in Norfolk and Baltimore. Demand from Europe and Asia for U.S. coal used in steel-making declined even as supply was constricted by production problem's at Consol's Buchanan mine in southwestern Virginia, Prillaman said. Even as Norfolk Southern beat Wall Street's best estimates, executives expressed some caution about 2006. Prillaman estimated that Norfolk Southern would lose between $35 million and $40 million of revenue from plant closings announced recently by Ford Motor Co. and General Motors Corp. Increasing diesel fuel costs, especially as the railroad phases out a price- hedging program, will prove a "headwind" in 2006, as will rising wage and benefit costs, said Henry Wolf, Norfolk Southern's vice chairman and chief financial officer. I mplementation of a new rule for accounting for stock options will result in about $20 million to $25 million in added compensation costs in the current quarter, Wolf said. Despite the cautionary words, Norfolk Southern officials remained optimistic about the economy and the railroad's opportunities. "I have every expectation that NS will continue to push ahead, and we will gain new business and margin expansion," said Moorman, the president and chief executive officer. Independent rail analyst Anthony B. Hatch of ABH Consulting in New York says Norfolk Southern will continue to take advantage of what he calls the railroad renaissance. "If you had told me that automotive and export coal were struggling, I would have assumed that the obstacles would have been too big to overcome for NS," Hatch said. He credits Goode and his team for transforming Norfolk Southern by adding a dimension of market savvy to what was an operationally and financially sound, yet old-school railroad. When Goode assumed the mantle of chairman in 1992, Norfolk Southern was a coal and merchandise carrier serving the Southeast. During his tenure he engineered the break-up of Conrail Inc.'s northeastern rail network with rival CSX Corp. after a contentious takeover battle. In the process, Norfolk Southern assumed billions of long-term debt and encountered operational difficulties, but Goode and his team managed the railroad through it. In the past two years, the railroad's stock has doubled as its results have steadily improved. Wednesday's "outstanding" announcement capped it off, Hatch said. "This has been a very good year," Hatch said. "These are flashy numbers from an 'unflashy' company." The numbers were f lashy enough to leave Moorman wondering how he's going to improve on them . "This quarter he's raised the bar to the point where I look up and my heart beats a little faster," Moorman said of the outgoing chairman. Goode will remain at the railroad through February, traveling to talk to and thank employees, he said. H e will serve out his term on the railroad's board, which ends in May. He is looking forward to some down time with his wife and two grown daughters after what he called an "intense" tenure as Norfolk Southern's chairman. He doesn't know what else retirement holds for him, but he said he has agreed to join the board of the Chrysler Museum of Art in Norfolk and another public company, though that has yet to be announced. Goode admits that passing the mantle to Moorman is bittersweet. However, "it's certainly fun to be able to retire with something like this," he said . Reach Chris Dinsmore at (757) 446-2271 or chris.dinsmore@pilotonline.com.
By Christopher Dinsmore

Copyright

[actr]

Baldwin Technology Q2 Net Income Up 75%

SHELTON, Conn., Jan 26, 2006 (BUSINESS WIRE) -- Baldwin Technology Company, Inc. (AMEX: BLD), a leading global manufacturer of press accessories and control equipment, announced today that net income for the second fiscal quarter ended December 31, 2005 rose 75% to $1,383,000, or $0.09 per diluted share, up from $788,000, or $0.05 per diluted share, from the comparable quarter last year. Currency translation negatively impacted quarterly net income by $208,000.
Net sales for the quarter were $43,826,000, compared to $41,232,000 for the second quarter last year, an increase of more than 6%. However, excluding the unfavorable effects of currency translation of $3,524,000 in the quarter, sales would have increased by close to 15%.

Net sales for the six months ended December 31, 2005 of $86,471,000 represented an increase of more than 6% from net sales of $81,229,000 for the six months ended December 31, 2004. Excluding the effects of currency translation, net sales grew by more than 11%. Year-to-date net income was $2,576,000, or $0.17 per diluted share, compared to $1,507,000, or $0.10 per diluted share, for the comparable six-month period in the prior year. The currency impact decreased year-to-date net income by $213,000.

Backlog at the end of the quarter was $51,580,000, essentially flat when compared to the level at September 30, 2005, but up approximately 7% from the beginning of the fiscal year.

Vijay C. Tharani, Vice President and CFO, commented, "Earnings improved significantly in comparison to the same quarter last year despite the loss of royalty income from expired patents. Our gross margin percentage improved by about 3% quarter over quarter, and our interest expense was less than half of the comparable quarter's figure of a year ago. I am particularly pleased with the strength of our top-line growth, which was approximately 15% excluding the effects of currency. In addition, our operating cash flows for the quarter were approximately $2,800,000."

President and COO Karl S. Puehringer, said, "The second quarter results reflected another strong business performance by Baldwin Technology. Printing markets worldwide continued to see steady, stable growth. At the same time, however, market dynamics are driving a growing need in the industry to aggressively reduce costs and improve press productivity. This translates into more demand for the type of process automation that Baldwin Technology's products provide the market."

Chairman and CEO Gerald A. Nathe added, "Our products and their benefits will be on display during the next several months at exhibitions such as Graphitec in France and IPEX in England as well as other shows in America and Asia. We remain optimistic about our business prospects, and we see additional opportunities in the global printing accessory and controls business."

Baldwin will review its second quarter results and discuss its business outlook during a conference call today beginning at 11 a.m. EST. Call-in information is available on the company's website at http://www.baldwintech.com under the Investor Relations section. Interested investors are encouraged to log onto the website and either participate in the call or access the webcast and replay of the call.

Participating in the call will be Baldwin Technology Chairman and CEO Gerald Nathe, President and COO Karl Puehringer and Vice President and CFO Vijay Tharani.

About Baldwin

Baldwin Technology Company, Inc. is a leading global manufacturer of press accessories and controls for the commercial and newspaper printing industries. Baldwin offers its customers a broad range of market-leading technologies, products and systems that enhance the quality of printed products and improve the economic and environmental efficiency of printing presses. Headquartered in Shelton, Ct., the company has sales and service centers, product development and manufacturing operations in the Americas, Asia and Europe. Baldwin's technology and products include cleaning systems, fluid management and ink control systems, web press protection systems and drying systems. For more information, visit http://www.baldwintech.com.

Investors may contact Frank Hawkins or Julie Marshall at (305) 451-1888 or e-mail info@hawkassociates.com. For an online investment kit, visit http://www.hawkassociates.com. An investment profile about Baldwin Technology may be found at http://www.hawkassociates.com/baldwin/profile.htm.

[actr]

AIG Edison Life Replaces Siebel With Onyx; Leading Japan-based Insurance Company Replaces Siebel With More Cost-effective Solution

BELLEVUE, Wash., Jan 26, 2006 (BUSINESS WIRE) -- Onyx(R) Software Corporation (Nasdaq: ONXS), a worldwide leader in customer management solutions for the enterprise, today announced that AIG Edison Life Insurance, a Tokyo-based division of American International Group, Inc. (NYSE:AIG), world leaders in insurance and financial services, has selected Onyx to support its ongoing Customer Relationship Management (CRM) strategy and business growth. AIG Edison Life is leveraging the Onyx Migration program, announced September 28, 2005, to replace a Siebel (Nasdaq: SEBL) implementation that had proven extremely costly to maintain.
"After considering our options, it was clear that AIG Edison had to re-address our CRM strategy. Our current CRM environment with our current vendor was requiring a lot of maintenance for every AIG Edison product change, and an upgrade to the latest supported web-based version was going to cost over one million dollars," said Tohru Futami, chief information officer of AIG Edison Life. "Thus, AIG Edison wanted to be able to leverage work being done by other projects in AIG Japan since Onyx was chosen as the standard in June 2004," continued Futami.

AIG Edison determined that an Onyx solution would provide the best integration with their current systems, a strong analytical tool set, and an architecture that would allow them to scale as they grow, at a cost effective price. "The Onyx solution will be seamlessly deployed into our existing architecture and require minimum resources to maintain. That's a very important consideration to AIG Edison Life as our CRM software needs to enable us to scale up to support our growing business. Onyx stood clearly above its competitors for AIG Edison Life -- it's the ideal solution for our needs," concluded Futami.

"Enterprise CRM customers like AIG Edison are naturally concerned with the future and ongoing costs of their existing CRM infrastructure in light of recent market events," said Todd Chambers, chief marketing officer of Onyx Software. "AIG Edison understands that Onyx provides them with an enterprise solution that will support them as they continue to grow."

About AIG

American International Group, Inc. (AIG), world leaders in insurance and financial services, is the leading international insurance organization with operations in more than 130 countries and jurisdictions. AIG companies serve commercial, institutional and individual customers through the most extensive worldwide property-casualty and life insurance networks of any insurer. In addition, AIG companies are leading providers of retirement services, financial services and asset management around the world. AIG's common stock is listed in the U.S. on the New York Stock Exchange and ArcaEx, as well as the stock exchanges in London, Paris, Switzerland and Tokyo. For more information visit www.aig.com.

About Onyx Software

Onyx Software Corporation (Nasdaq: ONXS) is a worldwide leader in customer management and process software for mid and large size enterprises. Onyx provides flexible solutions that enable organizations to automate, manage, and evolve their customer processes quickly and cost-effectively for strategic advantage. By providing an integrated suite of customer process automation applications encompassing customer management, process management, and analytics capabilities, Onyx enables enterprises to reduce costs, increase productivity and grow revenue. Major companies are aligning their customer-facing departments and managing their customer processes with Onyx software -- companies such as Amway Corporation, Mellon Financial Corporation, The Regence Group and State Street Corporation. More information can be found at 888-ASK-ONYX, info@onyx.com or http://www.onyx.com.

[actr]

LaCrosse Footwear Opens New Sourcing Office in China Focus on Improved Efficiency and Flexibility While Maintaining High Product Quality

PORTLAND, Ore., Jan 26, 2006 /PRNewswire-FirstCall via COMTEX/ -- LaCrosse Footwear, Inc. (Nasdaq: BOOT), a leading provider of branded work and outdoor footwear for expert users, announced the opening of its first sourcing office, located in Zhong Shan, China, in the heart of the Pearl River Delta manufacturing district.
The new China location offers a number of key benefits including: reducing LaCrosse's product development timelines; increasing the Company's ability to diversify its sourcing and improve the delivery of premium-quality footwear; and allowing for closer monitoring of the production process to comply with the Company's high quality standards. Approximately 20% of LaCrosse Footwear's manufacturing takes place in its US facility and 80% in China.

"We are continually striving to improve our efficiency, product quality and the reliability of our manufacturing base," said Joseph P. Schneider, President and CEO. "We also see the ability to develop products quickly and efficiently as key to being competitive in today's ever-changing marketplace. The opening of our China office is a significant step for us in our long-term strategy to become a global leader in premium, branded footwear."

"We are also thrilled to have Steve Schneider overseeing our Asian operations as Country Manager. Steve brings a wealth of expertise as a long-time footwear professional with extensive experience developing and manufacturing rubber and leather footwear in Asia."

About LaCrosse Footwear

LaCrosse Footwear is a leading developer and marketer of branded, premium and innovative footwear for expert work and outdoor users. The Company's trusted Danner(R) and LaCrosse(R) brands are distributed domestically through a nationwide network of specialty retailers and distributors, and internationally through distributors in Asia and Europe. Work customers include people in law enforcement, agriculture, firefighting, construction, industry, military services and other occupations that need high-performance and protective footwear as a critical tool for the job. Outdoor customers include people active in hunting, outdoor cross training, hiking and other outdoor recreational activities. For more information about LaCrosse Footwear products or to locate a dealer, please visit our Internet websites at www.lacrossefootwear.com, www.danner.com, www.firetechboots.com and www.lacrossesafety.com. For additional investor information, see our corporate website at www.lacrossefootwearinc.com.

[actr]

L-3 Communications Link Simulation and Training Division Awarded $33.4 Million Option to Build AVCATT Helicopter Training Systems

NEW YORK, Jan 26, 2006 (BUSINESS WIRE) -- L-3 Communications (NYSE: LLL) announced today that its Link Simulation and Training (Link) division has been awarded a $33.4 million follow-on production contract to build four additional U.S. Army Aviation Combined Arms Tactical Trainer (AVCATT) suites.
Under this award Link will be building the twelfth, thirteenth, fourteenth and fifteenth AVCATT suites ordered by the U.S. Army to date. These four AVCATT suites will be delivered during 2007. The U.S. Army currently has plans to acquire 23 AVCATT trainer suites. Link has been prime contractor on AVCATT since the program's award in 1999 and is providing both the U.S. Army and U.S. Army National Guard with helicopter training systems that support realistic, high-intensity virtual combat training.

"Award of this new production option closely coincides with positive reports coming from our U.S. Army and U.S. Army National Guard users as to how AVCATT systems are better preparing aviators to execute company-level missions involving a wide range of helicopter assets in a high threat environment," said Lenny Genna, vice president of U.S. Army programs for Link. "We are very pleased to have received this contract option and look forward to continuing to deliver AVCATT training suites that help prepare Army aviators to succeed on the battlefield."

AVCATT's networked training capability includes the ability to be interoperable with the U.S. Army's Close Combat Tactical Trainer system, the service's currently fielded mechanized armor training system. This interoperable combined arms training capability provides an unprecedented level of training realism, involving both simulated air and mechanized armor vehicle forces.

AVCATT suites consist of two mobile 53-foot trailers that house six reconfigurable simulators, a battle master control room and an after-action review theater. The AVCATT simulators can be reconfigured to represent any combination of AH-64D, AH-64A, OH-58D, UH-60 and CH-47D platforms.

During a simulated AVCATT exercise, commanders can mix and match rotary wing platforms to best support the training objective. Friendly and opposing intelligent semi-automated forces, communications degradation, adverse weather effects and visual, infrared and radio frequency clutter all contribute to AVCATT's ability to support realistic training.

AVCATT's battle master control station, home to the battle master, training unit observer controller, semi-automated force controller and role players, provides the capability to monitor and record each unit's mission performance. Four role player stations in the battle master control room enable individuals to serve as artillery, joint air support, ground, engineer or logistics force commanders.

When a mission is completed, the recorded data and video is presented in the after-action review theater. During this mission debrief, aircrews review their performance and determine which skills or tactics need to be further honed. The after-action review theater can also be used to view training in progress.

Link Simulation and Training is a systems integration organization that delivers and supports training systems and equipment to enhance operational proficiency. Link's services include conducting front-end analysis, program design, simulator design and production and field support. Link has major operations in Arlington, TX, and other key bases of operation in Binghamton, NY; Orlando, FL; Broken Arrow, OK and Phoenix, AZ.

Headquartered in New York City, L-3 Communications is a leading provider of Intelligence, Surveillance and Reconnaissance (ISR) systems, secure communications systems, aircraft modernization, training and government services. The company is a leading merchant supplier of a broad array of high technology products, including guidance and navigation, sensors, scanners, fuzes, data links, propulsion systems, simulators, avionics, electro optics, satellite communications, electrical power equipment, encryption, signal intelligence, antennas and microwave components. L-3 also supports a variety of Homeland Security initiatives with products and services. Its customers include the Department of Defense, Department of Homeland Security, selected U.S. Government intelligence agencies and aerospace prime contractors.

[actr]

Teryl Resources Corp. Announces New Gold Targets Located by the 2005 Exploration Activities on the Gil Joint Venture

FAIRBANKS, Alaska, Jan 26, 2006 (BUSINESS WIRE) -- Teryl Resources Corp. (TSX VENTURE:TRC)(Pink Sheets:TRYLF) is pleased to announce an exploration update for the Gil Joint Venture as follows:
Exploration Introduction

The objective of the 2005 Gil Venture exploration program was to generate new gold targets by integrating geologic and geochemical information with newly acquired geophysical data. Work by Fairbanks Gold Mining Inc./Kinross Gold consisted of an update of the geologic database and a high-resolution electromagnetic (HEM) airborne geophysical survey.

The database update began in January and continued intermittently throughout the year. Work focused on revising soil sample locations using updated GPS coordinates, compiling data for geologic map production and revising the resource model. Additional database work is planned for the first quarter of 2006.

In July, Fugro Airborne Surveys Inc., under contract to Fairbanks Gold Mining Inc./Kinross Gold, initiated an HEM airborne geophysical survey of the area. HydroGeophysics Inc. interpreted the geophysical data and identified several targets within the Gil Joint Venture claim block. Additional geophysical analysis is scheduled for 2006.

In July of 2005, Hydrogeophysics Inc. (HGI) delivered an interpretation map with recommendations for geological and geophysical follow-up based on the low resolution geophysical data. Two target areas were identified and recommended for further geologic and geophysical investigation within the Gil Joint Venture area. These targets are as follows:

1) Last Chance Creek

This target occurs on a shear zone approximately 3.1 miles east and 1.2 miles south of the Fort Knox Mine in close proximity to the south end of an interpreted intrusive. The claims in this area are part of the Gil Joint Venture or are held by Fairbanks Gold Mining Inc.

2) Too Much Gold Creek

The Too Much Gold Creek target lies on a shear located on the west edge of an intrusive approximately 6.2 miles east and 1.8 miles north of the Fort Knox Mine. This target is largely located within the Gil Joint Venture, although a portion lies in the Fish Creek Claims. The Fish Creek claims are 50% owned by Linux Gold Corp. and optioned to Teryl Resources Corp., but are not part of the Joint Venture.

The final interpretation was completed on December 16th, 2005 and outlined six areas of interest within or partially within the Gil Joint Venture. Drill holes for three of these target areas were proposed within the Gil Joint Venture.

Gil Joint Venture Recommendations

The goal of the 2006 Gil Joint Venture exploration program should initially focus on completing an overall update of the database. This would include the production of new geologic and geochemical maps. Fieldwork should consist of mapping and sampling across interpreted geophysical and geochemical anomalies. This updated information could then be integrated with the geophysical data to further define existing exploration targets or generate new targets in the Gil Joint Venture claim block.

About Teryl Resources Corp.

With interests in four gold properties, Teryl Resources Corp. is one of the main landowners in the Fairbanks Mining District, Alaska. The Gil project is a joint venture (80% Kinross/20% Teryl) with Kinross Gold Corporation (TSX: K; NYSE: KGC). The Company's holdings also include the Fish Creek Claims, 50% optioned from Linux Gold Corp. (OTC BB: LNXGF), and the Stepovich Claims, where Teryl has a 10% net profit interest from Kinross. The Company also has a 100%-interest in the West Ridge property, and has obtained a mining lease on the adjoining Fox Creek Claims. Teryl Resources Corp. also has one joint venture silver prospect located in Northern BC, Canada. For further information visit the Company's website at http://www.terylresources.com.

[actr]

Bush kritisiert GM und Ford

In Detroit ist die Stimmung trübe. Die Automobilindustrie steckt in einer schweren Krise, allein in dieser Woche hat man etwa 35 000 Entlassungen bei Ford und DaimlerChrysler und einen Verlustvon 5 Milliarden Dollar bei GM gemendet. Und jetzt kommt auch noch Schelte aus Washington, wo man eigentlich Hilfe erwartet hatte.

Seit langem nämlich versuchen General Motors und Ford, die Milliardenlöcher in ihren Pensionskassen vom Steuerzahler auffüllen zu lassen. Und dank guter Beziehungen zu Bush & Co. war das gar kein allzu gewagter Gedanke. Zwar verhandeln die Unternehmen weiter mit der Gewerkschaft über Zugeständnisse von Mitarbeitern und Pensionären sowie eine künftige höhere Eigenbeteiligung an der Krankenversicherung, doch war die Notlösung Washington immer ein durchaus realistisches Szenario.

Nun die Absage. „Statt in Washington auf Hilfe zu hoffen, sollen die einfach bessere Autos bauen“, knurrt Präsident George W. Bush nach Informationen des Wall Street Journal. Das sind ganz neue Töne gegenüber der Industrie. Doch trifft Bush ausnahmsweise einmal den Nagel auf den Kopf. Kritische Experten sagen schon lange, dass ein Auto-Hersteller nicht nur wegen hoher Pensionsverpflichtungen in Schwierigkeiten sein kann, sondern immer auch weil er nicht genug Autos verkauft.

In den Sorgen um Renten und Versicherungen, Bilanzen und Entlassungen haben GM und Ford längst ihr Kerngeschäft vergessen. Aktuelle Umfragen vom Marktforscher J.D. Powers zeigen das. Das Institut führt seit Jahren Statistik über die Zuverlässigkeit aller möglichen Modelle und notiert, welcher Wagen in den ersten drei Jahren wie oft zur Reparatur muss.

Eines vorweg: Die Amerikaner haben sich in den letzten beiden Jahren gegenüber der japanischen Konkurrenz durchaus verbessert. Im Luxus-Segment, zum Beispiel, fahren die Detroit-Marken Lincoln, Cadillac und Buick nur knapp hinter Porsche und Lexus und haben die teuren Serien von Toyota ebenso abgehängt wie die Luxustöchter Infiniti von Nissan und Acura von Honda.

Unterhalb der Oberklasse sieht es weniger gut aus, da fahren GM und Ford im internationelen Vergleich nur im Mittelfeld mit.

Fast durchweg enttäuschend fallen allerdings Verbraucherumfragen aus, die J.D. Powers neben den Wartungsstatistiken führt. In der Meinung der Verbraucher kommen die amerikanischen Marken deutlich schlechter Weg als Toyota und Subaru, und selbst die technisch etwas abgeschlagene Markt Suzuki bekommt in vielen Kategorien besere Noten.

Die Diskrepanz beruht größtenteils darauf, dass Autofahrer längst andere Schwerpunkte setzen als die Unternehmen. Die bauen zwar sicherere Autos als früher, konzentrieren sich sonst aber eher auf Zubehör und bessere Ausstattung statt auf wesentliche Dinge wie den Motor. Der verbraucht bei GM und Ford noch immer mehr als bei den Asiaten, und in Zeiten hoher Benzinpreise ist das ein schlagendes Argument für oder gegen den Kauf eines Autos – das zeigt nicht zuletzt die unterdurchschnittliche Bewertung der GM-Luxuskiste Hummer, der übelsten Spritschleuder auf amerikanischen Straßen.

Laut einer aktuellen Statistik der US-Umweltministeriums EPA verbaucht der durchschnittliche Kleinwagen bei GM 7,6 Liter auf 100 Kilometer, bei Ford ganze 8,6 Liter. Das Vergleichsmodell kommt bei Toyota mit 6,6 Litern und bei Honda mit 6,2 Litern aus. In der Mittelklasse sieht es nicht anders aus, und erst bei Kleinbussen und SUV gleichen sich die Zahlen etwas an, immer noch mit einem Vorteil für die Asiaten.

Ein weiteres Problem für US-Wagen sind die zahlreichen Rückruf-Aktionen. Sorgfältiges Arbeiten und bessere Kontrollen bei Zulieferern hätten GM und Ford in den letzten Jahren hunderte Millionen Dollar gespart und das Image bewahrt. Das nämlich leidet auch unter einer Rückrufaktion, wenn nur ein kleines, noch so bedeutungsloses Plastikteil ausgetauscht werden muss. Ein Grund mehr für GM, sich bei den Verhandlungen mit dem wichtigsten Zulieferer Delphi auf das Wesentliche zu konzentrieren. Das dürfte jetzt aber auch leichter fallen, denn der verlockende Ausweg nach Washington scheint nun erst einmal blockiert zu sein.

Lars Halter

[actr]

Maritime Disaster

By Lawrence Carrel
January 26, 2006


--------------------------------------------------------------------------------
Brunswick Corporation (BC1)

--------------------------------------------------------------------------------
Share price as of Wednesday's close: $41.44
Share price now: $36.04
Change: -13.0%
Volume: 6.9 million shares, daily average 677,000 shares
Last time this low: Oct. 27, 2005
52-week high: $49.77
52-week low: $35.00
Forward P/E before announcement: 11.2 (based on $3.70 a share)
Forward P/E after announcement: 10.8 (based on $3.35 a share)

--------------------------------------------------------------------------------

INVESTORS WERE IN no mood to go down with this ship maker.
Despite a 52% increase in Brunswick's (BC2) fourth-quarter profits, shares of the manufacturer of pleasure boats, bowling balls and billiards tables slipped 13% to $36.04 on Thursday. Wall Street was put off by the Lake Forest, Ill., company's disappointing outlook for 2006, which placed earnings well below analysts' expectations.

"We see nothing which indicates retail demand across the marine industry will be anything but flat with 2005," said Dustan McCoy, Brunswick's chairman and chief executive, in a written statement. "In fact, there could be downward pressures on marine retail demand driven by economic weakness in certain markets such as the Midwest."

Fourth-quarter earnings swelled to $88.3 million, or 90 cents a share, from $58.8 million, or 59 cents, in the year-ago quarter. Excluding a one-time tax benefit, Brunswick posted earnings of 73 cents a share, a penny better than the Thomson First Call consensus estimate. Revenues increased 12% to $1.49 billion.

But 2006 guidance drenched shareholders. The company said it would earn 56 cents to 60 cents a share in the first quarter; analysts were looking for 73 cents. For the full year, Brunswick said sales would increase 6% to 8% and earnings would stay mostly flat, totaling $3.25 to $3.45 a share. The sales guidance was in-line with analysts' forecasts, but the earnings outlook wasn't even close. First Call's consensus stood at $3.88 a share.

Brunswick sells an array of leisure and fitness products including yachts, marine engines, Life Fitness and Hammer Strength home gyms, billiard tables, bowling gear and more. In 2005 boats contributed 47% of total sales and marine engines, 45%. The company's new technologies division sells things like satellite-based navigation systems and software for marine dealers.

Brunswick said all of its business segments contributed to its fourth-quarter sales gain, led by strong performances from boat brands Sea Ray, Boston Whaler, Bayliner and Hatteras. By segment, fourth-quarter sales increased by 8% within the marine engine division, 19% in boats, 2% in fitness equipment, and 5% in billiard and bowling. Acquisitions helped, too, contributing half the sales increase. Operating margin for the quarter improved by half a percentage point to 6.8%.

The country's No. 1 boat maker by sales said it expects to post low- to midsingle digit sales growth for 2006 in its marine businesses on a combination of pricing, new products, 2005 acquisitions, share gains and growth in international markets. In its nonmarine businesses, fitness equipment sales are expected to increase in the high-single digits, and bowling and billiards sales, in the midsingle digits. The company said its new technologies division would "continue its fast-paced growth." In 2005 the unit's sales surged 76%.

"We're looking for 2006 [industry] sales to be very similar to 2005, flat in units but dollars up in the midsingle digits," says Thom Dammrich, president of the Chicago-based National Marine Manufacturers Association, a trade group representing 1,600 boat manufacturers. "Sales have been flat for a couple of years. The economy is growing, but the growth is expected to moderate and interest rates are going higher. We are being cautious because we don't know what will happen with oil prices. If everything goes our way, then this estimate will be conservative." McCoy, Brunswick's recently appointed CEO, is a member of the association's 32-member board of directors.

The disappointing forecast for Brunswick adds to investor unease over the December departure of CEO George Buckley. Analysts call Buckley a visionary who transformed the boating industry during his five years at the helm of Brunswick. Several say it was Buckley's skill with brand-building and technology that led industrial giant 3M (MMM3) to lure him to a CEO post there.

Quote:
"We believe the story has changed significantly — what is in part an ongoing turnaround story involving a 'reinvention' of the boating industry was supposed to drive significant margin expansion and earnings growth, and it appears that will not be the case this late into cycle," wrote Goldman Sachs analyst Jonathan Shapiro in a Thursday note downgrading the stock to Neutral from Outperform. "We do not believe investors were paying for top-line acceleration. That said, without margin expansion and with a potential slowdown in U.S. consumer [spending] not even in the numbers, we believe it is difficult to make a compelling argument for owning the shares." (Goldman Sachs has an investment-banking relationship with Brunswick.)

[actr]

Patriot Capital Funding Closes $9.15 Million ``One Stop'' Financing in Support of the Acquisition of Sidump'r Trailer Company by Gemini Investors and Timepiece Capital

WESTPORT, Conn., Jan 27, 2006 (BUSINESS WIRE) -- Patriot Capital Funding, Inc. (Nasdaq: PCAP), a specialty finance company providing customized financing solutions to small- and mid-sized companies primarily in transactions initiated by private equity sponsors, today announced that it closed a $9.15 million "one stop" financing in support of the acquisition of Sidump'r Trailer Company ("Sidump'r") by Gemini Investors and Timepiece Capital. Sidump'r is a leading manufacturer of proprietary, patented bi-directional side dump trailers, primarily for the road construction, quarry and general construction industries.
"With a clear focus on the lower middle market, Gemini Investors and Timepiece Capital are a great fit for Patriot Capital Funding, and we are excited to be working with them on this transaction," said Richard Buckanavage, President and CEO of Patriot Capital Funding.

About Patriot Capital Funding, Inc.

Patriot Capital Funding, Inc. (www.patcapfunding.com) is a specialty finance company providing customized financing solutions to private equity sponsors focused on making investments in small- to mid-sized companies. Patriot Capital Funding typically invests in companies with annual revenues between $10 million and $100 million, and which operate in diverse industry sectors. Investments usually take the form of senior secured loans, junior secured loans and subordinated debt investments - which may contain equity or equity-related instruments. Patriot Capital Funding also offers "one-stop" financing, which typically includes a revolving credit line, one or more senior term loans and a subordinated debt investment. Patriot Capital Funding also makes equity co-investments up to $2.0 million.

[actr]

Apollo Gold Closes Previously Announced US$3.5 Million Private Placement with Jipangu Inc.

DENVER, Jan 27, 2006 (CCNMatthews via COMTEX) -- Apollo Gold Corporation ("Apollo" or the "Company") (TSX: APG) (AMEX: AGT) is pleased to announce the closing of the US$3.5 million private placement with Jipangu Inc. on January 26, 2006, which the Company previously announced in its press release issued November 21, 2005. After giving effect to the closing, Jipangu owns 21,650,000 Apollo common shares, representing 18.2% of Apollo's issued and outstanding common shares, based on 119,106,451 common shares outstanding as of the close of business on January 26, 2006. In addition, Jipangu may be deemed to beneficially own an additional 2,000,000 common shares of Apollo, which are issuable upon exercise of the warrants Jipangu purchased in the private placement.
Mr. R. David Russell, Apollo's President and CEO, stated: "We are pleased to complete the closing of the private placement with Jipangu. Following completion of this closing, we will continue to focus our efforts on the Black Fox exploration and development program, which continues to exceed our expectations with high-grade gold intercepts and continued demonstration of continuity. The Company expects to release an updated Black Fox project NI 43-101 report in the first quarter of 2006, which we expect will outline both open pit and underground gold reserves. In addition, we expect to complete the Black Fox project feasibility study in the third quarter of 2006."

Black Fox Project

The Black Fox project is located along the Destor-Porcupine fault system within the Abitibi Greenstone Belt, a world-class mining district that has yielded over 75 million ounces of cumulative gold production from renowned mines such as the Dome, Hoyle Pond, Hollinger, Holt McDermott and Harker Holloway. Black Fox was acquired by Apollo in late 2002 during a period of depressed metal prices as part of a strategic plan for the Company to explore and develop high-grade gold assets to replace its older and lower-grade producing properties.

Apollo Gold Corporation

Apollo Gold is a gold mining company with a mine in Montana, the Black Fox advanced stage development project in Ontario, Canada, and the Huizopa Project an early stage exploration project in the Sierra Madre Gold Belt in Chihuahua, Mexico.

Jipangu Inc.

Jipangu is a Tokyo-based gold mining and exploration company that also invests in companies that explore for and produce gold. Wellington West Capital Markets is acting as financial adviser to Jipangu in connection with the private placement.

[actr]

P&G Delivers Results Above Expectations - Raises Fiscal Year Outlook Strong Sales Growth on P&G and Gillette Drives Higher EPS Results

Jan 27, 2006 /PRNewswire-FirstCall via COMTEX/ -- The Procter & Gamble Company (NYSE: PG) announced earnings per share for the October - December quarter of $0.72. Earnings growth was driven by strong sales growth on P&G and Gillette businesses. P&G's organic sales increased eight percent behind broad-based increases across all business units and geographies. Organic sales exclude the impact of acquisitions, divestitures, and foreign exchange. Reported net sales, which include the addition of the Gillette business, increased 27 percent.

Executive Summary

- Unit volume grew 27 percent. Organic volume, which excludes

acquisitions and divestitures, increased six percent. Organic volume

increased across every segment and every region.